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Portfolio Abstract 
Background: Involvement with psychotropic medication is not traditionally 
viewed as an aspect of the clinical psychologist’s job, and there are currently no 
professional guidelines advising on a role. International research suggests that 
psychologists are likely to encounter a variety of opportunities to become 
involved, and are frequently (indirectly) involved in the process of prescribing 
and managing of clients’ psychotropic medications. There is a lack of research 
into psychologists’ involvement with psychotropic medication in the United 
Kingdom (UK), but given the widespread use of psychotropic medication similar 
opportunities and practice may occur. The collective clinical psychology 
profession is also taking an increased stance against biological approaches 
towards mental health, such as issuing guidance on use of diagnosis and 
promoting movement away from its use. The question remains as to whether 
the professional movement with diagnosis extends into any role with 
psychotropic medication, be this a critical stance or any other. 
 
Aims: This study aimed to explore whether clinical psychologists in the UK 
have a role with their client’s psychotropic medication by exploring forms of 
involvement undertaken, and decision-making behind involvement. 
 
Method: A mixed method design was employed; 147 clinical psychologists took 
part in an online survey, and 11 respondents were interviewed. Descriptive 
statistics, logistic regression, and thematic analysis were used to analyse the 
quantitative and qualitative data respectively. 
 
Results: Results suggest that clinical psychologists are engaging in various 
forms of involvement with medication on a regular basis, often with intent to 
influence prescribing based on their agendas. A thematic map was created 
identifying a process by which clinical psychologists weigh up factors prior to 
deciding to have involvement in order to establish their rationale, and then 
flexibly navigate their approach and actions. This all occurs within the context of 
professional uncertainty and conflict, under dominant societal narratives around 
epidemiology of mental health difficulties and the effectiveness of medication. 
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Following involvement, participants reflected on their strategy which led them to 
consider future approaches. 
 
Conclusions and Recommendations: Findings echo previous international 
research; clinical psychologists recruited in the study are regularly engaging in 
roles with their client’s psychotropic medication. This is despite lack of guidance 
from professional bodies, no professional position statement, and minimal (or 
no) teaching during training. To the author’s knowledge this is the first study to 
explore the topic area within the UK. Study findings are considered important 
due to uncovering the extent to which involvement forms part of the role, which 
was previously unknown. Findings translate into two main clinical implications: 
1) supporting the idea of training on psychotropic medication for clinical 
psychologists, and 2) professional guidance to inform clinical psychologists’ 
practice. 
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Clinician and Service User Perspectives of Shared Decision Making 
Interventions in Mental Health Services: A Meta-Ethnographic Synthesis 
 
Amy Aston and Danielle De Boos 
Trent Doctorate in Clinical Psychology, Universities of Lincoln and Nottingham 
 
Abstract 
Background. Shared Decision Making (SDM) is an emerging area of research 
in mental health. The SDM model is defined as a collaborative process between 
a client and a practitioner whereby both parties bring their own expertise in 
order to arrive at a healthcare decision. 
Aims. The aim of this review was to identify, appraise, and synthesize the 
current qualitative literature exploring health clinician and service user 
perspectives of SDM interventions used in mental health settings. 
Methods. A comprehensive systematic search of the literature was conducted. 
Six qualitative and two mixed method studies met the inclusion criteria. An 
appraisal tool was used to assess their quality, and a meta-ethnographic 
approach was used to synthesize the data extracted. 
Results. Third order themes centred around: barriers to facilitating SDM, the 
notion of power, and the therapeutic relationship. Particular clinician barriers 
were identified, alongside a shared difficulty in adjusting the power balance. 
Conclusions. SDM interventions may be effectively implemented by supporting 
clinicians via training and supervision, emphasizing the importance of 
establishing an initial relationship and ‘setting the scene’ for SDM, and focusing 
on dialogue to build the therapeutic relationship. 
Declaration of Interest. No conflict of interest reported. 
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Background 
Shared Decision Making 
Various models of the clinician-patient relationship have been proposed, each 
with differing degrees of power located with the patient. The paternalistic model 
which has traditionally been the dominant model in healthcare (Duncan, Best, & 
Hagen, 2010) proposes that the power and responsibility lies with the clinician, 
who will take the lead in healthcare decisions. The informed decision making 
model contrasts this in that the clinician acts solely as a source of information, 
and all decision making capacity lies with the patient (Shepherd, Shorthouse, & 
Gask, 2014). The shared decision making (SDM) model is proposed as a 
middle ground between the two. It is defined as a collaborative process 
between a client and a practitioner whereby both parties bring their own 
expertise in order to exchange information, clarify values, and work together to 
arrive at a healthcare decision (Charles, Gafni, & Whelan, 1997).  
 
Shared Decision Making within Mental Health 
SDM is increasingly advocated as an ideal model of treatment decision making 
in healthcare (Duncan et al., 2010). To date, SDM has primarily focused on 
physical health, particularly in primary care settings (Barry & Edgman-Levitan, 
2012; Davis et al., 2003). There is a growing awareness however of the need 
for SDM to extend in to mental healthcare (Stacey et al., 2016). In the United 
Kingdom, policy framework within mental health has shifted with the aim to 
reassess the role of the ‘patient’ within their own care. This follows movements 
advocating an increase in service user choice such as within consumerism 
models of healthcare and the mental health service user movement 
(Department of Health, 2001, 2012). Research also suggests that those who 
meaningfully participate in treatment planning are more likely to meet their 
treatment goals and be satisfied with services (Bassman, 1997; Liberman, Hilty, 
Drake, & Tsang, 2001; Roth & Crane-Ross, 2002). SDM in mental healthcare is 
therefore an emerging area of research and an idealised treatment approach, 
as recognised in National Institute of Health and Care Excellence (NICE) 
guidelines for mental health conditions (termed ‘patient-centred care’) and as 
demonstrated by an increase in ‘decision aids’ within the National Health 
Service (National Health Service, 2016). 
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Shared Decision Making Interventions 
Research focusing on SDM has highlighted obstacles such as: time constraints, 
limited service user interest, (Légaré & Witteman, 2013), limited staff agreement 
and motivation (Légaré, Ratté, Gravel, & Graham, 2008), and presumption of 
roles (Joseph-Williams, Elwyn, & Edwards, 2014). The focus of much research 
has been to consider how SDM is experienced within everyday practice (e.g. 
Eliacin, Salyers, Kukla, & Matthias, 2014; Chong, Aslani, & Chen, 2013). There 
has been an increase in adopting an active approach to SDM however in the 
form of specific interventions, with an aim to overcome these barriers. As the 
concept of SDM as an intervention is in the early stages, there is no current 
method of best practice and services are therefore approaching this by using 
experimentation and creativity. Examples include: mobile phone decision aid 
applications, computer-based programs, and peer-led support centres (Deegan, 
Rapp, Holter, & Riefer, 2008; Korsbek & Tønder, 2016). Charles et al. (1997) 
proposed specific criteria in order for information exchange to qualify as SDM, 
which have been widely acknowledged in SDM research (Duncan et al., 2010). 
The current review has considered these in terms of inclusion criteria (Appendix 
A).  
 
A Cochrane review (Duncan et al., 2010) assessed the effects of SDM 
interventions for people with mental health conditions, but as only two studies 
were found to meet inclusion criteria it was not possible to draw any firm 
conclusions on the efficacy of the interventions. There is a growing body of 
qualitative literature exploring how both clinicians and service users experience 
these interventions. This is important as qualitative research is acknowledged 
as vital in evidence based healthcare as it represents consumers experiences 
and provides a voice outlining preferences and priorities (Evans, 2002).  
 
Aims of the Present Review 
To explore the perspectives of individuals who have experienced SDM 
interventions a review of the existing literature was undertaken using a meta-
ethnographic approach. The overall aim of this review was to respond to the 
question: “What are clinician and service user experiences of engaging with 
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SDM interventions?”. Qualitative research aims to seek detailed complex 
interactions and allows the researcher to explore the experiences of meanings 
in context (Joffe, 2011). Meta-ethnography is an interpretative approach that 
aims to synthesise findings across qualitative studies to provide a higher level of 
analysis and new research questions. We anticipated that synthesizing the 
perspectives of two groups would facilitate comparisons, and lead to a 
foundation from which to move forward with SDM interventions in mental 
healthcare.  
 
Methods 
The review comprised three stages: a systematic search of the literature, critical 
appraisal of included studies, and a meta-ethnographic synthesis as described 
by Noblit and Hare (1988). 
 
Searching 
The following electronic social science and medical databases were searched: 
PsycINFO (1806-present), Medline (1996-present), Cumulative Index of Nursing 
and Allied Health Literature (CINAHL; 1981-present), SCOPUS (1960-present), 
EMBASE (1980-present) and Web of Science (1900-present). Supplementary 
searches were also conducted to increase the comprehensiveness of the 
search and to minimise the risk of excluding relevant papers including 
perspectives (Evans, 2002). This included ‘grey literature’ databases (Opengrey 
and Ethos), British Psychological Society publications, and a free text Google 
Scholar search. Reference lists of included papers were also hand searched.  
 
Previous reviews on SDM have advocated using a simple search of the phrase 
“shared decision making” in titles and abstracts (Makoul & Clayman, 2006; 
Shay & Lafata, 2015). This was felt to contain risks of accidental exclusion, 
therefore a comprehensive search strategy was created. Terms were derived 
following scoping searches and consideration of search terms used in similar 
reviews. The following terms were used both singularly and in combination, and 
exploded as appropriate to each database: - 
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Shared decision making, shared decision making model, decision aid*, decision 
making, decision support technique*, treatment decision making, mental health, 
mental health service*, mental health condition*, mental health disorder*, 
mental illness, emotional disorder*, perspective*, perception*, attitude*, 
opinion*, experience*, view*, belief*, involvement, account*, response*, 
understanding, qualitative, qualitative research. 
 
Inclusion and Exclusion Criteria 
Studies were required to include (1) a shared decision making intervention that 
was implemented within a mental health service, and (2) the perspectives (e.g. 
attitudes, views, opinions) of clinicians and/or service users who had been 
involved in the intervention. The term ‘clinician’ is inclusive to a variety of 
professions and perspectives of clinicians were not excluded based on their 
profession. There were no exclusion criteria based on characteristics of service 
users, and papers including perspectives of both health clinicians and service 
users were included. Mixed method studies with a qualitative component were 
also included.  
 
Studies were included based on the following criteria: - 
1) Study reported carrying out an intervention specifically aimed towards 
SDM 
2) Intervention was conducted in a mental health setting 
3) Included the first hand perspectives of either a clinician or service user 
who experienced the intervention 
4) Use of a qualitative method for data analysis 
5) Written in the English language 
Studies were excluded based on the following: - 
1) The intervention did not meet the SDM criteria as outlined by Charles et 
al. (1997) 
2) The study explored aspects of SDM in treatment as usual 
3) SDM intervention was for a physical health condition 
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Selection 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement was used to outline article selection (Moher, Liberati, 
Tetzlaff, & Altman, 2009) as presented in Figure 1. Following the search 
process, duplicates were removed and abstracts were screened against the 
inclusion criteria. The remaining full text articles were then screened against 
exclusion criteria. 
 
Figure 1. PRISMA diagram 
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Data Abstraction 
The synthesis process was informed by Noblit and Hare’s (1988) meta-
ethnographic seven-phase approach. This interpretative form of synthesis aims 
to propose a new level of understanding, as opposed to integrative reviews 
which provide “a basic comparability between phenomena” (Noblit & Hare, 
1988, p.15). The studies were read, re-read, and the relevant data was 
extracted using a data extraction tool in order to inform the quality appraisal and 
synthesis process.  
 
Meta-ethnography consists of three synthesis methods: translating 
themes/concepts from one study to another (reciprocal translations), 
considering the implied relationship between contradictory findings (refutational 
analysis), and reflecting on the synthesised information to interpret the findings 
as a ‘whole’ (line-of-argument synthesis). The synthesis in the present review 
did not incorporate refutional translations as despite different outcomes, findings 
pointed towards mutual conclusions.  
 
Reflexivity 
The product of qualitative research is invariably shaped by the researcher and 
their position on the given subject. During the process of meta-ethnography, the 
analyst is translating studies into their own world view (Noblit & Hare, 1988) 
therefore transparency is considered fundamental for good quality qualitative 
synthesis (Finlay, 2006). The primary author’s interest in SDM stems from past 
work experience whereby service users’ opportunity for decision making was 
not always apparent. This resulted in observed coercion and disempowerment 
for service users, and translated into a desire to increase service user 
collaboration and involvement in decision making. To minimise bias placed on 
clinicians for not allowing SDM to occur (given past experience) attention 
focused on the interpretation of why SDM may have been unsuccessful, rather 
than fixating on where blame may lie. 
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Results 
From the initial 1,514 records identified, 27 full text articles were reviewed. 
Nineteen were excluded for not meeting the inclusion criteria. Reasons for this 
were due to exploring SDM in treatment as usual and not as part of an 
intervention (n = 17), the paper being unavailable in the English language (n = 
1), and inability to access the full text (n = 1). Eight articles were included in the 
synthesis including a total of 260 participants (126 clinicians, 134 service 
users). A summary of study characteristics can be found in Table 1. All studies 
but one (Deegan et al., 2008) were published in the last five years, suggestive 
of SDM in mental health being an emerging area of research. 
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Table 1.  
Study Characteristics 
Study 
No 
Authors, year 
of publication 
and country 
Participants (N) Context of 
recruitment 
Data analysis 
method 
Shared decision making 
intervention 
Research aims 
1 Abrines-
Jaume et 
al.,2016, UK 
Clinicians 
N = 23 (psychiatrists, 
psychologists, nurses, 
family therapists, social 
works, play therapists) 
4 NHS CAHMS 
mental health 
services 
Framework 
analysis 
Staff training What are the 
barriers to 
implementing 
SDM in CAMHS 
services? 
 
2 Farrelly et al.,  
2016, UK 
Clinicians 
N = 45 (29 care 
coordinators, 16 
psychiatrists) 
Service users 
N = 51  
Within a larger 
trial conducted in 
4 mental health 
trusts in England 
 
Grounded 
theory 
Joint Crisis Plan (JCP) 
for psychosis 
How do 
clinicians and 
service users 
experience the 
JCP 
intervention? 
 
3 Goscha & 
Rapp  
2014, USA 
Clinicians 
N = 9 (3 prescribers, 5 
case managers, 1 case 
management team 
supervisor) 
Service users 
N = 12 
Community 
mental health 
centre 
 
Grounded 
theory 
CommonGround: 
computer based tool 
How is 
CommonGround 
experienced by 
staff and service 
users? 
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Table 1 cont.  
Study Characteristics 
Study 
No 
Authors, year of 
publication and 
country 
Participants (N) Context of 
recruitment 
Data analysis 
method 
Shared decision 
making 
intervention 
Research aims 
4 del Barrio, Cyr, 
Benist, & Richard 
2013, Canada 
Service users 
N = 26 
8 Community 
based mental 
health 
organisations 
 
Not reported Autonomous 
medication 
management: a 
dialogue/peer 
support 
approach 
 
How does the 
intervention 
influence the 
ways in which 
service users 
relate to their 
medication? 
 
5 Korsbek & 
Tønder,  
2016, Denmark 
Clinicians 
N = 19 (nurses, 
occupational therapists, 
psychologists, social 
workers, doctors) 
Service users  
N = 7  
 
Mental health 
community centre 
 
Not reported Momentum: a 
smartphone 
application 
Does the use of 
the decision tool 
affect the 
experience of 
participation in 
treatment 
consultations? 
 
6 Deegan, Rapp, 
Holter & Riefer,  
2008, USA 
Clinicians 
N = 18 (14 case 
management staff, 4 
medical staff) 
Service users 
N = 16 
Urban mental 
health centre 
Not reported Transformation 
of a typical 
waiting area into 
a peer-run 
decision support 
centre (DSC) 
To describe 
participants 
experiences in 
using the DSC 
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Table 1 cont.  
Study Characteristics 
Study 
No 
Authors, year of 
publication and 
country 
Participants (N) Context of 
recruitment 
Data analysis 
method 
Shared decision 
making 
intervention 
Research aims 
7 Bonfils et al., 
2016, USA 
Clinicians 
N = 12 (supervisors, peer 
specialists, registrars, 
psychiatrists, and upper 
management) 
Two assertive 
community 
treatment teams 
and two outpatient 
teams 
Study is mixed 
methods: 
Qualitative 
method used 
content analysis 
CommonGround: 
a computer based 
tool along with a 
decision support 
centre 
 
To explore the 
current 
CommonGround 
implementation 
process and 
indentify 
strategies to 
enhance the 
programs impact 
at future sites 
 
8 Moncrieff, Azam, 
Johnson, 
Marston, Darton 
& Wood, 2016, 
UK 
Service users  
N = 22 
Community 
recovery teams 
Thematic 
analysis 
Medication 
Review Tool: a 
website to access 
information and a 
downloadable tool 
Can the 
medication review 
tool help patients 
assess and 
communicate 
more effectively 
about the risks 
and benefits that 
taking psychiatric 
medication 
involves? 
 
 Page 24 of 272 
Quality Appraisal 
Despite extensive research on the appraisal of qualitative research there 
remains a lack of consensus on definitive criteria, potentially due to the 
heterogeneity of methods (Walsh & Downe, 2006). This review utilised the 
Critical Appraisal Skills Programme (CASP; Public Health Resource Unit, 2013) 
as a tool to evaluate the methodological quality of the included studies; a 
summary of which can be found in Table 2. Papers were rated separately by the 
two authors; discrepancies were discussed and final scores agreed upon. 
 
Table 2. 
CASP Criteria 
CASP criteria 1 2 3 4 5 6 7 8 
Clear statement of aims? Y Y Y Y Y Y Y Y 
Qualitative methodology appropriate?  Y Y Y Y Y Y Y Y 
Research design appropriate to aims? Y Y Y Y Y Y Y Y 
Recruitment strategy appropriate to aims? Y Y Y Y Y Y U U 
Data collected in a way that addressed the 
research issue? 
Y Y Y Y U U Y N 
Relationship between researcher and 
participants adequately considered? 
N N N N Y N N N 
Ethical issues taken into consideration? N Y N N N N Y Y 
Data analysis sufficiently rigorous? Y Y Y U U N Y U 
Clear statement of findings? Y Y Y Y Y U Y N 
Note: Y = Yes, N = No, U = Unclear 
 
The process of critically appraising qualitative literature lends itself to the 
philosophical assumption that qualitative research can be flawed, and that 
inclusion of such studies may result in a flawed meta-synthesis (Walsh & 
Downe, 2006). Two studies did not meet the majority of the CASP criteria 
(Deegan et al., 2008; Moncrieff et al., 2016) which may suggest caution in 
interpreting the study’s findings. In consideration to weighting the papers within 
the synthesis, as the findings in the study by Deegan et al. (2008) weren’t 
particularly controversial, it was deemed appropriate to include them. 
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Furthermore, research has found that including studies deemed poorer quality 
is unlikely to distort the synthesis (Campbell et al., 2011). The study by 
Moncrieff et al. (2016) was excluded however following quality appraisal. 
Despite reporting that they used thematic analysis, no themes were reported in 
their results and the quantity of qualitative data reported was extremely minimal. 
It was therefore considered to add little value to the synthesis.  
 
All studies outlined clear aims for their research, and a qualitative methodology 
was deemed appropriate for their research questions. Ethical considerations 
were largely absent, as description of ethical approval was present in just three 
studies (Bonfils et al., 2016; Farrelly et al., 2016; Moncrieff et al., 2016). 
Reflexivity is considered an important aspect of qualitative studies in order to 
increase credibility and the rigour of the research process (Jootun, McGhee, & 
Marland, 2009). A researcher’s beliefs and values will influence their approach 
to the methodology and analysis, however none of the studies reported their 
epistemological perspectives or included any reference to reflexivity. Two 
studies did address potential bias wherein the researchers helped develop the 
technology behind the intervention so therefore had competing interests 
(Korsbek & Tønder, 2016; Deegan et al., 2008). This is reported as a limitation 
within both papers. One study reported that the research team had a long-
standing relationship with the centre in which the research was conducted, but 
did not state how this may affect the research (Bonfils et al., 2016). Six of the 
studies used direct quotes as a substantial part of their findings which supports 
the reader in understanding how conclusions were made. Two studies included 
brief and infrequent quotations only; the extent to which the findings were 
substantiated by the raw data is questioned (Deegan et al., 2008; Moncrieff et 
al., 2016). 
 
The CASP has attracted criticism for not requiring researchers to specify the 
method of data analysis used within the study (Walsh & Downe, 2006). Three 
studies do not explicitly state their method of analysis but report that they 
identified significant patterns or themes (Korsbek & Tønder, 2016), carried out 
codification based on emerging themes (del Barrio, Cyr, Benisty, & Richard, 
2013) or in one case appear to have used content analysis by summarising 
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findings into headings (Deegan et al., 2008). The process by which findings 
were derived is therefore unclear, limiting the quality of papers. However due to 
an inability to access raw data, findings were taken at face value for the 
purpose of synthesis, with this acknowledged as a limitation. 
 
Studies were not awarded a score based on quality appraisal as this assumes 
that each category holds the same weight. Overall, six studies were deemed to 
be of reasonable quality, and two of lower quality (Deegan et al., 2008; 
Moncrieff et al., 2016). Two of the papers were mixed methods (Bonfils et al., 
2016; Moncrieff et al., 2016); only the qualitative aspects were subject to quality 
appraisal. The quantity of qualitative data within the mixed methods papers was 
substantially less than the purely qualitative papers; particularly in the study by 
Moncrieff et al. (2016).  
 
Summary of Findings 
The nature of the intervention varied across all six studies, some aimed to 
improve SDM specifically in regards to medication whereas some aimed for 
more collaboration in overall mental health treatment. The variance in 
intervention and context is considered during the synthesis. A summary of the 
interventions can be found in Table 3. The majority of studies report positive 
outcomes as a result of the SDM interventions, however one predominantly 
reports on the barriers to SDM which appears a result of unfavourable 
outcomes of the intervention (Farrelly et al., 2016). 
 
Interpretation of Findings 
The meta-ethnography identified third order constructs that can be categorised 
by three key themes: (1) Barriers to shared decision making [subthemes: 
changing roles, clinician exposure]; (2) Power [subthemes: transferring of 
power, achievability of true shared decision making, protective withholding, 
mistrusting withholding]; (3) Therapeutic relationship [subthemes: prerequisite 
or goal?, authenticity of the relationship]. The presence of themes within studies 
is outlined in Table 4.  
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Table 3. 
Summary of SDM interventions 
 Shared Decision Making (SDM) Intervention 
Abrines-Jaume 
et al.,  
(2016) 
Across two years staff received regular training events (one every three months) which included provision of 
information and materials, group disucssions, and action learning sets. Clinicians were also supported in 
implementation of approach and use of the tools via regular site meetings, and phone and email guidance. Details of 
these tools are not provided in the study. 
SDM aims: Overall treatment in therapy 
 
Farrelly et al.,  
(2016) 
Clinicians engaged with service users to develop a Joint Crisis Plan (JCP) as part of a larger randomized control trial. 
The JCP contains the service users preferences for treatment in the event of a future relapse of their mental health 
condition. The plan is jointly made with the service user’s psychiatric team. There are two meetings during this 
process; the first is attended by the care coordinator, the service user, and a JCP facilitator. The service user is given 
a list of options they would like to consider using in their JCP, and they are then given time to consider this and 
prepare for the second meeting. The second meeting entails the creation of the JCP with the service user, their clinical 
team (care coordinator and psychiatrist), the JCP facilitator, and the service user’s family members. 
SDM aims: Specific to a care plan in event of relapse 
 
Goscha & 
Rapp  
(2014) 
CommonGround, a web-based SDM application was introduced. It comprises six components: (1) Prior to the 
medication consultation service users work with a case manager to develop a Power Statement – a self-advocacy 
statement setting the tone for exploring considerations regarding the use of medication. Service users also identify 
Personal Medicine which are self-initiated, non pharmaceutical, self-care activities that the service user values and 
deems helpful to their mental health. (2) Prior to meeting with the prescriber, service users answer questions on a 
touchpad screen located at a kiosk in the waiting room. (3) The information is collated into a report, and support is 
provided to help the service user understand the report and form any questions they have prior to the consultation. (4) 
The CommonGround report is taken into the medication consultation and reviewed together. (5) A SDM format is used 
by the prescriber in terms of them reviewing each aspect of the report and exploring the service user’s subjective 
experience of their situation, and any uncertainty regarding use of medication. (6) The CommonGround report is 
updated to reflect the shared decision and shared with the rest of the service user’s treatment team. 
SDM aims: Decisions about the use of psychiatric medication 
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Table 3 cont. 
Summary of SDM interventions 
 Shared Decision Making (SDM) Intervention 
del Barrio, Cyr, 
Benist, & 
Richard 
(2013) 
The Autonomous Medication Management approach aims to support practices so that servce users can identify 
changes they wish to make and utilise the available resources to ensure that medication is contributing to their 
wellness. The focus is on making room for dialogue between the service user, their loved ones, peers, and the 
professionals they encounter. Service users have accessibility to information regarding medication, individual support 
to prepare for meeting prescribing physicians, and opportunities for expression and discussion with peers to consider 
experiences with medication. A guide is also provided to support the service user throughout the process and provide 
information. 
SDM aims: Decisions about the use of psychiatric medication 
 
Korsbek & 
Tønder 
(2016) 
Momentum is a smartphone application (app) consisting of a treatment site where clinicians can see the preparations 
that service users choose to share. The app has an interactive element which allows service users to prepare for 
treatment consultations through a series of guided questions before deciding which topics they consider central for the 
meeting. Following the consultation the user can evaluate the meeting and how useful they felt the app was in terms of 
preparation. There is also an element to the app that includes a tool to develop coping strategies. 
SDM aims: Overall treatment in therapy 
 
Deegan, Rapp, 
Holter & 
Riefer,  
(2008) 
 
A psychiatric medication clinic was transformed into a peer-run Decision Support Centre (DSC). Services included: 
offering a snack and beverage, assisting service users in creating a report for use in the medication consultation, 
giving service users access to health-related information via the internet, providing informal peer support, and 
providing support with completing decision aids used for addressing areas of conflict in regards to medication. The 
computer program consists of an introductory to recovery as written from a peer perspective, vignettes of others 
talking about their recovery, and information of Personal Medicines; enjoyable activities that can contribute to 
wellness. A survey is also completed concerning perceived symptoms and psychosocial functioning which can be 
customised. 
SDM aims: Decisions about the use of psychiatric medication 
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Table 3 cont. 
Summary of SDM interventions 
 Shared Decision Making (SDM) Intervention 
Bonfils et al., 
(2016) 
CommonGround: as described above. 
SDM aims: Decisions about the use of psychiatric medication 
 
Moncrieff, 
Azam, 
Johnson, 
Marston, 
Darton & 
Wood, (2016) 
A Medication Review Tool was developed that intended to help patients systematically review the pros and cons of 
taking medication. A website was created to provide information about psychotic conditions, types of anti-psychotic 
medication, and points for people to consider when making decisions about medication. The Medication Review Tool 
can be downloaded from the website and is a form which an individual can fill in (potentially with support) prior to a 
medication consultation. This aims to help them express their views about medication more clearly and have their 
concerns addressed more systematically. 
SDM aims: Decisions about the use of psychiatric medication (specifically anti-psychotic medication) 
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Table 4. 
Themes and subthemes across studies 
Theme or subtheme 
Abrines-
Jaume et 
al. 
(2016) 
Farrelly et 
al. 
(2016) 
Goscha & 
Rapp  
(2014) 
del Barrio 
et al. 
(2013) 
Korsbek 
& Tønder  
(2016) 
Deegan 
et al.  
(2008) 
Bonfils et 
al.  
(2016) 
Barriers to shared decision making * * * * * * * 
Changing roles * *      
Clinician exposure * *   *   
Power * * * * * * * 
Transferring of power *   *   * 
Protective witholding *       
Mistrusting witholding  *      
Therapeutic relationship   * * * * * 
Prerequisite or goal?    *    
Authenticity of the 
relationship 
  * * * * * 
Note: * indicates the presence of the theme within the study. 
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Barriers to shared decision making. 
All studies highlighted barriers to engaging in SDM reported by the perspectives 
of both clinicians and service users. Many of the barriers highlighted are evident 
in previous research such as limits on staff time, training, and resources. 
However there also appears to be both active and unconscious resistance 
acting as a barrier to the process on both sides, as discussed under the 
following subthemes. 
 
Changing roles.  
Despite willingness to engage with the SDM intervention, there appeared to be 
a struggle in some cases to deviate from the paternalistic model of decision 
making. Both parties entered the intervention with the pre-existing roles of 
‘clinician’ and ‘service user’ and despite efforts to shift from these traditional 
roles, both sides struggled and would slip back into ‘expert’ and ‘advice-seeker’. 
Some clinicians felt that they were ‘already doing SDM’ however on 
examination the exchange appeared more of a consultation, suggesting that 
there may be an unconscious shift back into the familiar role: - 
 
…and then I say, “the other thing that needs to go in is this” and we go 
through it. That’s it. I ask them to agree and that’s it. (Farrelly et al., 
2016, p. 453, clinician discussing joint care planning). 
 
Service users in the Korsbek and Tønder (2016) study also appeared to 
struggle with adopting a more active role in decision making. Despite using a 
decision tool to prepare for meeting a clinician, one service user said that she 
“did not dare share it, as some of her considerations might be irrelevant for the 
staff” (p. 171). This suggests a continuation of viewing the clinician as 
authoritarian, and a reluctance to consider a shift from the traditional ‘patient’ 
role to feel that she is the expert in her mental health experiences within the 
relationship. 
 
Clinician exposure.  
Apprehension in implementing the intervention was evident across four studies 
(Abrines-Jaume et al., 2016; Farrelly et al., 2016; Korsbek & Tønder, 2016; 
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Bonfils et al., 2016) and a common theme underpinning all appears to be 
concern over the impact of changing practice, whereby the flexibility required 
has potential to expose the clinician. This would result in uncovering deficits in 
skill and competence: - 
 
I think this is something pretty new that psychiatrists are coming round to 
in terms of offering choices. (Farrelly et al., 2016, p. 453, clinician). 
We just had such a difficult time I think getting the prescribers on board 
(Bonfils et al., 2016, p.5, clinician). 
 
In the Farrelly et al. (2016) study clinicians (particularly psychiatrists) largely 
reported negative attitudes towards the intervention, questioning its value. 
Limited motivation led to a half-hearted attempt and unsuccessful outcomes, 
reinforcing negative beliefs in the worth of SDM. As psychiatrists are often 
perceived as responsible for decision outcomes given their social position 
(Stacey et al., 2015), acknowledging  uncertainty to service users or other staff 
may leave the clinician feeling vulnerable in their position, and potentially 
threaten their professional identity. Externally attributing the (expected) limited 
success of the intervention to the client would prevent the clinician from feeling 
to blame, and thus deskilled. Evidence for this suggestion is that the clinician 
would have been aware that their implementation of the intervention was also 
for research purposes, which adds extra focus on their performance. This lead 
to some staff dismissing the value of the intervention and their potential role 
within it. This is echoed within the Korsbek and Tønder (2016) study in that 
some psychiatrists reported that they “did not believe that Momentum [the SDM 
smartphone application] was relevant to them” (p. 171). 
 
In the study by Abrines-Jaume et al. (2016) the authors report that clinicians 
moved between states of ‘apprehension’ and ‘feeling clunky’ before achieving 
the state of ‘integrated into practice’. This is suggestive of a delay in 
implementing the intervention due to limited confidence and skill, and limits the 
risk of exposure whilst the clinician learns to adapt: - 
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I found it difficult asking the young person to answer these questions in 
front of me. (Abrines-Jaume et al., 2016, p. 24, clinician). 
 
The clinicians in this study were required to complete a plan-do-study-act log 
book to capture their implementation of SDM tools and approaches. This places 
the clinicians under close observation by the researchers, and may have been 
the driving force behind persistence of the intervention given the feelings of 
apprehension and ‘clumsiness’. Under circumstances whereby researcher 
pressure is non-existent there may be the risk of clinician avoidance to limit 
feeling unskilled. 
 
The apprehension and negative attitudes appear to serve a protective function 
by allowing clinicians to stall or disengage with the intervention, which thereby 
reduces the risk of clinician exposure. Lack of confidence in abilities and the 
limited success is a key factor in driving ambivalent approaches to SDM, and 
can lead to a depersonalised effect on care for the service user. 
 
Power.  
One of the key outcomes for SDM is for the service user to feel empowered by 
having opportunity to exercise choice and control over their treatment. All 
studies made reference to empowerment; or disempowerment in one case 
(Farrelly et al., 2016). Through reciprocal translations it became evident that in 
order for empowerment to occur there is a requirement on the clinician’s behalf 
to permit power. Motives behind reluctance in permitting power differ across 
contexts. 
 
Transferring of power.  
Three studies including service user perspectives found that those who had 
taken part in the intervention felt a sense of empowerment in terms of gaining 
autonomy and control over decisions about their treatment (Goscha & Rapp, 
2014; del Barrio et al., 2013; Deegan et al., 2008): - 
 
It means being able to make your own decisions, make your own 
choices, and have a vision of the thing other than just this little magic 
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pill… It gives you back power over your life. Once you realize[sic] you are 
able to make decisions you’ve taken a major step forward. (del Barrio et 
al., 2013, p. 2883, service user). 
 
Positive attitudes towards service user empowerment was also evident for 
clinicians within four studies (Goscha & Rapp, 2014; Korsbek & Tønder, 2016; 
Abrines-Jaume et al., 2016; Bonfils et al., 2016). Clinician positive attitudes 
appear to be fundamental to the process of transferring power, as evidenced in 
the Farrelly et al., (2016) study whereby negative attitudes resulted in an 
unsuccessful intervention and feelings of disempowerment from service users: - 
 
I sort of felt to myself now that you know, well what can I do about it – I 
can’t really change my team. I can’t really change their decision, they’re 
qualified… so it’s their decision. I can’t really do much about it to be 
honest. (Farrelly et al., 2016, p. 454, service user). 
 
These feelings of disempowerment are reported to damage service user trust in 
their clinician and themselves, and appear to instil feelings of hopelessness that 
are historically associated with informal coercion in mental health treatment 
(Linhorst, 2006). 
 
Achievability of true shared decision making.  
The authors present positive outcomes in the Korsbek and Tønder (2016) study 
but also question whether tools to aid SDM may in fact continue to perpetuate 
the active-passive interaction between clinicians and staff. Service users may 
engage with the intervention by adopting the role of a “good client” and doing as 
they are asked. This desire may also be driven by the wish to avoid conflict, and 
wanting the clinician to be “on your side” (Joseph-Williams et al., 2014) which 
leads to questions regarding the extent to which true SDM can be achieved. It is 
inevitable that prior knowledge of SDM, and being the party who will introduce 
the intervention will place the clinician in a role of authority. Attempts to manage 
this may be facilitated by clinicians setting the scene for the SDM process in 
terms of roles and expectations, in order to keep the service user fully informed 
of their rights and options. 
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Protective withholding.  
Clinicians working in Child and Adolescent Mental Health Services (CAMHS) 
appear to withhold power as a form of protection: -  
 
CAMHS professionals tend to be understandably protective of young 
people and SDM may have seemed to contain risks, thereby making 
them hesitant to try something different”. (Abrines-Jaume et al., 2016, p. 
23, authors).  
 
Reluctance in granting power in this context appears to stem from the 
preconceived belief that young people may not have the capacity to make 
appropriate decisions about their care. 
 
Mistrusting withholding.  
Clinicians within the Farrelly et al. (2016) study were more explicit about their 
reluctance to hand over power, citing that service users may not make 
appropriate choices, and the service will be unable to meet their requests: - 
 
And also, there are things that the service user will want and request and 
you know it’s not really what they need. (Farrelly et al., 2016, p. 453, 
clinician). 
 
Yeah we can ask you what your needs are and what you want to 
happen, but essentially this is what we do, this is what we can do, and 
this is what will happen should you ring up. (Farrelly et al., 2016, p. 454, 
clinician). 
 
Attitudes and organisational limitations therefore perpetuate the withholding of 
power. Reluctance in permitting this power may be underpinned by different 
motives, yet results in limited opportunity for the service user to adopt a more 
active approach in decision making. 
 
Handler (1996) found that empowerment is very context dependent and is 
highly reliant on the stability of relationships integral to empowerment, the 
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continued availability of resources, and on the needs of those in power. 
Empowerment of those considered vulnerable is therefore fragile, and may be 
affected by the changing context in which empowerment occurs. This 
consideration highlights the concept of service user empowerment in SDM as 
very dependent on clinicians’ approach to the intervention. Whilst the SDM 
aspect aims to be collaborative; there appears to be heavier responsibility on 
the part of the clinician to allow empowerment to occur. 
 
Therapeutic relationship. 
Issues relating to the therapeutic relationship were present in five studies 
(Goscha & Rapp, 2014; del Barrio et al., 2013; Korsbek & Tønder, 2016; 
Deegan et al., 2008; Bonfils et al., 2016). The therapeutic relationship has been 
considered an important driving force behind successful outcomes within mental 
health treatment (Norcross & Wampold, 2011) therefore factors which 
strengthen or damage the relationship are important within SDM.  
 
Prerequisite or goal?  
Service users in one study described the SDM intervention as having 
“transformed their relationship with healthcare clinicians – particularly 
prescribing physicians” (del Barrio et al., 2013, p. 2883). Increased 
communication is generally viewed as a positive outcome of many of the 
interventions: - 
 
Another thing that comes out of that place is to where a person does 
begin to talk and engage with specialist because they are feeling 
comfortable [sic] (Bonfils et al., 2016, p.4, clinician).  
 
In other cases, however it appears that engagement with the intervention was 
determined by the quality of the pre-existing relationship. Two studies report 
that the relationship was essential for easing service user concerns about the 
intervention, and encouraging them to engage (Korsbek & Tønder, 2016; 
Goscha & Rapp, 2014): - 
 
 Page 37 of 272 
If we say here is something we think can be a really good thing for you, 
they listen to it (Korsbek & Tønder, 2016, p. 170, clinician). 
 
This suggests that at some level, an established therapeutic relationship is 
required for an effective SDM intervention. This appears to be driven by 
established trust in the clinician, which increases the service users’ confidence 
in their ability to engage in SDM. A pre-existing relationship however may mean 
that both parties naturally fall into a paternalistic relationship, making it difficult 
to then shift into SDM due to the barriers highlighted above. 
 
Authenticity of the relationship.  
Five studies reported an improved therapeutic relationship and increased trust 
and communication as a result of the intervention (Goscha & Rapp, 2014; 
Deegan et al., 2008; Korsbek & Tønder, 2016; del Barrio et al., 2013; Bonfils et 
al., 2016). On closer examination however, the authenticity of these 
relationships is questioned as to whether certain decision aids improve or 
actually hinder the relationship. It was noted in two studies that disclosure of 
information increased (Goscha & Rapp, 2014; Deegan et al., 2008): - 
 
I wouldn’t talk as much or say as much. They wouldn’t get as much 
information out of me (prior to CommonGround) … once I tell the 
computer what my situation is and they discuss it with me… that has 
helped. (Goscha & Rapp, 2014, p. 270, service user). 
 
It is much easier to tell the computer. (Deegan et al., 2008, p. 605, 
service user). 
 
The authors interpret this as an increase in trust, and therefore an improved 
relationship. A reliance on technology to enhance the relationship however may 
be suggestive of a move towards a dehumanized approach, in that the 
relationship cannot flourish solely on the basis of human interaction. This 
questions the authenticity of the therapeutic relationship between the two 
parties. The intervention in which the clinician-service user relationship is 
described as “transformed” focuses on “making room for dialogue” with 
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supplementary information resources available, rather than a reliance on a 
computer-based intervention (del Barrio et al., 2013): - 
 
Gradually, a mutual recognition of their respective areas of knowledge 
develops, which creates room for negotiation and for making decisions 
that can be qualified as shared. (del Barrio et al., 2013, p. 2883, authors). 
 
These findings suggest an interplay of the collaborative intervention both 
potentially strengthening the therapeutic relationship, whilst in some respects 
requiring that some level of relationship is already established. Perspectives 
indicate that the therapeutic relationship may especially be enhanced when the 
intervention is driven by aspects focusing on dialogue rather than interventions 
based on technology. 
 
Line of Argument Synthesis 
A line of argument synthesis aims to collate findings from individual studies and 
provide an interpretation (Noblit & Hare, 1988). By synthesizing clinician and 
service user perspectives of engaging in SDM interventions, potential 
explanations are uncovered as to why the much advocated ‘collaborative care’ 
mental health services aspire to can struggle to play out in reality. Clinicians 
appear to both advocate SDM yet struggle to put this into practice, as adjusting 
the power dynamic within the relationship is associated with risks of uncovering 
a deficit in clinician skills, allowing the service user to make ‘poor’ choices, not 
being able to meet service user requests, and a worry that as a young person 
they aren’t ready for the responsibility. Furthermore, the pre-determined roles 
that people employ (as ‘service user’ or ‘clinician’) appear to loom over the 
therapeutic relationship despite best efforts in creating equality. Hesitancy from 
clinicians coupled with the difficulty in role change seems to lead to a situation 
whereby both parties are attempting to engage in SDM but are stuck in the 
paternalistic relationship. Examining perspectives has uncovered priorities for 
improving the success of SDM interventions as outlined below. 
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Discussion 
The meta-ethnography aimed to appraise and synthesize existing qualitative 
research into clinician and service user perspectives of SDM interventions. By 
examining first hand perspectives, the review has highlighted potential 
implications for clinical practice and future research. 
 
Several barriers that have previously been identified in regards to SDM were 
present in the review, suggesting that some difficulties prevailed despite the 
intervention. The aim was not to specifically identify barriers, but the 
examination of perspectives uncovered that this was an important element of 
what participants said. Clinicians’ concern about their competence and the 
threat to clinician identity as a barrier is largely absent from previous research. 
Effective approaches to SDM interventions are also currently unidentified, 
therefore consideration of how decision aids may affect authentic therapeutic 
relationship is useful in developing future interventions. A particular difficulty 
highlighted in the review was in shifting from the paternalistic model, which is 
congruent with previous research on barriers (Joseph-Williams et al., 2014). 
This can be understood in terms of social role theory, in that individuals are 
believed to act in line with socially defined categories to which they identify. 
Social roles outline a set of behaviours and norms that a person fulfils (Koenig 
& Eagly, 2014). The roles of ‘client’ and ‘service user’ hold a set of expectations 
about how a person within these roles will act, therefore increasing the difficulty 
of behaving in an unexpected manner as SDM proposes.  
 
Overall, findings suggest that clinician confidence and attitudes are fundamental 
to the effective implementation of SDM. It is helpful if there is an established 
relationship between both parties prior, and interventions appeared to best 
strengthen the therapeutic relationship when the focus was on dialogue as 
opposed to computer-based aids. 
 
It is through examining perspectives that priorities can be identified in which to 
drive forward interventions within healthcare (Evans, 2002). In terms of future 
recommendations, thorough training may support clinicians in understanding 
the aims and proposed benefits, in order to facilitate motivation towards the 
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intervention. Clinical supervision may also provide a forum of support for 
clinicians in allowing a safe space in order to explore motivations and 
apprehension in their willingness to transfer power and share decision making 
(Clouder & Sellars, 2004; Stacey et al., 2016). To minimise service user 
deference to authority, it may be required for the clinician to initially adopt a 
more active role during the initial building of the therapeutic relationship, whilst 
trust is established (Patel, Schnall, Little, Lewis-Fernández, & Pincus, 2014). 
This also creates opportunity to ‘set the scene’ and openly discuss roles and 
expectations within the relationship. Once this has occurred, the clinician is in a 
position to permit power to the service user, and may regularly engage in 
reflective practice (and supervision) in order to consider the SDM process and 
whether roles have unconsciously shifted back into a paternalistic model. 
During the early stages whereby an initial relationship is being established it 
may also be beneficial for open dialogue in regards to influential factors that 
may impact the SDM process, including a perceived hierarchy, to promote 
transparency and attempt to balance the power (Stacey et al., 2016).  
 
Future research may wish to compare the outcomes of different SDM 
interventions. Findings from the current review suggest that interventions 
focused on increasing dialogue may support an authentic client-service user 
relationship. This is not to say however that technology-based interventions are 
inappropriate, as an increase in collaboration can still be perceived as a positive 
step for individuals who may otherwise have adopted a passive role. An 
individualised approach to SDM may be necessary in terms of supporting the 
service user to collaborate in the means they are most comfortable with, which 
is congruent with the notion of offering choice and allowing the service user to 
make decisions about their care. 
 
As decision made in mental health treatment can often involve a restriction of 
liberty, previous research has suggested that some service users may distance 
themselves from decision making as to avoid accepting responsibility for these 
decisions (Stacey et al., 2016). This was not evident within the review, however 
all interventions took place within community settings therefore findings may 
have differed within inpatient services where a lack of choice may be more 
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prominent. Future research may also consider differences in implementing SDM 
across a wider variety of contexts. 
 
Limitations 
A potential limitation of the current review is that studies were geographically 
diverse, and included a range of healthcare settings and interventions. The 
participants sampled also had varying mental health concerns. Whilst the 
heterogeneity allowed for a wide range of experiences to be considered, study 
findings are therefore limited in generalisability. Inclusion of heterogeneous 
studies however has been identified as fundamental in determining higher order 
interpretations in meta-ethnography (Britten et al., 2002).  
 
Due to the lack of transparency of some studies (in terms of lack of reflexivity or 
minimal use of original data to support findings), the influence of the authors on 
their conclusions could not be determined in all cases. Some studies were not 
open about their method of analysis; the extent to which the interpretations 
generated from the synthesis are supported by primary data is therefore 
unclear. 
 
The review looked at clinicians as a whole, however within a staff team 
hierarchies will likely pre-exist based upon training, responsibility, and perceived 
power (Mason, Williams, & Vivian-Byrne, 2002). A limitation of the review is the 
inability to largely distinguish clinician perceptions by occupation. Future 
research may consider SDM in terms of different occupations.  
 
Conclusion 
On the whole, service users reported positive feedback in regards to SDM 
interventions. This suggests that despite the aforementioned barriers and 
question of truly achieving SDM, the offer of collaboration is met favourably. 
SDM interventions may be effectively implemented by supporting clinicians via 
training and supervision, emphasising the importance of establishing an initial 
relationship, ‘setting the scene’ for SDM, and focusing on dialogue to build the 
therapeutic relationship. 
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Abstract 
Objectives: This study aimed to explore whether clinical psychologists in 
the United Kingdom (UK) have a role with their clients’ psychotropic 
medication by exploring forms of involvement undertaken, and decision-
making behind involvement. 
Method: A mixed methods design was employed; 147 clinical psychologists 
took part in an online survey, and 11 respondents were interviewed, 
selected using intensity sampling. Descriptive statistics, logistic regression, 
and thematic analysis were used to analyse the quantitative and qualitative 
data respectively. 
Results: All respondents reported having some role with their clients’ 
psychotropic medication. A thematic map diagram was created to capture 
the process of how clinical psychologists choose to become involved.  
Conclusions: Consensus was reached in that clinical psychologists do 
have a role with their clients’ psychotropic medication, although this varies 
by clinician and takes on many forms. In light of the changing role, 
professional guidance would help to promote clarity and consistency. 
 
Keywords: psychologists, psychotropic medication, psychiatric medication 
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Background 
 
Psychotropic Medication and the Medical Model 
Psychotropic medication1 refers to drugs capable of affecting the mind, 
emotions, and behaviour which are commonly prescribed for the treatment of 
‘mental illness’ (Moncrieff, 2009). Medicalised treatment is underpinned by a 
biological understanding of mental health problems which proposes that 
medication may reverse or stop an effect or alter some form of ‘chemical 
imbalance’ in the brain. The prescribing of psychotropic medication works in 
accordance with the model of diagnosis; an individual suffers from a medical 
illness and is treated primarily by medication (Johnstone, 2014). The dominance 
of a diagnostic model akin to physical disease minimises psychosocial factors 
contributing to distress, and over-emphasises biological interventions such as 
psychotropic medication (Boyle, 2013; Cromby & Harper, 2013). Existence of a 
drug to treat a specific disorder increases plausibility of a diagnosis, and drug 
marketing is strengthened if there is a known specific disorder to target 
(Moncrieff, 2009). This creates a shared view of the importance of psychotropic 
medication and diagnostic categories to justify their use (Cosgrove & Wheeler, 
2013). 
 
The notion of diagnosis is frequently contested and is increasingly attracting 
critique, particularly from the clinical psychology profession. The Division of 
Clinical Psychology (DCP) of the British Psychological Society (BPS) published 
a position statement in 2013 advocating the need for psychological formulation 
and highlighting flaws in current diagnostic classification systems (Division of 
Clinical Psychology, 2013). Following this, The Power Threat Meaning (PTM) 
Framework (Johnstone & Boyle, 2018) was created to further challenge 
medicalisation by providing an over-arching structure for formulation as an 
alternative to diagnosis. Whilst noted as beyond the scope of the PTM 
framework, it is acknowledged that adherence to the principles may likely lead 
                                            
1 Throughout the article the term ‘medication’ is sometimes used to avoid repetition. This 
continues to refer to psychotropic medication unless otherwise specified. 
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to reduced levels of prescribing (Johnstone & Boyle, 2018)2. As such, a 
secondary effect of the work around diagnosis may influence psychotropic 
medication. There is an established professional movement away from 
diagnosis, and a clear relationship between diagnosis and psychotropic 
medication. The question remains as to whether the professional movement 
with diagnosis extends into any role with psychotropic medication, be this a 
critical stance or any other. 
 
Psychologists and Psychotropic Medication 
What is currently known about involvement?  
There is little research exploring the relationship between clinical psychologists 
and medication; extant research primarily focuses on attitudes towards gaining 
prescription privileges and is conducted outside of the United Kingdom (UK). A 
study by VandenBos and Williams (2000) explored roles outside of prescribing 
during which 596 psychologists in the United States (US) were surveyed about 
different forms of involvement with psychotropic medication they assumed 
within their roles. Based on survey findings, the researchers concluded that 
psychologists are extensively, albeit indirectly, involved in the process of 
prescribing and managing client’s psychotropic medications. It was additionally 
speculated that the average psychologist may not be fully aware of the extent to 
which knowledge about, and involvement with medication already forms a 
significant part of their practice. Cultural differences in medical practice and the 
psychologists’ role limits the generalisation of these findings to the UK. 
Similarities might be expected in UK practice but there is currently a lack of 
research exploring this.  
 
Some insight into roles clinical psychologists are already adopting can be 
attained on a local level, such as supporting community medication groups. 
Medication support groups exist to help service users safely withdraw from 
medication, or think through broader aspects of medication use. For example, 
the Nottingham Mind Medication Group includes clinical psychologist support, 
and provides a forum for peer support and access to knowledge about 
                                            
2All authors included in reference list but not in the main text as requested by authors. 
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psychotropic medication (Nottingham Mind Medication Group, 2013). The group 
does not advocate that medication should not be used, but aims to support 
access to information about medication. The group was developed with help 
and support from other similar groups, suggesting similar initiatives may be 
occurring yet not widely recognised. 
 
Debates and controversy.  
Despite little research, debate on the topic is by no means new, with 
longstanding publicised discussions on the appropriateness and ethicality of 
psychologists’ involvement, stemming from discussing medication up to 
prescribing. In the US, debate around psychologists discussing medication with 
clients was considered following an incident whereby a psychologist was 
accused of “practicing medicine without a licence” after supplying a young 
client’s father with information on the safety and efficacy of a specific 
medication (Littrell & Ashford, 1995). The authors highlighted that there are 
numerous scenarios in which psychologists might be queried about medication, 
yet no clear precedents in regards to how they might ethically respond. Since 
this time some States have adopted prescription privileges for psychologists, 
enabling psychologists to prescribe by completing further training. The debate 
on psychologists prescribing has also extended to the UK, where this remains a 
controversial issue dividing opinion (British Psychological Society, 2003).  
 
In addition to cautioning the use of diagnosis, there has been critique from 
clinical psychologists about psychotropic medication (Kinderman, 2014) with the 
underlying message of encouraging a shift away from its use in practice by 
adopting a similarly critical stance. In a recent DCP Forum article, Houghton 
(2016) anecdotally proposes a number of roles clinical psychologists might 
undertake which are not limited to solely challenging medication use from a 
critical position, but opening up wider discussions to inform client decision 
making. Examples include: encouraging those wanting to come off medication 
to gain appropriate support, exploring the psychological meaning of taking 
medication, and providing a balanced perspective to the dominant medical 
discourse. The author argues that it is incumbent on the profession to raise 
ethical and clinical issues surrounding psychotropic medication use, and 
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avoidance of doing so may result in a disservice for clients. As discussed, there 
are a variety of views represented across the profession in regards to 
prescribing and wider forms of involvement (British Psychological Society, 2003, 
2018; Houghton, 2016). However, the extent to which such discourses influence 
clinicians practice remains largely unknown. 
 
Drivers for involvement.  
Increasing public domain campaigns about the use of psychotropic medication 
serve as an additional driver for the research, for example, the NHS England 
STOMP campaign (Stopping the overmedication of people with a learning 
disability, autism or both) (Voluntary Organisations Disabilty Group, 2017). The 
STOMP initiative developed following a care review triggered by the 
Winterbourne View hospital scandal, raising deep concerns about over-use of 
antipsychotic and antidepressant medicines for people with an Intellectual 
Disability (ID) (NHS Improving Quality, 2015). Initiatives such as STOMP 
represent contextual factors likely to influence clinical psychologists to become 
involved with clients’ medication, regardless of broader debates. STOMP outline 
aims for staff such as ensuring an understanding of psychotropic medication, 
including its main uses and side effects, encouraging staff to speak up if they 
are concerned a person may be over-medicated, and promoting psychological 
and person centred alternatives to medication (Voluntary Organisations 
Disabilty Group, 2017). Consequently, clinical psychologists working in ID 
services may be well-placed to promote such initiatives and become 
increasingly involved as a result of such campaigns.  
 
Roles and professional identity.  
Professional socialisation is a construct of role theory which emphasises how 
an individual conforms to a societally expected role (Baldwin, 2008). Clinical 
psychologists socialise to a professional norm in terms of professional 
standards set out by the Health and Care Professions Council (HCPC), DCP 
core competencies (Division of Clinical Psychology, 2010) and also wider 
expectations about what constitutes a clinical psychologist as held by the public 
and other healthcare professionals. Issues relating to psychotropic medication 
are not traditionally viewed as an aspect of the psychologist’s role (Walker, 
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2002), and there are no fixed standards for teaching on medication within 
clinical psychology training programmes. As such, many clinical psychologists 
have perhaps historically adhered to a socially expected role which is distinct 
from that of a prescriber. However, there is clear advancement through 
members of the profession proposing potential roles and voicing critique around 
its use, challenging traditional ideas of professional socialisation. Alongside a 
lack of specific professional guidance on the matter, role ambiguity is created 
whereby the accepted norm for the profession is ill-defined and unclear 
(Baldwin, 2008). Role blurring and reduction of traditional practices has become 
a significant issue for many practitioners, and whilst diffusion in roles has been 
considered progressive and flexibly desirable, concerns of losing a sense of 
professional identity within the multi-disciplinary team (MDT) are also noted 
(Brown, Crawford, & Darongkamas, 2000). Preserving a psychologist 
professional identity and having involvement with psychotropic medication might 
be considered a juxtaposition for some, blurring the line between prescriber and 
non-prescriber, and potentially creating tension between professions. The 
above considerations are likely to leave many clinical psychologists unsure of 
their role with psychotropic medication, resulting in inconsistent practice when 
navigating decisions around involvement. It appears surprising that there is no 
research into clinical psychologists’ roles with medication given the 
longstanding debates. The current research is warranted, and particularly timely 
given recent developments of proposing a task group to consider prescription 
privileges for psychologists in the UK (British Psychological Society, 2018).  
 
Research Aims 
The overall aim of this research is to investigate when and how clinical 
psychologists involve themselves in any aspect of psychotropic medication use 
with clients. It will also explore personal experiences of this involvement. The 
investigation will look specifically at psychotropic medication, and not 
medication as a whole. This is due to clinical psychologists’ primary treatment 
focus on psychological distress (Division of Clinical Psychology, 2010), which is 
also the target of psychotropic medication. The research questions are: 
1. What accounts do clinical psychologists provide in terms of their 
involvement in clients’ experience or use of psychotropic medication? 
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2. What rationales or reasons do clinical psychologists provide for the 
choices they make in this involvement?’ 
 
Method 
Given the paucity of literature, a mixed methods approach was deemed 
appropriate for complementarity in order to first gather widespread data, and 
then explore participant experiences in closer detail. An online survey was 
devised and employed, and eleven of these participants later took part in follow-
up interviews. The epistemological position adopted for this research was 
critical realism. The position assumes that a true reality independent to 
observers exists; however, it is impossible to fully apprehend this reality 
because perceptions are framed by investigative interests and theoretical 
resources (Harper & Thompson, 2012). This research was granted ethical 
approval by the University of Lincoln Research Ethics Committee and 
participation was voluntary. 
 
Instruments 
An online survey was created asking participants about their involvement with 
their clients’ psychotropic medication and general views towards medication 
use. Involvement was defined as a variety of activities that have the potential to 
influence a change in the client’s medication regime, or may also maintain its 
current state. The survey was based on previous research in the field 
(VandenBos & Williams, 2000) and asked respondents to select forms of 
involvement they had used: - 
 within the last six months; 
 that they would do given the opportunity; 
 the three they considered most important for clinical psychologists to be 
engaging in; 
 any considered inappropriate for Clinical Psychologists to be engaging 
in. 
A question inviting free-text responses was also included for respondents to 
report their general feelings on the use of psychotropic medication. The survey 
was piloted with trainee and clinical psychologist colleagues prior to use to test 
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its feasibility on a sample closely-matched to the intended audience. The survey 
contained an option to consent to a follow-up interview if selected. An interview 
schedule was created and then amended following online survey data analysis 
to reflect common themes. The interview schedule was similarly piloted with 
colleagues prior to use. 
 
Participants and Recruitment 
Online survey.  
Inclusion criteria were controlled as far as possible using skip-logic within the 
online questionnaire and were: - 
 aged over 18 years; 
 qualified clinical psychologist holding registration with the Health and 
Care Professions Council (HCPC); 
 proficiency in the English language (requirement of HCPC registration); 
 working in the United Kingdom. 
Targeted and opportunistic sampling was used in attempt to reach a large 
number of clinical psychologists. The survey was live for four months advertised 
online via social media, within the DCP Forum publication, and sent via email to 
UK Clinical Psychology training programmes and private healthcare companies 
employing clinical psychologists.  
 
Semi-structured interviews.  
Eleven participants who completed the online questionnaire engaged in a 
follow-up interview, consistent with a ‘moderate’ sample size as advised by 
Braun and Clarke (2013). Intensity sampling (Palinkas et al., 2015) was used to 
identify participants for recruitment from the online questionnaire who provided 
consent to be contacted. Selection criteria was developed to systematically 
choose an even mix of respondents who reported low and high levels of 
involvement with their client’s psychotropic medication, whilst representing a 
variety of services. Two researchers independently scrutinized the data 
following agreed criteria and consensus was reached on selection. Potential 
participants were contacted via email and through correspondence agreed 
means of interview (face-to-face, video conference, or telephone). 
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Analysis 
Descriptive statistics and logistical regression analysis were generated for the 
quantitative survey data was using IBM SPSS Statistics version 22. Qualitative 
data from the survey was coded and organised into themes (Braun & Clarke, 
2006). Both data sets were combined to form a deductive framework; this 
provides a structure to which the researcher can systematically check for 
occurrence of pre-defined codes (Gale, Heath, Cameron, Rashid, & Redwood, 
2013). 
 
Semi-structured interviews were analysed using thematic analysis following 
Braun and Clarke's (2006) six phase guidelines. The data was read several 
times for familiarity, coded to capture features of the data, and then grouped 
into emerging themes. A dual inductive-deductive approach was adopted by 
doing a secondary sweep of the transcripts using the deductive framework. 
Identified themes were then reviewed in order to construct an explanatory 
framework on the basis of the most important themes (Willig, 2013). 
 
Reflexivity 
The beliefs and values of the researcher will invariably influence the approach 
to methodology and analysis, therefore, reflexivity is considered important to 
increase credibility and rigor of the research process, particularly in qualitative 
research (Jootun, McGhee, & Marland, 2009). A reflective diary was used by 
the primary researcher to record thoughts and experiences in order to reflect on 
how this may influence the research process. This was referred to throughout 
research supervision particularly during the analysis phase to maintain 
awareness of, and limit any bias. 
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Results 
 
Sample characteristics – survey.  
147 participants completed the online questionnaire (120 females, 26 males, 1 
identified as other). Descriptive information about the sample can be found in 
Table 5.  
 
Table 5.  
Survey sample descriptive information 
Years 
qualified 
Service Service type Dominant psychological 
approach used 
<5 
49% 
Inpatient 
21.1% 
Child and Adolescent 
Mental Health Services 
(CAMHS) 
19% 
Cognitive 
2.7% 
5-10 
19% 
Community 
60.5% 
Intellectual Disability (ID) 
11.6% 
Behavioural  
5.4% 
11-15 
17% 
Both 
18.4% 
Adult 
44.9% 
Cognitive-Behavioural 
48.3% 
16-20 
6.1% 
 Older Adult 
10.2% 
Psychodynamic 
4.1% 
20+ 
8.8% 
 Physical Health 
15.6% 
Systemic 
4.2% 
  Other3 
21.8% 
Other4 
29.3% 
 
 
 
 
 
 
                                            
3 Other service types include: Eating disorders, neuropsychology, forensic, perinatal, early 
intervention in psychosis, military mental health, and occupational health. 
4 Other dominant psychological approaches used include: Acceptance and Commitment 
Therapy, Compassion Focused Therapy, Eye Movement Desensitisation and Reprocessing 
(EMDR) Therapy, Schema, and integrative working. 
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Table 5. cont. 
Survey sample descriptive information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                            
5 Either during training or post-qualification 
6 Professional group of trainer other options: author, biologist, drug rep, nurses, self-study. 
7 Unsure about having completed training: a long time ago in my training, as part of my doctoral 
training (2 days), attended talks discussing the current research and evidence base for 
medication for dementia, team CPD activities relating to various psychotropic medication, 
training delivered by psychiatrists on Dclinpsy, as part of UG teaching, few days on doctorate on 
impact of medication, term module at UG on psychopharmacology. 
Completed training on 
psychotropic medication5 
Length of time 
since training 
Professional group  
of trainer 
No 
49.7% 
<5 years ago 
29.3% 
Psychiatrists 
26.5% 
<one day 
17% 
5-10 years ago 
10.2% 
Pharmacists 
8.2% 
One day-one week 
23.8% 
11-15 years ago 
6.8% 
Psychologists 
8.8% 
>one week 
3.4% 
16-20 years ago 
1.4% 
Other6 
6.8% 
Unsure7 
6.1% 
20+ years ago 
2.7% 
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Sample characteristics – interviews.  
Eleven participants from the survey took part in semi-structured interviews. 
Descriptive information about the sample can be found in Table 6.  
 
Table 6.  
Interview sample descriptive information  
Name8 Service Involvement 
Louise Adult Low 
Nicole ID High 
Lucy Physical Low 
Hannah CAMHS High 
Hayley CAMHS High 
Alice ID Low 
Bradley Adult High 
Kate Other – Eating disorder Low 
Jessica Other – Forensic Low 
Saffron ID High 
Kristy Older adult Low 
 
Survey Findings 
The overwhelming majority of respondents (98%) reported they had recent 
involvement with their client’s use of psychotropic medication, and all 
respondents reported they would be willing to have some form of involvement 
given the opportunity. This is despite approximately half of participants (49.7%) 
not having attended any specific training related to psychotropic medication. 
The most common form of current involvement was reflecting with a client on 
their general experience of taking psychotropic medication, followed by 
discussing psychotropic medication issues within individual client sessions, and 
supporting clients to discuss their psychotropic medication with their prescriber. 
A high proportion of participants (89.1%) responded that given the opportunity 
they would engage in a collaborative discussion to help a client make a decision 
                                            
8 Pseudonym used 
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about their psychotropic medication, which was also reported as the most 
important form of involvement, despite this not being one of the most frequent 
forms of involvement for participants within current practice. Recommending or 
requesting specific psychotropic medication was perceived as inappropriate by 
just under half of participants (49%).  Table 7 details the forms of involvement 
voted as most important in ranked order in response to which three were 
considered most important to the role. Further frequencies can be found in 
Table 8; responses are ranked in order of frequency regarding the question 
“What kinds of involvement have you had with psychotropic medication in the 
last six months?”, with corresponding responses to the remaining two questions 
listed alongside. Numerical data refers to the frequency that the option was 
selected and the corresponding percentage. 
 
Logistic regression analysis found that participants working in Child and 
Adolescent Mental Health Services (CAMHS) (OR= 4, 2(1)=14.7p=.018), 
Intellectual Disability (ID) (OR= 8, 2(1)=14.7p=.005), and services which fell 
under ‘other’ (OR= 3, 2(1)=14.7p=.024) were statistically more likely to have 
been involved in the decision-making process to prescribe a service user 
psychotropic medication, compared to those working in adult, older adult, and 
physical health services. Participants working in ID services were also 
statistically more likely to have requested or recommended that a service user 
be taken off psychotropic medication (OR= 18, 2(1)=14.7, p<.001). 
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Table 7.  
Options voted as most important 
 Form of involvement Frequency 
option was 
selected 
1 Engaged in a collaborative discussion with a service user to support them 
in making a decision about their psychotropic medication.  
82 
(55.8%) 
2 Supporting service users to discuss their psychotropic medication with their 
prescriber 
61 
(41.4%) 
3 Involved in the decision making process to prescribe a service user 
psychotropic medication 
57 
(38.8%) 
4 Reflecting with a service user on their general experience of taking 
psychotropic medication 
56 
(38.1%) 
5 Reflecting with a service user on how their psychotropic medication may 
affect their engagement with psychology 
42 
(28.6%) 
6 Referral to a psychiatrist/other prescriber for psychotropic medication 39 
(26.5%) 
7 Discussed psychotropic medication issues within individual service user 
sessions 
32 
(21.8%) 
8 Consulted with a psychiatrist/other prescriber about changing a service 
user's psychotropic medication 
18 
(12.2%) 
9 Taking the time to research information about a service users' psychotropic 
medication (e.g. internet search, asking colleagues) 
17 
(11.6%) 
10 Requested or recommended that a service user be taken off a specific 
psychotropic medication 
12  
(8.2%) 
11 Supplied information about psychotropic medication to a service user 6  
(4.1%) 
12 Using psychological and/or neuropsychological tests to monitor and 
measure psychotropic medication effects 
6  
(4.1%) 
13 A psychological or neuropsychological assessment prompted 
recommendations for psychotropic medication 
5  
(3.4%) 
14 Requested or recommended that specific psychotropic medication be 
prescribed for a service user 
4  
(2.7%) 
15 Discussed psychotropic medication issues in group therapy sessions 1  
(.7%) 
16 None 0 
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Table 8. 
Survey results 
Form of involvement What kinds of 
involvement have you 
had with psychotropic 
medication in the last 
six months? 
What kinds of 
involvement 
would you do 
given the 
opportunity? 
Are there any options 
you feel are 
inappropriate for 
clinical psychologists 
to be engaging in? 
Reflecting with a service user on their general experience of taking psychotropic 
medication 
120 
(81.6%) 
136 
(92.5%) 
0 
Discussed psychotropic medication issues within individual service user sessions 117 
(79.6%) 
118 
(80.3%) 
3 
(2%) 
Supporting service users to discuss their psychotropic medication with their 
prescriber 
106  
(72.1%) 
134 
(91.2%) 
1 
(.7%) 
Engaged in a collaborative discussion with a service user to support them in 
making a decision about their psychotropic medication 
101 
(68.7%) 
131 
(89.1%) 
0 
Consulted with a psychiatrist/other prescriber about changing a service user's 
psychotropic medication 
91  
(61.9%) 
111 
(75.5%) 
5 
(3.4%) 
Taking the time to research information about a service users' psychotropic 
medication (e.g. internet search, asking colleagues) 
82 
(55.8%) 
122 
(83%) 
1 
(.7%) 
Referral to a psychiatrist/other prescriber for psychotropic medication 73 
(49.7%) 
102 
(69.4%) 
9 
(6.1%) 
Reflecting with a service user on how their psychotropic medication may affect 
their engagement with psychology 
73 
(49.7%) 
128 
(87.1%) 
0 
Involved in the decision making process to prescribe a service user psychotropic 
medication 
65 
(44.2%) 
105 
(71.4%) 
10 
(6.8%) 
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Table 8 cont. 
Survey results 
Form of involvement What kinds of 
involvement have you 
had with psychotropic 
medication in the last 
six months? 
What kinds of 
involvement 
would you do 
given the 
opportunity? 
Are there any options 
you feel are 
inappropriate for 
clinical psychologists 
to be engaging in? 
Supplied information about psychotropic medication to a service user 49 
(33.3%) 
87 
(59.2%) 
32 
(21.8%) 
Requested or recommended that specific psychotropic medication be prescribed 
for a service user 
30 
(20.4%) 
49 
(33.3%) 
72 
(49%) 
Requested or recommended that a service user be taken off a specific 
psychotropic medication 
29 
(19.7%) 
70 
(47.6%) 
39 
(26.5%) 
 
A psychological or neuropsychological assessment prompted recommendations 
for psychotropic medication 
28 
(19%) 
54 
(36.7%) 
30 
(20.4%) 
Discussed psychotropic medication issues in group therapy sessions 15 
(10.2%) 
68 
(46.3%) 
9 
(6.1%) 
Using psychological and/or neuropsychological tests to monitor and measure 
psychotropic medication effects 
13 
(8.8%) 
61 
(41.5%) 
8 
(5.4%) 
Other 8 
(5.4%) 
9 
(6.1%) 
0 
None 3 
(2%) 
0 49 
(33/3%) 
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Interview Findings 
The analysis identified five overarching themes, some with corresponding 
subthemes. The thematic map (Figure 2) has been created to capture a 
prominent narrative within the data of the process by which clinical 
psychologists’ weigh up factors prior to deciding to have involvement, and then 
flexibly navigates their approach to and actions during involvement. This 
process incorporates stages (which have formed themes) and been separated 
for clarity, but may overlap in practice. 
 
 
Figure 2. Process of involvement 
 
Conflicts and uncertainties.  
This theme highlights pre-existing conflicts and uncertainties that clinical 
psychologists face prior to making any decision about involvement. This was 
particularly within the context of the profession holding a broad critical stance, 
and what was felt as a duty to advocate against biological frameworks of mental 
health. The majority of participants reported strong encouragement during 
training to challenge the medical model, and a lack of teaching specific to 
psychotropic medication. This left many feeling uninformed and ill-prepared 
given the prevalence of medication use in practice, having to navigate the 
challenges of working in systems with entrenched medical underpinnings: - 
 Page 67 of 272 
 
“It felt as though our job, as psychologists, is to advocate for, you know, on 
behalf of the patient, and kind of shift away from this taxonomic DSM9 
model, to this kind of wonderful world where everyone formulates and 
nobody prescribes, you know. And in practice that’s, that’s just not 
realistic”. - Lucy 
 
Disparity between professional expectations and reality of practice added 
further conflict in terms of medication use being at odds with the dominant 
professional stance, with hesitancy to be too critical of a widely used treatment 
option that many clients and colleagues value. Uncertainty also arose in how 
knowledgeable participants felt they were expected to be about medication: - 
 
“So I think there’s that dichotomy between wanting to be seen as 
knowledgeable and, you know, I know about medication, I can pronounce 
these, I know what you’ve prescribed for. And on the other hand going, 
well actually, I’m not a medic, I’m not a nurse, I’m not going to pretend that 
I have full grasp of why this person’s taking this”. - Nicole 
 
These conflicts and uncertainties shape the context of clinical practice, with 
decisions being navigated in their presence. There is participant consensus 
about clinical psychologists having a role with psychotropic medication, but 
where this role begins and ends feels unclear, particularly amid perceived 
expectations from the profession to adopt a critical stance. 
 
Weighing up.  
‘Weighing up’ attempts to capture what seems to be an implicit process 
whereby participants consider a variety of factors before choosing to have 
involvement. Certain aspects were found to encourage or discourage 
involvement; these factors have been grouped under two subthemes: values 
driven responses to clients, and team context. 
 
                                            
9 Refers to Diagnostic and Statistical Manual of Mental Disorders 
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Values driven responses to clients.  
Prior to involvement, participants considered whether they felt able to provide 
information when a client appeared to be ill-informed, or misinformed about the 
effects of medication. A desire to provide information appeared to stem from 
personal and professional values of supporting informed consent. Some 
considered it “part of my duty of care to my clients… to encourage them to be 
informed about medication” (Hayley). There was acknowledgement that it may 
fall outside of role remit, but psychologists might feel driven to intervene if other 
professionals did not appear to provide information: - 
 
“And in a way that’s not my role, I don’t think, it’s the GP’s role. She should 
have given the staff member and the client, you know, some literature 
about it. But because that’s not been done, I kind of feel like a pull really, 
to think, well you do need this knowledge”. - Jessica 
 
Participants also described a sense of duty to explore client beliefs about what 
medication can achieve and to manage expectations and minimise false hope: - 
 
“I think a lot of people think, well I’m taking this and I’ve been taking it for 
two months, so I should now feel at least sort of fifty percent better. And 
then you have to have conversations about exactly sort of what medication 
can and can’t do. That it’s sort of not a magic pill and that it sort of might 
have a, might make a slight shift, but it wouldn’t sort of fix your problem”. - 
Hayley 
 
Even when driven by values, decisions to intervene were weighed up with fear 
of potential negative consequences of addressing medication issues: - 
 
“I think there’s always the fear of litigation in the NHS and sort of, I’m 
always very cautious to make sure I stay within the boundaries of my role 
because if I start, even if I’d had further training, if I’m starting to advise 
and, you know, I think I would be worried about giving the wrong advice”. -  
Lucy 
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Weighing up may result in not becoming involved despite a values-driven desire 
to, due to concerns of overstepping boundaries, providing inaccurate 
information, appearing unknowledgeable, offending colleagues by encroaching 
into their area, or fear of blame and litigation. 
 
Most participants believed medication was appropriate in some circumstances, 
but that it was over-prescribed and inappropriately used as a first-line treatment. 
A drive to challenge the use of medication and propose alternatives was, 
however, weighed up in practice with consideration of client distress and risk: -  
 
“I’m just thinking, just get them calm, get them a little bit calmer, get them 
to be able to just not do themselves harm… I think when there’s issues of 
risk, it’s not going to be for me to try and stop people benefitting from 
something that might help them in the short term”. - Louise 
 
This offers an example of values relating to maintaining client safety and 
reducing distress outweighing values that might drive critical involvement in 
clients’ medication. 
 
Clients’ diagnosis and presentation also influenced whether participants 
considered themselves as having the authority to respond, given narratives 
about the aetiology of a diagnosis and whether it was considered a 
‘psychological’ difficulty: - 
 
“I have a stronger argument if somebody has a personality disorder 
diagnosis… because the evidence backs me up, because it’s also seen 
as more of a psychological issue, so I’ve got more authority to talk about 
it”. - Louise 
 
Alternatively, dominant biological understandings of a diagnosis made it more 
challenging to offer alternative perspectives. Inclination to speak up also 
appeared motivated by a pull to advocate on behalf of clients when an individual 
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may lack capacity or present as suggestible, e.g. Nicole discussed clients with 
an ID: - 
 
“Not all, you know, some will have capacity to make decisions, but are still 
led massively by the opinions of those around them… So it’s sometimes 
about they’re being very influenced, being very led, by people in the 
system. So I think we have more of a role to advocate for our clients”. - 
Nicole 
 
This was particularly reflected in CAMHS and ID services, with values-based 
practice often prevailing during weighing up, perhaps due to feelings of 
protectiveness that a client’s perceived vulnerability may evoke.  
 
Team context.  
'Team context’ refers to external factors that influence decision making about 
involvement encompassing the immediate team and set-up of the service. 
Participants appeared to weigh up whether they needed to be involved based 
on whether the MDT’s actions were already aligned with their agenda. In some 
instances, this meant deciding to step back as there was felt to be little need to 
intervene: - 
 
“I might ask why somebody’s on something. Certainly, people who have a 
personality disorder diagnosis, I might say, why are they on all this stuff?  
But actually, usually the psychiatrist and pharmacist in the service that I 
work in are really hot on saying, let’s, it’s not going to help, so let’s get 
them off it, you know”. - Louise 
 
This appeared particularly evident in services whereby there were national 
drivers for medication reduction, such as dementia and ID services, or in 
services where clients had additional health risks, such as older adult and 
eating disorder services. In deciding whether to raise an issue about a client’s 
medication or offer an opinion, there was often a process of weighing up 
whether participants felt permitted to do so in the context of a team meeting. 
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Good quality relationships, particularly with prescribers, were felt to be key in 
broaching such conversations: - 
 
“I think it’s, we’re fortunate that the relationships, and I feel the 
relationships here with our medical professionals are very transparent and 
very honest. So I wouldn’t have difficulty saying to a medical professional 
in an MDT setting, well actually, it’s not helping, so we don’t want to give 
tablets”. - Nicole 
 
Nicole feels confident in challenging the use of medication due to an 
understanding that her views will be well received or at least considered. In 
contrast, others reported how power dynamics could impede authority to speak 
up: - 
 
“…this kind of heavy medication was suggested and I was sitting there 
thinking, oh my word. And so the mother turned to us, as people that, you 
know, were in the previous meeting with her, and just kind of, you know, 
was saying to us, well what do we think about that?  And straightaway the 
psychiatrist said, I’m the only one that can give information about 
medication, it’s only me that you need to listen to”. - Alice 
 
Such experiences consequently affect the weighing up process in future 
situations, based on expectations of receptiveness by the team.  
 
An additional challenge was being invited to take on a role, such as an 
intermediary role between service user and prescriber. This created difficulty in 
navigating requests as role boundaries felt unclear, and there were concerns 
about being perceived as aligning too closely with psychiatry: - 
 
“So I have actually, you know, had to do a bit of an assessment 
sometimes with a client, saying, how do you feel about your medication, 
do you want it to change, do you want to see psychiatry, what are your 
thoughts?  Because they’re not engaging with psychiatry… So 
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sometimes that feels a bit uncomfortable but I think it’s about positive 
working relationships, isn’t it?” - Nicole 
 
Nicole explains how taking on such a role is balanced with hoping to maintain 
good working relationships with colleagues, which can sometimes take 
precedence despite concerns about blurring role boundaries. 
 
The service in which participants work also influences the opportunities for 
involvement that arise. In a service with no co-located prescriber, the 
psychologist may have a lead clinical role, which necessitates greater 
involvement with medication: - 
 
“So yes, like if I didn’t think someone needed medication, then I wouldn’t 
refer them. And if I felt they do need it, then I’d need to refer, and if I don’t 
have that conversation with myself, then nothing happens”. - Kristy 
 
Kristy occupies this role comfortably and offers a clear account of being solely 
responsible for the decision to afford service users access to medication. In this 
extract the weighing up process is straightforward and routinely engaged in.    
  
Overall, participants’ values-based responses to clients frequently drive 
involvement, but are weighed up against a variety of factors before action takes 
place. This includes uncertainty about knowledge held, overstepping role remit, 
and dynamics within the team. 
 
Strategy re: agenda.  
A decision to become involved was underpinned by psychologists’ agendas 
towards medication, often aimed at influencing prescribing in some capacity. 
The strategy by which agendas were expressed varied both between and within 
participants depending on the situation, aligning on a continuum from neutral, to 
tentative, to challenging. Neutral refers to the dropping of views and personal 
agenda towards medication, and acting in a neutral or balanced way, whilst 
tentative and challenging reflect the expressing of agenda. 
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Neutral strategies were often responsive and used when relevant knowledge 
was felt to be lacking, or actions were considered out of remit. Hayley explains 
the reason she may choose not to express her agenda: - 
 
“I do feel like I have reasonable knowledge about what different 
medications do and how they work, it’s just I wouldn’t want to step outside 
of the boundaries, as you were saying, or sort of outside of my role in 
talking about it too much with my clients”. - Hayley 
 
Tentative strategies to gently query and challenge medication use were used by 
way of “inviting curiosity”, “introducing doubt”, and “thinking about the nudge, 
you know, where you might try to push people in the right direction with little 
things” (Bradley). Challenging strategies risk gaining a domineering reputation, 
and meeting resistance. However, others believed outwardly voicing 
disagreement was more effectiveness in influence change: - 
 
“…I think if you’re too tentative with it, which is a lot of the time what 
psychologists are encouraged to be like, tentative and curious, actually, it 
doesn’t get taken anywhere, it doesn’t get taken seriously”. - Saffron 
 
Whilst the underlying agenda remained consistent, strategies in expressing this 
were flexibly adopted and participants moved between stages of the continuum, 
as Hannah explains: - 
 
“…sometimes I’ve kind of just talked about the psychological approach 
and said, oh can you just give us a few weeks? Because otherwise, we 
won’t be able to know whether it’s the medication or the psychological 
work. And with other people I’ve kind of had more of a direct, but we don’t 
have any evidence that this medication would work… So it depends who 
I’m talking to, as to how I’d approach the conversation.” - Hannah 
 
Hannah assesses the most efficient strategy to communicate her agenda and 
influence change. This flexibility allowed participants to remain loyal to their 
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agendas in spite of unsuccessful involvement, as alternative strategies are 
adopted and used. 
 
Strategy of action.  
The actual process of involvement with medication broadly fell under two 
subthemes: direct work about medication, and offering psychological 
alternatives. Both forms operationalise underpinning agendas by putting these 
into practice. 
 
Direct work about medication.  
All participants reported engaging in direct work about medication, most notably 
adopting a reflective role helping clients consider medication and its usefulness, 
and discussing the utility of medication with the team: - 
 
“I have a therapy role and I also have a care coordination role in my team, 
and in both of those I would discuss medication with people if, whether 
that’s sort of them coming to me saying, oh I’ve been thinking about taking 
medication or I’m not sure about what I’m taking, you know, those kind of 
queries… And I do join their psychiatric reviews quite often and I’ll have 
conversations with the psychiatrists about whether or not medication’s 
likely to be helpful.” - Hayley 
 
Additional examples include: providing information about medication side 
effects, suggesting or advocating use of medication, supporting decision making 
by weighing up pros and cons, and attending joint psychiatry reviews. 
 
Offering psychological alternatives.  
Perhaps unique to clinical psychologists, awareness of clients’ medication and 
its effects helped to inform psychological formulation of the individual: - 
 
“So it can just tell you a lot about somebody’s coping at that moment in 
time. You can start to wonder why it is. Is it the culture of the hospital or is 
it because that person hasn’t got any other coping skills?” - Louise 
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Louise understands a client’s relationship with medication as part of a 
formulation about their coping styles, informing possible routes for intervention.  
 
Promoting psychological alternatives to medication was often used as a 
strategy for challenging medication use, an aspect considered vital within the 
role: - 
 
“I think as psychologists probably we do have a role in, we have a big role 
in promoting psychological approaches to mental health. And sort of 
thinking, sort of maybe showing examples of when it can be used as an 
alternative to medication.” - Kate 
 
This was achieved by sharing formulations, and promoting alternative coping 
strategies to medication, indirectly challenging diagnosis and medical 
understandings of mental health. Although considered an important role, 
challenges of doing so were recognised. Lucy highlights difficulties faced in 
implementing an intervention: - 
 
“So it was one of those, that kind of in practice, you could very much 
advocate for non-medication and sort of a more holistic psychologically 
informed intervention, but kind of actually, when it came down to it, 
sometimes resource levels made that not very feasible.” - Lucy 
 
Lucy’s attempted intervention demonstrates ongoing difficulties faced with the 
application of psychological alternatives. 
 
Offering alternatives and challenging medical narratives was also considered an 
aspect of the role on a wider scale by some. Alice shared critical articles about 
medication with colleagues with aims of influencing change by disseminating 
information and gaining like-minded allies: - 
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“So I think it’s not enough just to sit and sort of moan, you have to actually 
get out there and do the work and publicise it and influence wherever you 
can.” - Alice 
 
Similar sentiments were echoed across participants, however, this role of 
challenging the status quo was felt to be at risk of being lost if psychologists 
gradually emerge into performing solely therapeutic roles, as Bradley believed 
to be the case: - 
 
“I think as long as psychologists always put primacy on formulation and, 
you know, the biopsychosocial model, then, you know, just by doing that, 
then there will always be a challenge to kind of the more simplistic medical 
or biological view. But yes, there’s a risk that we could lose that if that isn’t 
seen as kind of like what a psychologist does.” - Bradley 
 
A clear role for clinical psychologists promoting alternatives to medication is 
outlined, however, potential barriers in feasibility highlighted.  
 
Reflection on strategy.  
The final part of the involvement process entails reflecting on the strategy used 
and its perceived success. This feeds back into the beginning of the process 
whereby the outcome is viewed in context of conflicts and uncertainties (which 
may or may not have changed) and hence forth. 
 
Mixed outcomes as a result of involvement were reflected, with some 
participants reporting “The amount of times that I’ve been able to influence 
anything are tiny, you know, just a handful of times” (Bradley), whereas others 
felt that “Psychology is really valued and we are quite respected, so my view 
does often count” (Saffron). Despite variation in outcome, there was general 
consensus that ‘unsuccessful’ involvement would not deter from deciding to 
become involved again in future. Hannah responds to a question about feeling 
discouraged when being shut down from expressing her views in a meeting: - 
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“No, they just really annoyed me. Because I just, I guess by that point, I 
just felt like I had a role and I’m employed to have this role, and I’m doing 
a really rubbish job if I don’t advocate a psychological approach when I’m 
that person’s psychologist.” - Hannah 
 
Hannah’s reflection can be seen to link back to the ‘values-driven responses’ 
subtheme in that based on past experiences of involvement, she continues to 
weigh up decisions and is directed by values of working in line with client’s best 
interests. Based on experiences of being shut down she may, therefore, adopt 
an alternative strategy of agenda and action.  
 
Summary of Interview Findings 
Results suggest that clinical psychologists are engaging in various forms of 
involvement with medication on a regular basis, often with intent to influence 
prescribing based on their agendas. Analysis identified a process by which 
clinical psychologists weigh up factors prior to deciding to have involvement in 
order to establish their rationale, and then flexibly navigate their approach and 
actions. This all occurs within the context of professional uncertainty and 
conflict, under dominant societal narratives around epidemiology of mental 
health difficulties and the effectiveness of medication. Following involvement, 
participants reflected on their strategy which led them to consider future 
approaches. 
 
Synthesis of Results 
The survey data was largely supported within the interview data, particularly 
reflected in personal opinions towards medication. Many forms of involvement 
within the survey were discussed during interview, but qualitative exploration 
enabled increased forms of involvement to arise. Additionally, processes of 
decision making and strategy selection were identified which represent an 
important elaboration on the findings of the survey. Whilst both data sets were 
largely aligned, there were some slight discrepancies which will now be 
discussed. 
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Requesting or recommending that medication be prescribed or discontinued for 
a client was largely identified as inappropriate during the survey, but the 
majority of interview participants spoke of their strategies in challenging 
medication use. One reason for this discrepancy might be the particular 
phrasing of the survey option in that clinical psychologists might not advise on a 
“specific” medication, but more broadly. Based on the interview data, knowledge 
on specific medication types would likely be seen as beyond the remit, whereas 
all participants reported having some general knowledge. Alternatively, it may 
be deemed more of an appropriate role to question or challenge medication use 
in a preventative manner prior to it being prescribed. This was not an available 
option on the survey, however, was the context of many of the examples 
participants described. VandenBos and Williams (2000) suggested that the 
average psychologist may not actually be aware of the extent to which 
knowledge and involvement with psychotropic medication may form a significant 
aspect of their practice. The manner in which participants attempted to 
challenge or reduce the use of medication within the survey is complex and 
often subtler as opposed to directly voicing disagreement. As such, participants 
may not have considered themselves to be actively trying to reduce or stop the 
use of medication, possibly explaining the discrepancies between data sets. 
 
Client vulnerability and possible lack of capacity prompted some participants to 
seek an advocacy role and feel increased empowerment to take on a role with 
clients’ medication. This offers context to the survey finding that participants 
working in CAMHS and ID services were more likely to be involved in decision-
making processes, and participants working in ID were more likely to request or 
recommend a client be taken off medication. 
 
Discussion 
Findings echo those of the US study by VandenBos and Williams (2000), who 
found that almost all psychologists in their study were involved with medication 
in some capacity. Current forms of involvement are also congruent with roles 
proposed by Houghton (2016), indicating that hypotheses around what the remit 
of the role might be are already occurring in practice. In addition, clinical 
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psychologists’ roles extend beyond those proposed by Houghton (2016), 
demonstrating more of an active and challenging role than might have been 
expected. These findings have clinical implications given that by and large, 
clinical psychologists are regularly engaging in roles with psychotropic 
medication despite a lack of guidance from professional bodies, no professional 
position statement, and minimal (or no) teaching during training.  
 
Vandenbos and Williams (2000) offer little speculation of agendas driving 
involvement other than suggesting that knowledge of medication may help in 
understanding the whole person, and support career progression into new roles. 
In the current study, participants’ involvement was both driven and justified by 
the belief that it was integral for remaining loyal to personal and professional 
values. Agendas propelling involvement can be understood within the key 
values underpinning the profession, outlined in the code of ethics and conduct: 
respect, competence, responsibility, and integrity (British Psychological Society, 
2009). Participants navigated their actions within their boundaries of 
competence by intervening to uphold their responsibility to reduce clients’ 
psychological distress. Ensuring client self-determination by claiming to support 
informed decision making, and managing expectations of medication in clients’ 
‘best interests’ can be framed under the values of respect and integrity. The 
notion of intervening in clients’ best interests raises interesting issues, however. 
With absence of a formal capacity assessment to determine a best interest 
decision in its true definition (British Psychological Society, 2010), this reflects a 
parallel idea to ‘best interests’ whereby own views are imposed with assumption 
of knowing best. This highlights the question of whether involvement is 
genuinely within clients’ interests, or is driven by a series of personal, 
professional, and broader societal agendas. 
 
Within context of emerging critical publications towards the medical model 
(Johnstone & Boyle, 2018), it was anticipated that findings might represent a 
largely critical stance erring away from supporting medication use. In contrast, 
participants experienced conflict arising from perceived pressure to advocate 
away from medical approaches, with challenges faced applying this in practice. 
Indeed, most participants were opposed to professional critical narratives and 
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took care not to adopt these into practice. The body of participants does not 
appear to be representative of the alleged professional view, raising the 
question of whether the profession does in fact hold a collective critical stance, 
but just some vocal members within it.  
 
Comparisons can be drawn with a recent study exploring clinical psychologists 
attempts of working beyond diagnosis (Randall-James & Coles, 2018). The 
authors found that many psychologists “played the diagnosis game” in order to 
pursue change, and sought balance of getting along with others whilst 
negotiating differences to make small changes. Similarities can be found in that 
clinical psychologists also factored in the team context when weighing up 
decisions to be involved. However, Randall-James and Coles (2018) found that 
the action of making a stand and voicing difference was found to be courageous 
or troublesome by clinical psychologists in their study, a concept not reflected in 
the current study. This discrepancy is interesting given the professional stance 
and guidance on diagnosis (Division of Clinical Psychology, 2013; Johnstone & 
Boyle, 2018), but not on psychotropic medication. This might perhaps be due to 
psychotropic medication being one aspect of clients’ treatment, whereas 
questioning diagnosis potentially challenges larger understandings and 
frameworks of mental health. In addition, negative consequences of medication 
could be more apparent when compared to those of diagnosis, increasing the 
rationale for challenging its use.  
 
Role ambiguity was apparent within the current study as all participants noted a 
clear role with psychotropic medication, but difficulty in judging these 
parameters. To a large extent, team context impacted decisions around 
involvement and influenced how participants shaped their role. Difference in 
authority, power and status have been found to limit a professional’s capacity to 
influence their team (Onyett, 2003), reflected in the findings by some who felt 
disempowered to become involved. Research into MDT working suggests that 
two alternative professional reactions are generally elicited by members; firstly, 
attempts to establish marked inflexible roles based on professional expertise, 
ensuring that professional interests do not overlap (Hannigan & Allen, 2011; 
Peck & Norman, 1999). This has been found to be particularly pronounced 
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when clinicians found themselves ‘feeling threatened’ by other professions 
(Donnison, Thompson, & Turpin, 2009). This may account for power dynamics 
impeding psychologists’ involvement due to perceived encroaching into 
psychiatry’s domain.  
 
Secondly, professionals may allow role blurring to occur when there is a shared 
body of knowledge (Onyett, 2003), resulting in disorganised role boundaries 
and overlapping responsibilities between professionals (Bailey, 2012). Role 
blurring was most apparent where professionals’ task boundaries were flexible, 
such as fulfilling an intermediary role between the psychiatrist and client. Some 
participants described feeling pulled into intervening beyond their remit to fill 
gaps missed by other professions. Role blurring has been found to impact the 
division of labour on teams (Maddock, 2015) and result in reduced team 
efficiency (Wall, 1998). Role ambiguity, therefore, has implications for effective 
team working but remains an unresolved issue given the current lack of 
consensus and clarity on roles with medication.   
 
Limitations 
It is important to consider the potential impact of self-selection bias; those with 
strong opinions on the use of psychotropic medication may have increased 
interest in voicing their opinions. However, attempts were made to minimise this 
risk through recruitment. The spread of responses in reply to being questioned 
about strong views in the survey, and balance of views within interviews 
suggests that this was at least in part successful. 
 
Generalisability  
Participants were recruited from a variety of services in order to facilitate 
comparison and increase transferability. The critical realists’ aim is not to 
generalise, but to develop deeper levels of explanation and understanding 
regarding the phenomenon under study (Mcevoy & Richards, 2006). 
Furthermore, there is debate as to whether generalisability is a meaningful goal 
for qualitative research (Braun & Clarke, 2013). Goodman (2008) proposed a 
concept of flexible generalisability which may be claimed when a discursive 
strategy achieves a certain function, and the strategy achieves this function in a 
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range of settings by a range of speakers. Study results support a claim of 
flexible generalisability, as analysis indicated a shared process underlying 
decision making (despite variety in actual forms of involvement) across both 
participants and service types. In addition, interviews largely supported survey 
findings, suggesting that participants interviewed are likely to be reflective of the 
wider sample (increasing generalisability claims). 
 
Clinical Implications and Future Directions 
To the author’s knowledge this is the first study to explore the topic area within 
the UK. Study findings are considered important due to uncovering the extent to 
which involvement forms part of the role, which was previously unknown. 
Findings translate into two main clinical implications: 1) supporting the idea of 
training on psychotropic medication for clinical psychologists, and 2) 
professional guidance to inform clinical psychologists’ practice. 
 
Houghton (2016) suggests that a position statement on psychotropic medication 
could be created in a similar vein to the DCP statement on diagnosis (Division 
of Clinical Psychology, 2013). Such a statement may balance some of the 
debates around medication use and the biological model of mental health, as 
well as support helpful prescribing. The current research supports Houghton’s 
proposal. Guidance and/or a position statement would serve to back clinical 
psychologists in their roles with medication, propose boundaries to help 
navigate decisions, and instill confidence in authority to talk about medication. 
As it stands, clinical psychologists are already involving themselves, therefore, 
professional guidance may help inform consistency and support individuals 
through the weighing up process who may previously have felt that the issue 
was unrelated to their role. Participants working in ID services felt particularly 
driven to advocate on behalf of clients due to perceived vulnerability and issues 
with capacity. This may reflect the impact of initiatives such as STOMP, 
suggesting how formal guidelines might permit greater involvement. 
 
VandenBos and Williams (2000) called for a generally agreed model of 
psychopharmacology training for psychologists to support them in 
understanding how psychotropic medication use can affect their clients, and to 
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increase ability to move into different employment positions (such as directors 
of inpatient hospitals). Participants in the current study had mixed views on 
whether they thought training should be received. Many felt that increased 
knowledge would be helpful, whereas others were unsure about the 
expectations this would create for psychology amid fears this would blur the 
profession with psychiatry. Nonetheless, perhaps increased focus on 
psychotropic medication during training would be relevant considering the 
extent to which medication already forms part of the role for many.  
 
There may also be increased relevance for training on psychotropic medication 
post-qualification, especially considering changing roles for clinical 
psychologists. The mental health workforce plan for England produced a 
document: Delivering the Expansion in the Psychological Professions (The 
Psychological Professions Network Alliance, 2018) outlining plans for mental 
health care forwards to 2020/21. Future opportunities note the idea of ‘flexible 
practice’ in that psychological professions are well placed to take up roles that 
have been traditionally held by psychiatrists. This includes Responsible 
Clinician (RC) roles wherein responsibility is taken for the whole of a person’s 
care where they may be detained under the Mental Health Act. Adopting such 
roles may call for increased awareness of psychotropic medication, and 
increased involvement with decisions about medication. In addition, as of 
January 2018 the BPS are seeking to create a task group to consider 
prescribing rights for psychologists. The intention is to increase the range of 
specialist support services that psychologists can offer, rather than replicating 
the expertise of other healthcare professionals (British Psychological Society, 
2018). This highlights the ongoing debate of clinical psychologists and 
psychotropic medication, further emphasising the need for clarity on roles and 
expectations. 
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1. Extended Background 
This section expands on the journal paper by providing further information on 
relevant literature, additional theory to support the research, and extended 
rationale for the study. 
 
1.1 Psychotropic Medication10 and the Medical Model 
Psychotropic drugs are the mainstay of psychiatric treatment, and have been 
since about the 1950s (Moncrieff, 2009). Prior to this time, drugs (particularly 
sedatives) were used in psychiatric hospitals, however, as new drugs were 
introduced, views about how they worked gradually transformed. An 
understanding developed that the drugs worked by reversing underlying 
psychiatric diseases akin to physical illness. As a branch of the medical 
profession, psychiatry has historically conceded that psychological distress can 
be understood and treated with drugs, not unlike physical health problems 
(Moncrieff, 2009). Although this view has also constantly been challenged, the 
1960s saw an antipsychiatry movement whereby philosophical and political 
objections arose against the concept of psychiatric disorder as a medical illness 
(Szasz, 1970). Despite contestation of the medical model, biological 
explanations for the causation of mental health problems and ensuing 
diagnostic categories perpetuated the widespread use of drug treatments. The 
development of a market for specific drugs has also served to shape views 
about the nature of disorders, and in some cases permitted creation of such 
diagnoses in order for drugs to seemingly target specific disorders. As an 
example, the concept of depression was not widely accepted prior to the 
introduction of drugs considered to be antidepressants (Moncrieff, 2008). 
Consequently, the pharmaceutical industry has been influential in shaping the 
course of psychiatric treatment.   
 
Interpreting the evidence base for psychotropic medication presents a complex 
picture, given the vast array of drugs and diagnostic categories of mental health 
disorders subject to research. Taking antidepressants as an example, there are 
numerous randomised control trials comparing the efficacy of antidepressants 
                                            
10 Throughout the article the term ‘medication’ is sometimes used to avoid repetition. This 
continues to refer to psychotropic medication unless otherwise specified. 
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with placebos in individuals who have been diagnosed with depression. Overall, 
most studies report better outcomes for those taking the antidepressants, 
however, many studies find no difference and often the size of the effect is very 
small (Moncrieff, 2009). Consensus on the efficacy of psychotropic medication 
has not been reached and remains a contentious issue; a recent systematic 
review determined that antidepressants were indeed more effective than 
placebos (Cipriani et al., 2018), a conclusion reaching newspaper headlines 
(Bosely, 2018) despite previous weak evidence (Moncrieff, 2009). Regardless 
of limited evidence for a disease model of mental health (Moncrieff, 2009), and 
mixed evidence for the efficacy of psychotropic medication, prescription rates 
continue to increase. Figures demonstrate a 6% rise in the prescription of 
antidepressant medications in the community in England between 2015 and 
2016 (Health and Social Care Information Centre, 2017). This increase is 
consistent with the overall rising trend for all psychotropic medication, which 
rose on average by 6.8% every year between 1998 and 2010 (Ilyas & Moncrieff, 
2012). Psychotropic medication remains a core component of modern 
psychiatric treatment, recommended within National Institute of Health and Care 
Excellence (NICE) guidelines for many psychological problems, e.g. depression 
(National Institute for Health and Care Excellence, 2016) and obsessive 
compulsive disorder (National Institute for Health and Care Excellence, 2005).  
 
1.2 Clinical Psychology and the Medical Model 
As outlined in the journal paper, there is a long history of movement within the 
Clinical Psychology profession advocating for a shift away from use of the 
medical model framework of mental health. This is most apparent in regards to 
psychiatric diagnosis. The British Psychological Society (BPS) propose that 
psychologists may use evidence-based psychological formulations, theories, 
and models as a means of supplementing or replacing diagnosis (Division of 
Clinical Psychology, 2011). Furthermore, a position statement was published 
outlining a collective professional view on diagnosis, and how a paradigm shift 
was needed to incorporate psychological formulation into mental health care 
(Division of Clinical Psychology, 2013). Recent research into clinical 
psychologists’ questioning diagnosis in practice suggests that attempts to 
create a paradigm shift are occurring by way of making small changes to 
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practice and sharing psychological alternatives (Randall-James & Coles, 2018). 
However, this practice was reportedly met with difficulty, as participants 
suggested a need to work with diagnosis due to the utility it can hold for the 
client, or to maintain working relationships. The authors concluded that an 
alternative conceptual framework for non-diagnostic practice was needed to 
support psychologists in working beyond diagnosis. Since publication of the 
research, the Power Threat Meaning Framework (PTM) has been issued in an 
attempt to offer such a conceptual framework (Johnstone & Boyle, 2018). 
Subsequently, continued research into psychologists influencing a shift from the 
medical model may be anticipated in future. 
 
A small number of professional publications make reference to psychotropic 
medication, however, consideration remains somewhat limited. The Division of 
Clinical Psychology (DCP) document ‘Understanding Psychosis and 
Schizophrenia’ considers psychotropic medication use (Division of Clinical 
Psychology, 2014). The document outlines both helpful and harmful effects of 
medication, challenges the use of medication under compulsion, and states a 
need for services to move beyond the medical model. Additionally, the PTM 
framework also encourages professionals to be aware of the potentially 
damaging effects of psychotropic medication, and how their use may cause or 
exacerbate emotional distress (Johnstone & Boyle, 2018).  
 
1.3 Psychologists and Psychotropic Medication 
This section will expand on the literature review in the journal paper by 
describing the literature search strategy, elaborating on previous research, 
including relevant additional papers, and justifying exclusion of attitudinal 
research papers 
 
1.3.1 Literature search. 
A literature search was conducted using a combination of the search terms 
“psychologist”, “medication”, “psychotropic”, “psychiatric” and “prescribing”. 
Papers were screened regarding their relevance to the research. A collection of 
papers returned from the search were both commentary and research articles 
exploring attitudes towards psychologists gaining prescription privileges in a 
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variety of countries. For example, questioning whether psychologists in New 
Zealand supported the idea of prescribing (Fitzgerald & Galyer, 2008), 
considering the pros and cons of psychologists prescribing in the UK (Newman, 
2013), and advocating against prescribing in the US (DeNelsky, 1996).  
 
A decision was made to exclude attitudinal papers in order to maintain 
‘involvement’ in a broad sense and avoid a narrow focus specifically on 
prescribing. Additionally, whilst it was anticipated that opinions on broader roles 
and prescribing may emerge during interviews, the research questions focus on 
what roles clinical psychologists are currently adopting as opposed to 
contributing to the ongoing debate around gaining prescription privileges.  
 
1.3.2 International research.  
Extant research on psychologists and their involvement with psychotropic 
medication has predominantly been conducted in the United States (US). This 
is likely given the debated Prescriptive Authority for Psychologists (RxP) 
movement, as there are currently three States in which psychologists can 
undertake further training to gain prescription privileges (American 
Psychological Association, 2018). This movement has not been without its 
critics; risks of prescribing with lesser medical knowledge have been 
highlighted, alongside judgement that prescribing is not where the profession’s 
expertise lies (Robiner, Tumlin, & Tompkins, 2013). The issue remains 
controversial and debated, extending to the United Kingdom (UK) whereby the 
BPS recently expressed plans to form a task group to consider prescribing 
rights for psychologists (British Psychological Society, 2018). The debate 
around psychologists prescribing in the UK is discussed further in ‘published 
articles in the UK’ below.  
 
There is little research into involvement with medication distinct from prescribing 
despite VandenBos and Williams (2000) finding that almost all responding 
participants in their survey (596 psychologists) were involved with medication in 
some capacity. The only other relevant study found was again conducted in the 
US, exploring school psychologists’ involvement with students taking 
psychotropic medication (Carlson, Demaray, & Hunter-Oehmke, 2006). Their 
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survey found that psychologists were engaging in various roles, such as 
monitoring behavioural responses to psychotropic medication, monitoring side 
effects, and developing psychotropic medication treatment goals. However, the 
purpose of the survey was to compare practice with psychopharmacology 
training that school psychologists received, and as such, involvement with 
medication was to be expected.  
 
1.3.3 Published articles in the UK.  
Whilst there is a dearth of UK research, commentary articles have been 
published in clinical psychology magazines and forums considering and 
debating psychologists and psychotropic medication. Article topics range from 
the debate on psychologists prescribing (British Psychological Society, 2003) to 
alternative roles that psychologists may assume (Houghton, 2016). Whilst 
logistical arguments have been proposed as a benefit for psychologists having 
prescription privileges (Resnick, 2003), the value of psychology as providing an 
alternative response to human distress has been proposed as a counter-
argument (Johnstone, 2003). An article was published in the Counselling 
Psychology Review in 2001 discussing the notion of prescription privileges for 
counselling psychologists (King, 2001). The author concluded that a more 
helpful strategy would perhaps be to obtain a recognised level of awareness of 
pharmacology to inform consultation with other professionals and clients, a 
suggestion similarly applicable to clinical psychology. Little appears to have 
changed for either profession since this time, evidenced by a recent article in 
The Clinical Psychology Forum speculating on whether clinical psychologists’ 
should join the debate around medication, and the suggestion of appropriate 
roles (Houghton, 2016).  
 
Despite ongoing debate, consensus on psychologists’ roles with psychotropic 
medication has not been reached, and any roles currently being adopted remain 
undocumented and unknown. In April 2018 the BPS proposed creation of a 
Prescribing Rights for Psychologists Task and Finish Group within The 
Psychologist magazine (British Psychological Society, 2018). The proposal 
 Page 96 of 272 
indicates that in 2016 the Society was approached by NHS11 England to 
consider whether there was a need for the extension of prescribing to include 
psychologists. The item was presented at the General Assembly meeting in 
2017, to which it was decided that a proposal will be developed to review the 
request and instigate consultations with the membership (British Psychological 
Society, 2018). This proposal remains ongoing and demonstrates the potential 
changing role of the clinical psychologist specifically in relation to psychotropic 
medication.  
 
1.3.4 Drivers for involvement. 
There are a number of initiatives to reduce the use of psychotropic medication 
across client groups within the UK, perhaps most notably STOMP (Stopping the 
overmedication of people with a learning disability, autism or both; Voluntary 
Organisations Disabilty Group, 2017). Medication use has been a particular 
focus for individuals with intellectual disabilities (IDs) following the Winterbourne 
View hospital scandal (NHS Improving Quality, 2015), but the over-use of 
medication has also been highlighted in other areas such as individuals with 
dementia (Thompson Coon et al., 2014) and children and adolescents (Marsh, 
2017). National drivers to reduce overall prescribing provide increased rationale 
for clinical psychologists to become involved with issues and decisions relating 
to medication, regardless of broader debates. Indeed, it is recognised that for 
prescribing levels to be reduced in the long term the availability and feasibility of 
nondrug alternatives need to be addressed and promoted (Thompson Coon et 
al., 2014; Voluntary Organisations Disabilty Group, 2017). This reflects a 
potentially important role for clinical psychologists who are arguably well-placed 
to promote psychological alternatives to medication. Indeed, leadership skills 
and use of psychological theory and data to support changes at a wider 
organisation level are key skills that are considered to make clinical psychology 
unique in health and social care (Division of Clinical Psychology, 2010).  
 
 
 
                                            
11 National Health Service 
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1.4 Roles, Professional Identity and Responsibility 
Elements of role theory will be considered in relation to why clinical 
psychologists may or may not perceive themselves to have a role with their 
client’s psychotropic medication. These aspects will then be considered as to 
how they may translate into forms of involvement using the triangle of 
responsibility model (Schlenker, Britt, Pennington, Murphy, & Doherty, 1994).  
 
1.4.1 Role theory.  
The origins of the study of ‘role’ trace back to three schools based on 
anthropological, sociological, and psychological traditions (Biddle & Thomas, 
1966). The schools are credited to the pivotal work of Mead (1934) who 
explored concepts of the ‘self’ and ‘socialisation’, further developing the notion 
of taking a ‘role’ in which the ‘self’ would be influenced by others. There is 
informal agreement between schools and approaches of several underlying 
propositions: some behaviours are patterned and are characteristic of persons 
within contexts, roles are often associated with people who share a common 
identity, people are aware of roles and they are to some extent governed by 
their expectations, roles serve a function and are often embedded in larger 
social systems, and people are socialised into roles (Biddle, 1979). Role theory 
is extremely broad, and what constitutes definition of a role is difficult (Biddle, 
1979). As such, critique has focused on the fact that there is insufficient clarity 
within the theoretical model and the various definitions proposed potentially 
invalidate its usefulness (Coulson, 1972). Whilst there may be no single role 
theory that proves universal in its application, within the overarching theory 
there are many constructs relating to role that can be singularly considered 
(Clifford, 1996). Possible constructs will be examined and hypotheses 
presented in relation to understanding how clinical psychologists construe and 
behave in their professional roles. 
 
1.4.2 Professional identity and socialisation.  
The concept of identity is a useful way of investigating how individuals perform 
a role or understand their place within a team. A professional identity is a 
person’s image of who they are as a professional, including the attributes, 
values, and skills that are used to define the professional role (Slay & Smith, 
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2011). A sense of professional identity is deemed important as it permits 
acknowledgement of specialised skills and knowledge, emphasising uniqueness 
from others in ability (Barker Caza & Creary, 2016). Furthermore, professional 
identity shapes work attitudes and behaviour (Siebert, 2005).  
 
Professional identities develop within the relational context, shaped by the 
comparison between one’s own identity and others. Davies (2003) terms this 
‘classic professional identity’ wherein the way that power is used between 
professional individuals defines the roles that individuals take. Mastery of 
knowledge and expertise, and a sense of self apart from others shapes a strong 
sense of professional identity, however, in doing so can lead to devaluing the 
‘other’. By process of ‘othering’, it makes sense to conceive that clinical 
psychologists differentiate themselves professionally from psychiatrists by the 
fact that they are not medical prescribers. Indeed, a fundamental answer to the 
question “what is the difference between professions?” may refer to difference 
in education and the prescribing of medications (Kingsbury, 1987). It may, 
therefore, be easy to not identity any role with medication and perceive this as 
belonging to another’s identity. In contrast, expertise that bounds a clinical 
psychologist to their professional identity is more likely to be psychological 
formulation; a core skill for practitioner psychologists (Health and Care 
Professions Council, 2015). This is commonly viewed as an ‘alternative’ to 
psychiatric diagnosis (Johnstone, 2018), and largely separate from medical 
frameworks of mental health. 
 
An additional construct within role theory is professional socialisation, which 
emphasises how an individual either conforms to a societally expected role, or 
risks being excluded from the group (Baldwin, 2008). Clinical psychologists are 
expected to socialise to a professional norm in terms of professional standards 
set out by the Health and Care Professions Council (HCPC; Health and Care 
Professions Council, 2015), BPS guidelines (Division of Clinical Psychology, 
2010), and also wider expectations as perceived by the public and other 
healthcare professionals. A sense of professional identity rooted in particular 
expertise (which does not include medication), ‘othering’ in terms of associating 
other professionals with medication, and a lack of current identified normative 
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roles are all factors which may act as barriers to clinical psychologists adopting 
roles with their client’s medication.  
 
1.4.3 Role ambiguity.  
Role ambiguity is characterised by disagreement on what is the accepted norm 
for a position by virtue of this being ill-defined or unclear (Baldwin, 2008). In 
relation to professional roles, formal roles are sets of official behaviours that 
employees perform as part of their job description and can be maintained by 
organisational policies. In addition, informal roles develop as a result of 
everyday dynamics of the organisation (Jackson & Schuler, 1985). Role 
ambiguity is generally operationalised as uncertainty concerning formal roles. 
Given the question of whether clinical psychologists have a role with their 
client’s use of medication and the uncertainty around this, role ambiguity seems 
an important construct. As previously discussed, clinical psychologists may not 
historically identify themselves as holding any form of role based on 
professional competencies and expectations that medication falls under the role 
of the psychiatrist. Clinical psychology continues to evolve as a profession, 
however, adapting to meet changing social demands. For example, the end of 
the Second World War brought an urgent need for psychotherapy for returning 
military personnel. By the late 1960s and early 1970s psychologists had 
become the pre-eminent and dominant providers of psychotherapy, despite 
initial reluctance of a unanimous embrace (British Psychological Society, 2003). 
Role ambiguity remains throughout professional role transitions, when 
parameters are not yet established. Based on increased movement within the 
profession to advocate a shift away from biological understandings of mental 
health, it is plausible to consider the role in an evolving state towards gradually 
embracing roles with medication.  
 
Important guidelines that dictate professional working standards for clinical 
psychologists in the UK include the Standards of Proficiency for Practitioner 
Psychologists set by the HCPC (Health and Care Professions Council, 2015) 
and the Code of Ethics and Conduct set out by the BPS (British Psychological 
Society, 2009). The Standards of Proficiency state that clinical psychologists 
must “understand the impact of psychopharmacological and other clinical 
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interventions on psychological work with service users” (13.17; Health and Care 
Professions Council, 2015). This suggests that a level of awareness about 
medication is required, however, it remains broad and does not extend to 
further roles outside of holding knowledge. As Houghton (2016) outlines in his 
article questioning the ethical dilemma about clinical psychologists joining the 
debate on medication, it is important for practitioners to be aware of the 
limitations of knowledge and not act outside of these boundaries (British 
Psychological Society, 2009). Lack of specific guidance from professional 
bodies fails to provide consensus on the accepted norm and role within the 
position. This leaves individuals to decide the role they wish to perform, 
potentially resulting in inconsistency across the profession and continued role 
ambiguity.   
 
1.4.4 Role blurring.  
Role blurring refers to the overlap between individual roles within a team, and is 
thought to be more commonplace in mental health settings compared with 
physical health, where clearer definitions for healthcare professions exist 
(Baldwin, 2008). A lack of clarity as to whether involvement with medication 
forms part of the clinical psychologist’s role may lead to concerns around such 
involvement being perceived as role blurring. This may particularly be the case 
when working with a team who do not hold such expectations for the clinical 
psychologist. Role blurring and reduction of traditional practices has become a 
significant issue for many practitioners, and whilst diffusion of roles has been 
considered progressive and flexibly desirable, concerns of losing a sense of 
professional identity within the multi-disciplinary team (MDT) are also noted 
(Brown, Crawford, & Darongkamas, 2000). Early work into MDTs saw 
professional identity as important in terms of navigating team environments 
(Payne, 1982), identifying the risk that role blurring may have on both 
individuals and teams. Additionally, Wall (1998) argues that there can be a loss 
of efficiency when staff share tasks and operate outside their area of expertise. 
 
In regards to medication, there will be some areas that are currently clearly 
defined as outside of the role, such as prescribing. However, there are many 
other possible roles that may be within remit but not ‘formally’ defined as such. 
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This adds to the prior construct of role ambiguity; blurring may occur in attempts 
to individually make sense of and personally define a role with lack of guidance. 
Alternatively, fears around role blurring may discourage clinical psychologists 
from considering any role with medication. Professional roles also change and 
develop, such as the move towards psychologists adopting responsible clinician 
roles, a position traditionally held by psychiatry (The Psychological Professions 
Network Alliance, 2018). In its early stages this might be perceived as role 
blurring, however, it demonstrates how professional identifies and roles are 
open to change. In this context of the changing profession it is conceivable to 
foresee future development in how clinical psychologists view their role with 
medication, with potential shifts in professional identity to account for such 
change. 
 
1.4.5 The triangle of responsibility.  
The triangle of responsibility (Figure 3) is a model that provides a coherent 
framework for understanding how an individual might act in a given situation 
based on personal responsibility versus identity, perceived control, and clarity of 
actions (Schlenker et al., 1994). The above constructs of role theory can be 
synthesised using the model to hypothesise how this translates into action, or 
no action as the case may be. According to the model, responsibility (and 
therefore inclination to act) is a direct function of the combined strength of the 
three linkages, as perceived by the individual who is making the judgement. In 
this view, responsibility is the adhesive that connects an individual with an event 
and a set of prescriptions for conduct. Studies have supported the model, 
showing that attributions of responsibility are a direct function of the combined 
strength of the three linkages, and when judging responsibility information 
relevant to the linkages is sought (Schlenker et al., 1994). The model has useful 
applications in considering the role of clinical psychologists and psychotropic 
medication. In regards to the model, ‘prescription’ refers to involvement with 
psychotropic medication, and is not to be confused with pharmacological 
prescribing. Each link will now be considered in regards to the clinical 
psychologist’s role.  
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Figure 3. Triangle of responsibility 
 
1.4.5.1 Identity-prescription link.  
The identity-prescription link refers to the extent to which the prescriptions are 
perceived as applicable to the individual by virtue of their characteristics and 
roles. As discussed, there is presently a great deal of role ambiguity for clinical 
psychologists given professional drivers to move away from the medical model, 
alongside a lack of clear guidance in regards to roles. This creates uncertainty 
and debate about the relevancy of the prescription, both of which are factors 
considered to weaken this link. The link is severed if the prescriptions are not 
relevant to the identity of the individual. This introduces subjectivity as to 
whether an individual considers medication relevant to one’s role, impacting the 
responsibility a person may feel to become involved. Identity crises are said to 
occur when people lack a clear sense of role and are uncertain about what 
prescriptions they should follow. Uncertainty surrounding a role with medication 
may leave psychologists questioning their professional identity. Identities 
change over time, and as identity shifts, prescriptions that are regarded as 
applicable will be adapted (Schlenker et al., 1994). Consequently, this link might 
be strengthened if clinical psychologists perceive medication as part of their 
role, increasing feeling of responsibility and likelihood of acting. 
 
 
 
Prescriptions 
Identity 
Event 
 Page 103 of 272 
1.4.5.2 Identity-event link.  
The identity-event link is the degree to which an individual appears connected 
to the event.  This may simply be due to their group membership, or the extent 
to which they have personal control over the situation. As perceived personal 
control decreases, so does responsibility for taking action. This link is 
anticipated to be weak for many psychologists, who might consider themselves 
to hold a lack of personal control over a client’s psychotropic medication due to 
not holding prescription rights. This is likely to reduce a sense of responsibility 
to become involved with medication, with the expectation that any role falls 
under the psychiatrist’s remit. 
 
1.4.5.3 Prescription-event link.  
The prescription-event link refers to the extent to which clear rules and 
expectations governing the prescription exist. The link is considered to be 
weaker when goals and rules are ambiguous, subject to alternative 
interpretation, or conflicting. Role ambiguity with medication creates a weak 
linkage, whereby there are no clear rules to guide involvement. A lack of clear 
expectations reduces responsibility for involvement due to no template for which 
to act in. The authors suggest that individuals may make excuses for not acting 
in such situations by highlighting a lack of instructions, in an attempt to further 
weaken the link. 
 
1.4.5.4 Triangle of responsibility summary.  
The model brings together prior role theory concepts of professional identity, 
role ambiguity, and role blurring to consider how such concepts might reflect 
clinical psychologists’ judgement around any role with medication. The model 
accounts for understanding how a role may be considered out of remit, 
however, at this stage cannot explain how and why clinical psychologists might 
undertake involvement. It is hoped that the current research can provide further 
insights as to how clinical psychologist judges a role with medication.  
 
1.5 Rationale for the Current Study 
International research suggests that psychologists are likely to encounter a 
variety of opportunities to adopt some form of role with clients’ psychotropic 
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medication, and are extensively, albeit indirectly, involved in the process of 
prescribing and managing clients’ psychotropic medications (VandenBos & 
Williams, 2000). There is a dearth of research exploring psychologists and their 
role with psychotropic medication in the UK. However, given the extensive use 
of psychotropic medication (Health and Social Care Information Centre, 2017) it 
seems likely that similar opportunities and practice may occur. This has 
important implications for practice, given current unawareness about how 
psychologists are navigating such issues in light of no structured guidelines 
advocating practice. This gap in the literature identifies a need for in-depth 
research that explores not only whether psychologists are choosing to involve 
themselves with psychotropic mediation, but how and when this is happening, 
and the rationales behind these choices. 
 
In addition, the collective clinical psychology profession is taking more of a 
stance against a dominantly biological understanding of mental health (Division 
of Clinical Psychology, 2013). This sets precedence for exploring the 
relationship between clinical psychology and psychotropic medication in terms 
of questioning what involvement clinical psychologists are currently having, and 
potentially what role they could have. 
 
1.6 Researching Clinical Psychologists 
It is important to research the experiences of clinical psychologists due to the 
reflective nature of the profession. Using reflection within clinical practice has 
been noted to help clinical psychologists understand their professional role as 
clinicians, and maintain professional and ethical standards (Fisher, Chew, & 
Leow, 2015). Furthermore, the BPS considers reflection as fundamental in 
continuing good practice in relation to clients, service delivery, and for 
professional and personal development (British Psychological Society, 2008).  
 
There is also a qualitative research base exploring clinical psychologists and 
decision making behind aspects in their role (Lilienfeld, Ritschel, Lynn, Cautin, 
& Latzman, 2013; Tickle, Brown, & Hayward, 2014), which is helpful in 
understanding challenges faced within clinical practice. A discursive analysis 
exploring how clinical psychologists conceptualise ‘mental health’ suggested an 
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ethical need for clinicians to be honest about their assumptions of what ‘mental 
health’ means in order to reduce the risk of service users complying with a 
process they do not fully understand (Lofgren, Hewitt, & das Nair, 2015). Putting 
these suggestions into practice creates opportunities for clinical psychologists to 
share how the use of psychotropic medication fits with their conceptualisation of 
mental health. Examining clinical psychologists’ involvement with psychotropic 
medication in a qualitative format can promote reflective thinking in order for 
clinical psychologists to consider (and potentially reconsider) their position in 
regards psychotropic medication. 
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2. Extended Method 
This section expands on the method section of the journal paper by providing 
the rationale behind methodological decisions, and increased detail about the 
researcher’s epistemological position. Qualitative approaches considered for 
data analysis will be briefly summarised before outlining the rationale for using 
thematic analysis (Braun & Clarke, 2006). Lastly, the study design, online 
survey development, interview schedule development, sampling, inclusion 
criteria, ethical considerations, data collection and quality assurance procedures 
are discussed. 
 
2.1 Method Overview 
Due to a paucity of literature on the research topic, a dual approach to research 
aims was adopted using a mixed method sequential explanatory design. The 
qualitative component aimed to expand on the quantitative, with findings from 
both phases synthesised. The research process aimed to gather data 
investigating methods and frequency of clinical psychologists’ involvement with 
client’s psychotropic medication on a broad level, before seeking more in-depth 
data about the rationales behind these decisions. A mixed methods approach 
was deemed appropriate for these dual aims. 
 
2.2 Epistemology 
Qualitative and quantitative research methods are underpinned by different 
philosophical assumptions. The use of mixed method research approaches has 
given rise to debates over the rationale for combining what have previously 
been considered incompatible paradigms (Hall, 2013). These include ontology 
which is concerned with what constitutes reality and epistemology, how reality 
can be created, acquired, and communicated (Scotland, 2012). All research has 
a philosophical foundation and researchers should be aware of the assumptions 
they make about knowledge, as this shapes the research process and method 
of inquiry (Creswell & Plano-Clark, 2011). 
 
Quantitative approaches are rooted in positivism which holds assumptions that 
reality is objective and absolute knowledge can be sought (Scotland, 2012). As 
such, meaning exists independently of the conscience of the researcher; it is 
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their aim to obtain this meaning as it exists (Pring, 2000). Positivist methodology 
attempts to identify causes and effects with a view to provide outcomes that can 
be generalised to a wider population than studied (Creswell, 2009). This study 
rejects the assumptions of positivism as the researcher believes that subjective 
experience plays an important role in what can be discovered about reality.  
Qualitative approaches stem from the interpretivist paradigm, rejecting the idea 
that there is one correct version of reality or knowledge (Braun & Clarke, 2013; 
Mcevoy & Richards, 2006). There are multiple realities and ‘knowledges’, and 
the aim is to understand how people make sense of the world and how they 
experience events (Braun & Clarke, 2013; Willig, 2013). Prediction of outcomes 
and generalisability are not meaningful goals within qualitative research, rather 
the aim is to understand and interpret phenomena within its context (Braun & 
Clarke, 2013). Rich data is sought, often through data collection methods such 
as interviews or focus groups, usually with a smaller sample size than 
quantitative methods (Braun & Clarke, 2013). 
 
A challenge recognised in mixed methods research is the capability of 
combining philosophical stances. In order to overcome paradigm incompatibility, 
pragmatism offers an approach which focuses on the question and 
consequences of research, rather than advocating a rigid position on the 
measurement of human experience (Bryman, 2007). As such, epistemological 
and ontological issues are diminished in favour of choosing methods best suited 
to answering the research question in order to solve real-life problems (Feilzer, 
2010; Hall, 2013). Whilst this may offer a practical approach to research, failing 
to provide philosophical justification for methods causes difficulties during data 
interpretation as to claims that can be made about the data (Hall, 2013).  
 
An alternative approach to the paradigm dilemma is for the researcher to draw 
from multiple epistemological approaches with assumptions shifting according 
to the method in current use (Creswell & Plano-Clark, 2011). This may be 
advantageous in keeping the methods separate in order to draw upon the 
strengths of each (Morse, 2003). However, conjoining incompatible paradigms 
creates challenges in clearly reporting how this has been done, impacting the 
 Page 108 of 272 
reliability of claims due to a lack of transparency in research decisions (Hall, 
2013). 
 
The single epistemological position of critical realism can be adopted to 
overcome difficulties in integrating paradigms based on different assumptions 
and still encompass both quantitative and qualitative approaches (Hall, 2013). 
 
2.2.1 Critical realism.  
Critical realism offers an alternative philosophical perspective to the established 
paradigms of positivism and interpretivism (Houston, 2001; McEvoy & Richards, 
2003), and has been advocated as an appropriate paradigm for combining 
quantitative and qualitative methods (Sayer, 2000). Its suitability is achieved by 
integrating positivism and interpretivism by making assumptions that by nature 
of studying reality through human participants, reality is unlikely to represented 
in a pure form (Harper & Thompson, 2012). The position assumes that a true 
reality independent to observers exists, however, it is impossible to fully 
apprehend this reality because perceptions are framed by investigative interests 
and theoretical resources. Empirical feedback about accessible aspects of the 
world can be collected, but this knowledge is mediated by discourses available 
(Sayer, 2004) and influenced by context (including participant-researcher 
interactions), prior beliefs, and socio-cultural factors (Deforge & Shaw, 2012).  
 
A critical realist researcher seeks explanatory understanding by moving from 
the level of observations and lived experience in order to hypothesise about 
underlying mechanisms accounting for the phenomena, known as ‘retroduction’ 
(Mingers, 2003). As the mechanisms themselves are dependent upon the 
variable conditions in which they operate, generalisability is not the researcher’s 
aim (Lawson, 2003). It is neither the aim to identify the lived experiences of 
individuals. Rather, the critical realist’s aim is to develop deeper levels of 
explanation and understanding regarding the phenomenon under study 
(Mcevoy & Richards, 2006). 
 
Critical realism was deemed to be an appropriate paradigm given the aims of 
the study: to explore frequency and of experiences of a phenomenon. The 
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approach permits quantitative and qualitative data to be combined to develop a 
deeper understanding. Philosophical assumptions inform theoretical stance, 
which in turn informs methodology (Creswell & Plano-Clark, 2011). 
Methodological decisions will now be explained. 
 
2.3 Mixed Methods Research 
Mixed methods research is recognised as the third major research paradigm, 
aiming to consider the viewpoints and perspectives of both quantitative and 
qualitative approaches (Johnson, Onwuegbuzie, & Turner, 2007). Quantitative 
and qualitative methods each make valid contributions to research, and using 
both methods together can reveal other areas of the topic at study (Harper & 
Thompson, 2012). Quantitative methods have the strength of developing 
reliable descriptions with the ability to provide comparisons, and can help to 
identify patterns that may otherwise be masked. Qualitative methods can help 
identify more complex concepts and relationships that may not be captured by 
predetermined response categories (Creswell & Plano-Clark, 2011).  
 
Despite the paradigm-compatibility debate it is argued that a mixed approach 
can be valid when used for complementary purposes, as combining approaches 
allows for a greater understanding of complex issues than either approach used 
alone (Sale, Lohfeld, & Brazil, 2002). Another cited advantage is triangulation, 
used to enhance the credibility of findings (Mertens & Hesse-Biber, 2012). As 
each method studies different phenomena the distinction of each is considered 
crucial (Sale et al., 2002). The phenomenon of ‘involvement’ may appear the 
same across both methods, but the distinction lies between a ‘measure’ and 
‘lived experience’. This promotes transparency and links the phenomenon to its 
corresponding paradigm and method. 
 
Mixed methods research has been subject to various criticisms which will now 
be addressed. It has been argued that qualitative aspects of the design can be 
undermined as precedence is can be given to quantitative components (Morse, 
2003). Johnson et al., (2007) define different types of mixed methods research, 
offering a continuum whereby research may be mixed at its “purest” form in the 
centre or may branch out to be dominantly qualitative or quantitative. 
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Positioning the research on this continuum is helpful in determining which, if 
any, method takes precedence within the research and minimises undermining 
one aspect. Within the current study, the qualitative component encompasses a 
larger volume of the results, however, both aspects are awarded equal 
weighting. The qualitative component was deemed important as the 
complexities behind participants’ involvement may not have been fully 
understood in adopting a solely quantitative study. Also, the quantitative 
component is important as the qualitative method on its own would have been 
limited in gaining a full understanding in the frequency and types of involvement 
clinical psychologists are typically engaging in. 
 
Finally, difficulties with integration are noted to be a challenge within mixed 
methods research. This is considered especially important during data analysis, 
otherwise resulting in misleading conclusions and the risk of representing 
multiple studies (Yin, 2006). Challenges were overcome by utilising research 
supervision to gain alternative perspectives during the process of analysis, and 
applying quality insurance measures (further discussed in section 2.7). The 
research time line has been suggested to impact the extent to which both data 
sets feel can feel separate and out of sync with one another, and may inhibit 
integration as one set is generated faster than the other (Bryman, 2007). This 
was managed by continuing to refer to the quantitative data during supervision 
of analysing the qualitative in order to compare and contrast findings, and gain 
initial ideas about synthesisation. 
 
When combining methods it is important to consider and address paradigm 
differences (Harper & Thompson, 2012). Firstly, an online survey was used 
which aligns with positivism; assumptions about the data being that it 
represents a true reality independent from participant effects. The survey also 
included a free-text question response, however, opening up individual 
interpretation and shifting away from positivism. From a critical realist position, it 
is assumed that the reality measured by the survey is imperfect as there will be 
subjectivity in how participants interpret the questions and choose to respond. 
Secondly, semi-structured interviews were analysed using thematic analysis, 
which is not tied to an epistemological position and so can be approached from 
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a critical realist perspective (Braun & Clarke, 2006). Focus is on individual 
experiences but unlike constructivism, which may caution against generalisation 
due to assuming multiple realities exist, it was assumed that individual 
experiences may share commonalities. As such, themes were derived across 
the data highlighting similarities and differences. 
 
2.4 Study Design 
In this section further information on decisions made in regards to the study 
design are discussed. 
 
2.4.1 Online survey.  
An online survey was used with the aim of collecting data from a large sample 
in order to maximise representativeness of the profession (Appendix B). Online 
surveys are considered cost-effective, efficient, and lessen the demand placed 
on participants who can opt-in and complete the survey in their own time 
(Murdoch et al., 2014). There is evidence to suggest that online surveys can 
produce valid and reliable data, and have the advantage of extending the 
geographical sampling area, increasing the chance of reaching a representative 
sample (Hewson, 2014).  
 
2.4.2 Semi-structured interviews.  
Semi-structured interviews were used to expand on the data collected from the 
online survey in order to gain further detail and insight into participant 
experiences. They are an appropriate method of data collection when using 
thematic analysis (Braun & Clarke, 2006), and were considered more 
appropriate than focus groups which would have caused organisational 
challenges due to the geographical spread of participants. Focus groups also 
may not have allowed for such in-depth exploration of individual experiences. 
 
Interviews are the most common method of qualitative data collection (Braun & 
Clarke, 2013) and are typically considered the ‘gold standard’ in terms of validity 
and rigour (McCoyd & Kerson, 2006; Novick, 2008). The method is not without 
limitations, however, as conducting individual interviews is time consuming for 
both the researcher and participants. Participants in the current study were 
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working professionals who would not necessarily derive gain through their 
participation. Nevertheless, interviews are advantageous in allowing collection 
of rich and detailed data about individual experiences, with the benefit of 
flexibility in terms of follow-up and unplanned questions based on participant 
responses (Braun & Clarke, 2013). As such, the researcher has the ability to 
guide the interview, increasing likelihood of obtaining useful data in relation to 
the research aims (Braun & Clarke, 2013). 
 
The advantage of collecting a geographically diverse sample during the first 
stage of data collection resulted in practical challenges in conducting face-to-
face interviews. Selection based on location would have limited the integrity of 
the data. Much social science research suggests that face-to-face interviewing 
is the most productive method of gathering narrative data, and has been 
assumed superior in ensuring quality of data (Holt, 2010). However, there is 
little evidence of data loss or a compromise on quality of findings when 
interview data is collected by telephone (Novick, 2008). Additional benefits to 
telephone interviews are also noted, such as practicality, decreased cost and 
travel, and increased articulation due to a lack of non-verbal communication 
(Holt, 2010; Novick, 2008). These advantages can also be extended to the use 
of video-conferencing software such as Skype, with the additional benefit of 
enabling the ‘visual’ in the interview setting (Hanna, 2012).  
 
In order to practically collect a range of responses based on the sampling 
method without impacting on the research budget face-to-face, telephone, and 
Skype interviews were considered feasible methods to collect data. Participants 
were offered a choice in how the interview was conducted; all were offered 
Skype and telephone, those within a 100-mile radius of the researcher were 
also offered face-to-face. Of the eleven interviews conducted, two were 
conducted face-to-face, three were via Skype and six were over the telephone. 
Interviews lasted between 40-60 minutes. 
 
2.4.3 Inclusion criteria.  
The inclusion criteria are detailed in the journal paper, although it is necessary 
to expand on why only clinical psychologists were recruited. The HCPC 
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Standards of Proficiency for Practitioner Psychologists reference awareness of 
psychotropic medication for only clinical and counselling psychologists, stating 
they should “understand the impact of psychopharmacological and other clinical 
interventions on psychological work with service users” (13.17; Health and Care 
Professions Council, 2015). It was felt important, however, to match participants 
as closely as possible in terms of profession in order to explore within-
profession variety, given the paucity of literature in the area and unnecessity of 
comparing different practitioner psychologists.  
 
In order to match participants as closely as possible in terms of professional 
training, the decision was made not to open the research to other practitioner 
psychologists. This is because alternative practitioners may be less likely to 
work with individuals who are prescribed psychotropic medication (such as 
sports psychologists or occupational psychologists), and there would be greater 
variance in professional training. There are undisputedly differences within 
clinical psychology training programmes, however, it was felt that this 
maintained participant similarity to the best of researcher ability.  
 
2.4.4 Sample size 
2.4.4.1 Online survey.  
A total of 147 participants participated in the online survey and there was no 
target number of participants required. The survey was live between the dates 
of 14.01.17 and 30.04.17. As this was an opportunistic opt-in study no data was 
collected on people actively choosing not to participate. Recruitment was 
achieved through a broad advertising strategy, as such it is not possible to state 
total numbers ‘approached’ to participate.  
 
It is important to consider how the sample relates to the overall number of 
clinical psychologists in the UK. There are approximately 12, 705 clinical 
psychologists registered with the HCPC (figured attained 02/01/2018) (Health 
and Care Professions Council, 2018). The sample of respondents are, 
therefore, less than 2% of the total number of clinical psychologists working in 
the UK which is important to bear in mind with regards to the generalisability of 
results. Participants worked in a variety of services, it is not possible to 
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ascertain whether the percentage of participants working in different areas is 
generalisable to the profession as a whole in the UK as such figures were not 
possible to attain. 
 
It is also noteworthy that just under half (49%) of participants had been 
qualified for less than five years. This may be reflective of the sampling strategy 
adopted; participants were primarily recruited using social media pages which 
may be used more frequently by newly qualified (and potentially younger) 
clinical psychologists.  
 
2.4.4.2 Semi-structured interviews.   
A total of fifteen participants were approached and invited to take part in 
interviews; eleven interviews were ultimately conducted. Within qualitative 
research the total number of participants recruited is often determined when 
data saturation is considered to be reached, a concept derived from grounded 
theory analysis (Bowen, 2008). There is no universal method in reaching data 
saturation given the diversity in research designs. Typically, saturation is said to 
occur when additional data fails to generate new information and the study 
could be replicated (Guest, Bunce, & Johnson, 2006; Morse, 1995). Whilst this 
appears a logical approach to sampling, in reality the concept of reaching 
saturation remains ambiguous as there are no pragmatic guidelines in existence 
(Fusch & Ness, 2015). Perhaps as a consequence, the concept of saturation is 
often mentioned in qualitative research reports, however, little explanation 
offered as to what this means within the context of the study (Bowen, 2008). 
Furthermore, it cannot be assumed that data saturation has been reached 
because available resources have been exhausted. It may be conducive then to 
think about sampling cut-offs in terms of when data sufficiency has been 
reached. That is, asking the question ‘Is the data I have collected sufficient to 
answer my research question?’. This was considered by use of reflective diary 
and research supervision. A reflective diary quote after interview number 8 
reads:  
 
“I feel the interviews are going well so far, although I am getting the 
sense of many participants reporting the same kinds of things”.   
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Within research supervision it was discussed that whilst there was a variety in 
narrative and experience, there was a general sense of coherence in participant 
stories. At this point further interviews were still scheduled and were completed 
with some confidence that sufficiency had been reached. As part of the analysis 
process, transcripts were read multiple times for familiarity. By becoming 
immersed in the data, researcher confidence further increased that data 
quantity was adequate in order to answer the research question. 
 
Furthermore, the final sample size falls within the ‘moderate’ criteria as advised 
by Braun and Clarke (2013). It is suggested that when conducting interviews, a 
small sample size would include six to ten participants, with moderate samples 
ranging from 10-20 participants.  
 
2.4.5 Recruitment. 
2.4.5.1 Online survey.  
In order to maximise recruitment methods of advertisement and direct targeting 
were used in conjunction. An advertisement (Appendix C) was posted on social 
media and professional web pages that were known to be used by clinical 
psychologists. An advertisement (Appendix D) was also published in the DCP 
Forum as a response to a previous article about clinical psychologists joining 
the debate around medication (Houghton, 2016). The advert provided an email 
address for potential respondents to contact if they were interested in taking 
part in the study. The advertisement was also emailed to private healthcare 
companies who employ clinical psychologists, and around administration staff 
working on Doctorate in Clinical Psychology training courses to circulate. 
Further details of the recruitment strategy can be found in Table 9. 
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Table 9.   
Recruitment networks 
Recruitment Network Additional Details 
Email advertisement  
Cygnet Healthcare  
St Andrews Healthcare  
DClinPsy Courses  
Advertised online  
ClinPsy Forum Posted once 
Facebook Clinical Psychology page Posted three times 
Facebook Assistant Psychologist page Posted once 
Twitter Tweeted 9 times (snowballed) 
Linkedin Advert posted once 
BPS Facebook page Advert posted once 
Publication of advertisement  
Division of Clinical Psychology Forum Email address provided as contact 
 
2.4.5.2 Sampling. 
2.4.5.2.1 Semi-structured interviews.  
Purposeful sampling is a widely used technique in qualitative research for the 
identification of information-rich cases (Patton, 2002). This involves a process of 
identifying individuals who are particularly knowledgeable or experienced with 
the phenomenon under interest (Creswell & Plano-Clark, 2011). Intensity 
sampling was used to sample prior participants who completed the online 
survey and provided consent to take part in interviews (Palinkas et al., 2015).  
Falling under the umbrella of purposeful sampling, intensity sampling requires 
the researcher to explore variation within the phenomenon under study before 
sampling relevant intense examples. This method assumes that much can be 
learned from the data by looking at the ends of the distribution range. This 
approach is not dissimilar to extreme sampling, however, is used with 
decreased emphasis on ‘extreme’ cases in order to identify and expand the 
range of variation or differences (Palinkas et al., 2015).  
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Intensity sampling was adopted due to interest in participants whose 
involvement with psychotropic medication was reported to be at either end of 
the continuum (i.e. no/little involvement and great involvement). This was in 
attempt to represent a selection of views and experiences, and minimise 
skewing data by only interviewing individuals with similar opinions. 
Consequently, respondents who fell into the ‘middle’ range were not sampled 
for interview. Selecting individuals who meet specific criterion in relation to their 
experience may fail to capture the experiences of other roles in the process 
(Palinkas et al., 2015). Given the small sample size selected for interview 
compared with the overall sample, this does risk excluding a proportion of 
clinical psychologists who fall in the ‘middle’ and may arguably be more 
representative of the overall profession. However, given lack of previous 
research the phenomenon is currently poorly understood, and so intensity 
sampling was deemed appropriate on the basis of drawing out opposing 
experiences and opinions in order to begin to define the phenomenon of 
interest. This approach maximises ability to compare, contrast, and identify 
similarities and differences whilst assuming that the middle falls between these 
points. Additionally, a systematic sampling strategy was required for practicality 
and selecting a sample of contrasting participants was deemed pragmatic. In 
order to maximise representation and include participants whose responses fell 
into the middle a larger number of interviews would be warranted, but there is 
little evidence to suggest that additional data would add value to overall 
findings. Finally, despite use of intensity sampling there did not appear to be 
definitive differences in views and opinions between participants rated as 
having ‘high’ or ‘low’ levels of involvement. This suggests that attempts to 
include participants within the middle range may not necessarily have added 
further value to findings. 
 
Use of a single strategy for purposeful sampling for qualitative components of a 
mixed methods study has been suggested to adhere to the same general 
principles that govern all forms of sampling (Palinkas et al., 2015). Seven such 
principles have been identified (Kemper, Stringfield, & Teddlie, 2003). These 
principles and how they were met are outlined in Table 10. 
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Table 10. 
Strategy for purposeful sampling 
Principles  How principles were met 
The sampling strategy should stem 
logically from the conceptual 
framework as well as the research 
questions being addressed by the 
study 
 The research question asked 
about current roles and forms of 
involvement which invites diversity 
in responses 
The sample should be able to 
generate a thorough database on the 
type of phenomenon under study 
 Diversity in service worked in and 
frequency of involvement aimed to 
maximise thoroughness 
The sample should at least allow the 
possibility of drawing clear inferences 
and credible explanations from the 
data 
 Intensity sampling aimed to 
maximise potential for interviewing 
participants with experience and 
knowledge on the phenomenon 
The sampling strategy must be 
ethical 
 Only participants who had 
provided consent were included 
The sampling plan should be feasible  A systematic plan was derived 
which was deemed feasible by 
researcher and supervisor 
The sampling plan should allow the 
researcher to transfer/generalize the 
conclusions of the study to other 
settings or populations 
 Inclusivity across services were 
included 
The sampling scheme should be as 
efficient as practical 
 The systematic plan allowed for 
efficiency and practicality 
(Kemper et al., 2003) 
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Recruiting participants with recent high and low levels of involvement presented 
the challenge of quantifying involvement. This study adopted the definition of 
involvement as gaining knowledge, considering how to put this knowledge into 
action, or a form of activity within practice that may influence a change or 
maintain a client’s medication regime. The survey offered a variety of 
involvement options, but determining whether some items carry more weight 
(i.e. indicate ‘more’ involvement’) introduces subjectivity, and as such, all items 
were considered equal in terms of quantification. Involvement was measured in 
terms of frequency of items selected. Respondents who ticked ‘none’ or fewer 
items were considered least involved, and respondents who ticked the highest 
numbers of items were considered most involved. It was also felt important to 
reflect the variety of services participants worked in, therefore, the selection 
process also aimed to involve fair representation of service types. 
 
2.4.5.1.2 Sampling strategy.  
Criteria were developed and independently used by two researchers against 
responses of all participants who consented to interview. The criteria are 
outlined below: - 
1. Responses are separated by service (adult, ID, CAMHS, older adult, 
physical health, other). In cases where more than one service has been 
selected (e.g. a respondent working in both adult and CAMHS) the 
service with the least overall number of participants is chosen, or they 
are placed according to the service they referred to in their qualitative 
answer (e.g. making reference to CAMHS). 
2. Frequencies are totalled for each respondent for the question “What 
kinds of involvement have you had with psychotropic medication in the 
last six months?”. The highest and lowest frequencies for each service 
are then selected. 
3. In instances when there are multiple responses per service with similar 
levels of involvement, qualitative responses are inspected to see if 
anything is written relating to the role of a psychologist with psychotropic 
medication, or whether a strong view is expressed one way or the other; 
these responses are prioritised. 
4. Equal numbers of high and low involvement across services are picked. 
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Following this, twelve of the same respondents were selected by both 
researchers. To select the remaining three, both researchers discussed the 
potential respondents and agreed based on ensuring representation of services. 
An invitation to interview was emailed to the 15 selected respondents. 
Remaining participants formed a ‘back up’ list should any of the participants 
have declined to take part. 
 
2.4.6 Data Collection. 
2.4.6.1 Demographic information.  
Demographic information was collected to contextualise the sample and aid 
researcher interpretation. The information in Table 11 was collected as part of 
the online survey. 
 
Table 11.  
Demographic information collection 
Demographic information Purpose 
Gender To see whether the percentage of 
participants reflect the profession in 
general 
 
Number of years qualified 
 
To contextualise the sample 
Working in inpatient or community 
 
To contextualise the sample 
Type of service currently working 
in 
 
To see whether service type affected forms 
or frequency of involvement 
Dominant psychological approach 
used 
To contextualise the sample 
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When analysing interview data this demographic information was also 
considered relevant in understanding the person behind the analysis, and how 
these factors might affect their responses. 
 
2.4.6.2 Instruments. 
2.4.6.2.1 Online survey.  
The survey was created using Qualtrics, an online survey tool. Construction of 
the survey was based on the previous study by VandenBos and Williams 
(2000), and discussion within supervision about research aims and expected 
outcomes. In order to answer whether clinical psychologists have a role with 
psychotropic medication it was felt that the survey should elicit data in relation 
to: 1) clinical psychologist’s current experiences of having a role with 
psychotropic medication, 2) clinical psychologist’s opinions on whether there 
should be a role (regardless of experience with involvement), and 3) 
opinions/views on psychotropic medication in general, as this was considered 
likely to shape involvement. 
 
2.4.6.2.2 Development of online survey. 
2.4.6.2.2.1 Decision-making in regards to involvement options.  
A range of potential options were required in order to gather quantitative data 
measuring the frequency of involvement. These options were influenced by the 
VandenBos and Williams (2000) study. The authors offered a variety of options 
and invited respondents to select which they regularly engage in (Appendix E). 
The authors do not explicitly state the decision-making process behind their 
selection of options. E-mail contact revealed that the survey was based on their 
knowledge and understanding of psychologists’ clinical practice in the US. 
Research supervision was used to discuss creation of the online survey. 
Options from the VandenBos and Williams (2000) survey were included with 
suitable adaptations to reflect UK practice. Further adaptations were made to 
include an increased range of response options to prevent restriction of narrow 
ideas, and incorporate wider ideas of involvement. Researcher professional 
positions of trainee and qualified clinical psychologists enabled discussion and 
extended options to be added based on own experiences and knowledge of 
practice. A free text option was also included for respondents to offer alternative 
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forms of involvement not mentioned to minimise exclusion and capture all 
potential experiences.  
 
2.4.6.2.2.2 Decision-making in regards to survey questions.  
Initial questions collected information relating to years qualified as a clinical 
psychologist, type of service worked in, and dominant psychological approach 
used in practice. It was hypothesised that such participant characteristics may 
potentially have some effect on decisions regarding involvement with 
psychotropic medication and were helpful in contextualising the data. The 
questions included in the study that invited respondents to select options of 
involvement were: - 
 What kinds of involvement have you had with psychotropic medication in 
the last six months? (Please tick all that apply) 
 Regardless of your current involvement, which of these options would 
you do given the opportunity? (Please tick all that apply) 
 Are there any options that you feel are inappropriate for Clinical 
Psychologists to be engaging in? (Please tick all that apply) 
 Which three forms of involvement do you consider the most important for 
Clinical Psychologists to be engaging in? (Please select three items, 
unless choosing option one) 
The primary aim of the research was to explore what involvement clinical 
psychologists are currently having, so this question was restricted to 
involvement in the last six months. This was also to increase the chances of 
accurate memory recall. In the potential instance that overall involvement was 
found to be very low, the three further questions were added so that 
respondents could report forms of involvement they would choose to adopt, and 
also any forms they felt to be inappropriate or particularly important. This was 
based on an assumption that some clinical psychologists may not currently 
have active roles with medication but would opt to do so should their role allow. 
 
Additionally, participants were asked whether they had completed any training 
relating to psychotropic medication within the following questions: - 
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 ‘Have you completed any significant training relating to psychotropic 
medication? If you answer 'Yes' please select approximately how many 
days training.’ 
 Approximately how long has it been since you completed any significant 
training relating to psychotropic medication? 
 Which professional group did the trainer(s) belong to? 
This was incorporated to explore whether clinical psychologists were largely 
receiving or seeking training on psychotropic medication, and who the training 
was frequently being delivered by.  
 
2.4.6.2.3 Development of semi-structured interview schedule.  
Extant literature on the research topic is limited; as such, the interview schedule 
(Appendix F) was developed through researcher discussion, piloting with 
trainee clinical psychologist colleagues, and refinement following online survey 
results.  
 
The interview schedule was used sequentially for the most part, however, was 
used in a flexible manner to allow for follow-up questions. Questions initially 
elicited participant opinions and views on psychotropic medication before asking 
about specific examples of when they had been involved with a client’s 
psychotropic medication. Questions were designed to allow for participants to 
report their thoughts on involvement even if they had little opportunity to do so 
themselves in their work.  
 
Interview data were collected by the researcher, and transcribed by external 
transcription services following signing of a confidentiality agreement (Appendix 
G).  
 
2.5 Ethical Considerations 
This study was reviewed and approved by the University of Lincoln’s Research 
Ethics Committee (Appendix H). Ethical guidance stipulated by the BPS (British 
Psychological Society, 2009) was adhered to throughout the research process.  
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2.5.1 Informed consent.  
Two participant information sheets were developed for each phase of the 
research (Appendix I). Both informed potential participants of the purpose and 
nature of the study. Both information sheets included researcher and supervisor 
email addresses to provide opportunity to ask questions, and stated that 
participation was voluntary. Consent was given by selecting the appropriate 
boxes on the questionnaire, or completing an electronic or paper consent form 
prior to interview (Appendix J). 
 
2.5.2 Right to withdraw.  
Participants were provided with a debrief following their participation (Appendix 
K) informing them that they were free to withdraw at any time without requiring 
to give a reason, and that there was a period of two weeks during which data 
could be withdrawn. Participants were informed that in the event of withdrawal, 
data may still be used anonymously in the project analysis. No participants 
opted to withdraw from the study; in the event of this occurring attempts would 
have been made to seek consent for data to be used in final analysis. 
 
2.5.3 Risks to participants.  
There were no serious risks posed to participants resulting from their 
involvement in this study. Time demands placed on participants were managed 
by offering choice as to time of day and method of conducting the interview was 
most convenient for the participant. 
 
2.5.4 Confidentiality and anonymity.  
Participant information sheets outlined the limits of confidentiality. Prior to 
interviews participants were reminded about confidentiality in relation to talking 
about their own experiences with clients. All participants were allocated a 
participant number which was saved with their email address in a password 
protected document on an encrypted memory stick, and pseudonyms were 
used in the final write up. Participants consented to quotes being used with 
awareness that these would be anonymised in report and publication.  
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2.5.5 Storage of information.  
Online survey data was held within the online survey tool Qualtrics. All other 
data was securely held in a locked filing cabinet at The University of Lincoln. 
Only the researcher and research supervisors had access to the interview data.  
All participant identifiable data was stored separately to interview transcripts. 
This information will remain securely stored at the University of Lincoln for 
seven years in accordance with University protocol, after which time it will be 
securely destroyed. 
 
2.6 Analysis 
2.6.1 Survey data.  
Survey data were largely subject to descriptive analysis in regards to the 
frequencies of options selected. Logistic regression analyses were also used to 
explore any relationships between type of service worked in and options for 
involvement within the last six months selected. Logistic regression is 
considered well-suited for describing and testing hypotheses about relationships 
between a categorical outcome variable and one or more categorical or 
continuous predictor variables (Peng, Lee, & Ingersoll, 2002). 
 
The qualitative survey data was coded and clustered into themes using a 
thematic analysis approach (Braun & Clarke, 2006). Following creation of 
themes, this data was not subject to further analysis but was used to develop a 
deductive framework along with aspects from the quantitative data analysis 
(Appendix L). This was achieved by incorporating the options that had been 
most frequently selected, along with the themes derived from coding.  
 
2.6.2 Interview data.  
Thematic analysis was used to analyse data within interview transcripts. This 
approach acknowledges how individuals make sense of their experiences within 
a broader social context, whilst retaining focus on the limits of reality (Braun & 
Clarke, 2006). Creation of the deductive framework allowed for a dual 
deductive-inductive approach to be used for the interview data analysis. 
Transcripts were initially coded inductively, then scanned using the framework.  
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Other qualitative approaches considered are outlined below, followed by a 
rationale of the approach taken. 
 
2.6.2 Qualitative Methods 
2.6.2.1 Interpretative Phenomenological Analysis (IPA).  
IPA aims to examine how people make sense of unique experiences and is 
informed by hermeneutics; the theory of interpretation (Smith, Flowers, & 
Larkin, 2009). The researcher plays a reflexive role in that they are interpreting 
the participants’ interpretation of their experienced phenomenon (Willig, 2013). 
IPA aims to capture the experiences and meanings associated with a 
phenomenon, rather than to identify opinions about it. It was not considered the 
most appropriate method of analysis as the current study was interested in 
participants’ opinions and ideas behind their decision making in order to 
understand the phenomenon under study.  
 
2.6.2.2 Grounded Theory.  
Grounded theory is an inductive approach that allows the researcher to develop 
new theory based on what is held in the data, rather than rely on pre-existing 
analytical constructs or theories (Tweed & Charmaz, 2012). Whilst grounded 
theory is useful when there is a limited amount of research in a particular area 
(Cho & Lee, 2014), it was not considered an appropriate method of data 
analysis due to the mixed method design of the research. It was intended for 
data from the online survey to influence the analysis of the interview data and a 
deductive framework was created to aid this process to facilitate integration of 
both phases.  
 
2.6.2.3 Foucauldian Discourse Analysis (FDA).  
Discourse analysis is concerned with how language is used in order to construct 
phenomena; FDA takes this beyond the immediate settings within which 
language is used and considers the effects of discourses within social context. 
Discourses can facilitate, limit, enable, and constrain what can be said, by 
whom, where and when, creating subject positions adopted by individuals which 
have implications for their subjectivity and experience (Willig, 2013). FDA could 
have permitted examination of how participants construed power in relation to 
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their role with psychotropic medication and their wider team. Whilst interesting, 
this would have provided a narrow focus, and not fully address the question of 
whether clinical psychologists have a role, and specifically what this role looks 
like. 
 
2.6.2.4 Thematic analysis.  
Thematic analysis is a method for identifying, analysing, and interpreting 
patterns of meaning across qualitative data (Braun & Clarke, 2006). As a form 
of qualitative analysis, thematic analysis is unique in that it can be applied 
across a range of theoretical frameworks and acts as a tool for which to 
approach data. The researcher adopts a systematic approach working through 
a series of steps in order to generate initial codes and develop themes 
representing patterns of meaning. Thematic analysis was adopted for its flexible 
approach and its usability as a technique to identify patterns across and within 
data in relation to individuals experience, views, and perspectives (Braun & 
Clarke, 2013).  
 
Whilst considered a strength, thematic analysis has also been criticised for its 
flexible nature with claims that it is undefined and lacks transparency (Antaki, 
Billig, & Potter, 2003). The use of thematic analysis as a tool does not in itself 
provide a clear theoretical basis for research (Willig, 2013). In order to 
overcome such limitations, the researcher is required to make a number of 
decisions and be explicit about these decisions. This includes epistemological 
position, how the data is approached and codes generated, and the extent to 
which the researcher interprets data beyond spoken word. The epistemological 
position for the study has been clarified as critical realism; the remaining two 
concerns will now be addressed. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
A deductive or ‘bottom up’ analysis is driven by the researcher’s theoretical 
interest and attempts to use a pre-existing frame by which to understand the 
data. Alternatively, an inductive or ‘top down’ approach is data driven and minus 
researcher analytic preconceptions (Willig, 2013). The interview data was 
initially approached inductively, then screened using a deductive framework 
generated with themes from the survey analysis. This process was completed 
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secondary to limit the risk of preconceptions affecting initial analysis. This 
approach to the data was chosen to increase attempts at generating a 
comprehensive thematic analysis, and to support the synthesis of both 
components of the research. 
 
Thematic analysis can also focus on different kinds of meaning. These can be 
manifest meanings, the explicit content of what has been said, or latent 
meanings, the researcher’s interpretation of what has been said (Willig, 2013). 
A latent approach to the data was opted for the current study due to an interest 
in what may be ‘unspoken’ information during the interview. To enhance 
credibility of researcher interpretation quotes were included in the write up of 
the report to demonstrate how conclusions were reached. 
 
2.6.2.4.1 Phases of thematic analysis. 
Interview transcripts were analysed using thematic analysis following the six 
outlined by Braun and Clarke (2006) (Table 12). Examples outlining the 
process, including coding excerpts and thematic maps are referred to in section 
2.7.2.1 (quality assurance). 
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Table 12 
Phases of thematic analysis 
Phase Description 
Familiarising yourself with the 
data 
Transcribe data, read and re-read the data, 
note any initial ideas. 
 
Generating initial data codes Systematically code interesting features 
across the data set, collating data relevant 
to each code. 
 
Searching for themes Collating codes into potential themes, 
gathering all data relevant to each potential 
theme. 
 
Reviewing themes Checking if the themes work in relation to 
the coded extracts (level 1) and the entire 
data set (level 2), generating a thematic 
map of the analysis. 
 
Defining and naming the themes Ongoing analysis to refine the specifics of 
each theme, and the overall story the 
analysis tells, generating clear definitions 
and names for each theme. 
 
Producing the report Final opportunity for analysis. Selection of 
vivid, compelling extract examples, final 
analysis of selected extracts, relating back 
of the analysis to the research question 
and literature, producing scholarly report of 
the analysis. 
(Braun and Clarke, 2006, p. 87) 
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2.6.3 Deductive analysis.  
Between phase 3 and 4 of thematic analysis the deductive framework created 
from the online survey was used to analyse the interview data. The process 
indicated that there were no concepts within the survey data that were not in the 
interviews and vice versa. Concepts within the interviews were reflected in the 
survey, however, were mainly restricted to opinions and expanded on in greater 
detail within the interviews. As such, no changes were made to the potential 
themes following the inductive analysis. 
 
2.7 Quality Assurance 
Quality assurance will first be considered in regards to the quantitative and 
qualitative components separately before considering quality appraisal of the 
study as a whole. 
 
2.7.1 Quantitative analysis.  
Due to the descriptive nature of the quantitative data checking the survey for 
face validity is most appropriate. Face validity measures the extent to which an 
instrument is viewed as covering the concept it aims to measure (Krippendorff, 
2004). Usage of the term has been cautioned, however, as the appearance of 
validity does not constitute scientific evidence (Royal, 2016). Despite critique 
over assessing validity of an instrument based on appearance, in this instance 
there is an absence of alternative methods for establishing quality. It is 
comprehended that face validity can be assumed with reasonable confidence, 
as the survey gathered data in line with its aims, and did not contradict 
comprehensive interview data. 
 
2.7.2 Qualitative analysis.  
In qualitative research there is no absolute criteria for judging quality, but in 
order to yield meaningful and useful results it is essential to ensure research is 
conducted in a rigorous and methodical manner (Attride-Stirling, 2001). Rather 
than relying on adaptations of quantitative criteria, quality criteria and 
techniques suited to qualitative research have been developed (Braun & Clarke, 
2013). Guidelines for assessing quality often comprise a checklist of criteria or 
overall characteristics the research should hold (e.g. Elliott, Fischer, & Rennie, 
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1999). Such guidelines have been subject to critique, however, given the 
diversity of theoretical approaches adopted over the field of qualitative research, 
and limited applicability in applying a single set of guidelines to all studies 
(Reicher, 2000). Braun and Clarke (2006) provide a 15-point checklist of criteria 
for a good thematic analysis, however, the problem remains with how to 
interpret guidelines as most are not absolute and are difficult to determine.  
 
Prior to analysing interview data, qualitative data from the survey was coded 
and organised into themes (Appendix M). This process was not analysed 
further, but formed a deductive framework along with collating the most 
frequently selected responses into a table. This process was not subject to 
rigorous quality assurance given the brevity of responses, but excerpts of data 
and codes were reviewed in research supervision alongside overall themes 
upon completion. 
 
2.7.2.1 Trustworthiness as quality assurance. 
Trustworthiness is one way that researchers can convince the reader of the 
quality of their work (Lincoln & Guba, 1985). Guidelines have been developed 
for demonstrating credibility using thematic analysis specifically, emphasising 
transparency (Nowell, Norris, White, & Moules, 2017). Criteria for 
trustworthiness is applicable regardless of epistemological and ontological 
position due to reliance on methodological arguments and techniques (Green, 
2000). This process of establishing quality is also congruent with the critical 
realist position, which emphasises replicability of research in that researchers 
are explicit about how data was collected and results drawn (Barker, Pistrang, & 
Elliott, 2002). The method includes audit trails and triangulation which are also 
commonly used techniques in establishing quality in qualitative research (Braun 
& Clarke, 2013). As such, the concept of trustworthiness will be applied to 
establish quality of the current research. 
 
Lincoln and Guba (1985) define trustworthiness in regards to research by the 
criteria of credibility, transferability, dependability, and conformability (paralleling 
the validity and reliability of quantitative assessment). Table 13 outlines the 
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stages of thematic analysis alongside how trustworthiness is established during 
each phase of analysing the interview data.  
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Table 13.  
Establishing trustworthiness in thematic analysis 
Phase Means of establishing trustworthiness 
Phase 1: Familiarising yourself with your data Prolong engagement with data 
Triangulate different data collection modes 
Document theoretical and reflective thoughts 
Document thoughts about potential codes/themes 
Store raw data in well-organized archives 
Keep records of all data field notes, transcripts, and reflexive journals 
Phase 2: Generating initial codes Peer debriefing 
Researcher triangulation 
Reflexive journaling 
Use of a coding framework 
Audit trail of code generation 
Documentation of all team meeting and peer debriefings 
Phase 3: Searching for themes Researcher triangulation 
Diagramming to make sense of theme connections 
Keep detailed notes about development and hierarchies of concepts and themes 
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Table 13 cont. 
 
Establishing trustworthiness in thematic analysis 
 
Phase Means of establishing trustworthiness 
Phase 4: Reviewing themes Researcher triangulation 
Themes and subthemes vetted by team members 
Test for referential adequacy by returning to raw data 
Phase 5: Defining and naming themes Researcher triangulation 
Peer debriefing 
Team consensus on themes 
Documentation of team meetings 
regarding themes 
Documentation of theme naming 
Phase 6: Producing the report Member checking 
Peer debriefing 
Describing process of coding and analysis in sufficient details 
Thick descriptions of context 
Description of the audit trail 
Report on reasons for theoretical, methodological, and analytical choices 
throughout the entire study 
(Nowell et al., 2017) 
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2.7.2.1.1 Phase 1: familiarising yourself with your data.  
Prior to conducting interviews, an excel spreadsheet was created to track 
progress in collecting data and was updated accordingly as interviews were 
completed (Appendix N). Interviews were not transcribed by the researcher and 
so were read through twice prior to coding for familiarity. All files were named 
with the corresponding participant number from the excel sheet, a table created 
to identify each participant number with the service they worked in and level of 
involvement (Appendix O). Short summaries for each participant were also 
created capturing the essence of the interview (Appendix P). Raw data were 
stored securely on an encrypted memory stick and were archived with dates to 
provide an audit trail. Researchers are encouraged to be honest and vigilant 
about their own perspectives and pre-existing beliefs (Starks & Trinidad, 2007). 
Prior to coding, initial thoughts and ideas were documented in a reflective 
journal (Appendix Q) and discussed in research supervision as interviews 
progressed.  
 
2.7.2.1.2 Phase 2: generating initial codes.  
Transcripts were uploaded to Nvivo and each interview was coded inductively 
by the primary researcher. Codes were generally completed line-by-line, 
however, individual extracts of data were coded in as many different themes as 
they fit in order to maximise depth of analysis. An example of coding can be 
found in Appendix R. Excerpts of interviews and the corresponding codes were 
reviewed in research supervision to enhance credibility of analysis. Meetings 
were recorded using a supervision log (Appendix S) as a means of establishing 
an audit trail. All data sets were worked through systematically, giving full and 
equal attention to each transcript. Use of the reflexive journal continued to note 
relevant concepts to the research question. 
 
2.7.2.1.3 Phase 3: searching for themes.  
Codes were initially clustered into similar concepts per transcript and an excel 
spreadsheet created to identify prominent concepts across all transcripts 
(Appendix T). Mind-maps were then created for each concept (Examples in 
Appendix U), bringing together all of the data sets.  
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At this stage, transcripts were revisited and re-coded using the deductive 
framework created from the survey data. Pre-determined codes were created 
for each category in the framework and each transcript was coded accordingly. 
Discrepancies were also noted, for example, for the code ‘inappropriate - 
requesting or recommending that specific psychotropic medication be 
prescribed for a service user’ it was noted when a participant acted in contrast 
to this (Appendix V). Similarities and contrasts were noted in the reflexive 
journal, however, the survey data supported the initial themes and so there 
were no changes made to the analysis process thus far. 
 
Due to the large volume of data, a further mind-map was created specifically 
drawing on the research aims to allow salient themes to begin to emerge 
(Appendix W). The use of diagrams allowed for connections to be made 
between initial themes and was further enhanced through discussion in 
supervision. A process diagram was created that was felt to collapse all 
concepts into over-arching themes, continuing to accurately capture the data. 
 
2.7.2.1.4 Phase 4: reviewing themes. 
During this phase, summaries were drafted of themes and subthemes prior to 
review and discussion in supervision. Amendments to the process diagram 
were made in accordance with the discussion and review of themes (Appendix 
X). For example, ‘Approaching involvement’ transformed into ‘Strategy 
selection’ following discussion that this theme better captured the essence of 
the data. Further clarification of subthemes within ‘Forms of involvement’ were 
also discussed and categorised. Investing sufficient time to develop and refine 
the themes will increase the probability of developing credible findings (Lincoln 
& Guba, 1985). Coded extracts for each theme and subtheme were reviewed to 
check for accuracy. To ensure that the themes were reflective of participant 
voice the raw data was also revisited and read through with the themes held in 
mind. This helps ensure that all conclusions are firmly grounded in the data 
(Lincoln & Guba, 1985). 
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2.7.2.1.5 Phase 5: defining and naming themes.  
Detailed analysis was written for each individual theme and subtheme which 
identified the story that each theme told, whilst considering how each fit within 
the research questions. Consulting an outside expert can help to determine 
whether themes are sufficiently clear and comprehensive (King, 2004). A 
meeting was held with an external supervisor in order to gain an independent 
review and perspective of the themes. Theme names were agreed as suitable, 
and a final process diagram was created to visually display the themes and how 
they interact as a process. 
 
2.7.2.1.6 Phase 6: producing the report.  
Once themes were established the report writing process began. Direct quotes 
from participants are considered essential in good quality qualitative research 
(King, 2004) and formed part of the write up. All reports were accompanied by a 
pseudonym to demonstrate that various participants were represented. Findings 
were synthesised with the survey results and discrepancies discussed. 
Considerations were made as to the clinical implications and importance of the 
study findings. Member checking was not utilised due to time constraints of the 
research process. 
 
2.7.2 Mixed methods critical appraisal.  
Consensus on the critical appraisal of mixed methods research is lacking 
despite availability of several critical appraisal frameworks (Heyvaert, Hannes, 
Maes, & Onghena, 2013). Heyvart et al. (2013) reviewed available frameworks 
and identified two groups of criteria specific to mixed method research: the 
mixing and integrating of the combined methods, and providing a rationale for 
conducting mixed method research.   
 
2.7.2.1 Integration.  
Integration has been reached during analysis by using a deductive framework 
created from the survey with the interview transcripts. In this way, results from 
the first phase are incorporated into the analysis of the second. In addition, a 
section in the results has focused on synthesising both strands by way of 
comparison, and hypothesising discrepancies. The manner in which data 
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support or contradict each other have been considered, and results from both 
were incorporated into the end process diagram.  
 
2.7.2.2 Rationale.  
The core rationale for using a mixed methods design was for complementarity, 
due to a lack of previous research in the topic area. Use of a survey alone 
would have provided some insight into the forms of involvement conducted 
within a relatively large sample, however, would fail to obtain rich data of 
participant views and decisions. On the other hand, whilst the interviews 
facilitated collection of meaningful and interesting data, without the larger 
context of the survey it would 1) have caused difficulties in recruiting a reliable 
variety of participants and 2) further limit generalisability and provide little 
information as to what clinical psychologists are doing on a larger scale.  
 
2.8 Service User Involvement 
The research project was proposed by the Trent Doctorate’s service user panel 
as a suggested topic. For continuation of service user involvement, a discussion 
was held with members of the service user panel at the University of 
Nottingham. General feedback indicated that the panel perceived that clinical 
psychologists increasing their involvement with psychotropic medication would 
be preferable. This stemmed from personal experiences of having good 
therapeutic relationships with clinical psychologists, and more frequent contact 
than with their psychiatrist. Increased opportunity to discuss medication issues 
within a trusting therapeutic relationship was identified as preferable by 
members of the panel. 
 
2.9 Reflexivity 
Reflexivity is important in qualitative research due to an ability for the 
researcher to completely detach from the research, and the manner in which 
the researcher is implicated in the research and its findings. The product of 
qualitative research is invariably shaped by the researcher and their position on 
the given subject. This extends beyond considering personal biases and 
encourages how personal reactions may facilitate interpretations and 
understanding of the data (Willig, 2013). 
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A reflective diary was kept throughout the research process to note down initial 
thoughts in relation to the incoming survey data, and re-read prior to conducting 
interviews in order to hold the data in mind. Research supervision sessions 
were also used to consistently re-visit collected data in order for all data to 
remain at the forefront and limit the risk of neglecting or forgetting findings.  
 
2.10 Researcher’s Statement of Perspective 
A statement of perspective can position the reader to the researcher and 
provide orientation for which to interpret and understand the research analysis 
(Elliott et al., 1999). This research has been undertaken as fulfilment of the 
course requirements. My interest in the topic stems from past experience of 
working in a secure ID service whereby service users resided under a restriction 
of liberty. At this stage in my career I had limited knowledge about psychotropic 
medication, reasons for its use, and its effects. I soon realised, however, that 
the majority of service users were taking several medications. Many service 
users were unable to articulate their understanding of what medication they 
were on and its purpose. In some cases, service users refused to accept 
medication and second opinion doctors were sought for the purpose of 
administering medication in best interest. I also observed a tendency to use 
psychotropic medication as an initial intervention, prior to psychological 
intervention. I started the research with the assumption that the majority of 
clinical psychologists would be against the use of psychotropic medication, and 
would seek to reduce its use but find this difficult to put into practice due to 
power dynamics within the MDT.  
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3. Extended Results 
This section elaborates on results from both the online survey and interview. 
Additional frequencies from the survey results are provided, additional 
information on infernal analysis, supplementary quotes to support the interview 
data, and two case examples of the involvement process. 
 
3.1 Survey Results 
3.1.1 Inferential analysis 
To investigate the relationship between service worked in and involvement in 
the last six months, logistic regression analyses were conducted. No 
assumptions are made about the distributions of the explanatory variables, 
however, the variables should not be highly correlated with one another as this 
may cause problems with estimation (Peng et al., 2002). A test for collinearity 
was found to be low (largest VIF = 1.7) and data was deemed suitable for 
regression analysis (Appendix Y). Large sample sizes are also required in order 
to provide sufficient numbers in both categories of the response variable. A 
general guideline indicates a minimum of ten cases with the least frequent 
outcome for each independent variable (Statistics Solutions, 2018). Based on 
this, 60 cases for each category of independent variable were required. 
Consequently, power was found to be low for some categories (Appendix Z). 
There were four significant results (Appendix AA) which at 96 tests is the false 
positive rate expected. Some caution in reporting findings is, therefore, 
warranted. However, despite being underpowered, one category (participants 
working in ID services are more likely to request or recommend that a service 
user be taken off psychotropic medication) had a very small p value which is 
smaller than expected by chance, increasing confidence in this finding.  
 
3.1.2 Frequencies 
3.1.2.1 Recent involvement (last six months).  
The form of involvement that the majority (81.6%) of participants reported 
engaging in was reflecting with a service user on their general experience of 
taking psychotropic medication. This was followed by discussing psychotropic 
medication issues within individual service user sessions (79.6%) and 
supporting service users to discuss their psychotropic medication with their 
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prescriber (72.1%). The option for no involvement at all was chosen least 
frequently with just 2% of participants selecting this; 98% therefore had been 
involved in some capacity within their recent clinical practice.  
 
3.1.2.2 Would do given the opportunity.  
In regards to options selected that participants would do given opportunity 
regardless of their current involvement, the two most selected options were: 
reflecting with a service user on their general experience of taking psychotropic 
medication (92.5%), and supporting service users to discuss their psychotropic 
medication with their prescriber (91.2%); both of which were reflected as being 
the most popular involvement options within recent practice. Following this, the 
third highest selected option was engaging in a collaborative discussion with a 
service user to support them in making a decision about their psychotropic 
medication (89.1%). There were no participants who selected that they would 
not have any involvement if given the opportunity.  
 
3.1.2.3 Three most important.  
When participants were asked to select the three options they felt were most 
important for clinical psychologists to be engaging in, responses clustered 
around four which proved to be the most frequently selected: Engage in a 
collaborative discussion with a service user to support them in making a 
decision about their psychotropic medication (55.8%), support service users to 
discuss their psychotropic medication with their prescriber (41.4%), be involved 
in the decision making process to prescribe a service user psychotropic 
medication (38.8%) and reflect with a service user on their general experience 
of taking psychotropic medication (38.1%). 
 
3.1.2.4 Inappropriate.  
In response to whether participants felt any of the options were inappropriate for 
clinical psychologists to be engaging in, the most frequently selected response 
was requesting or recommending that specific psychotropic medication be 
prescribed for a service user (49%). The second most selected response, 
however, was that no options were inappropriate (33.3%), followed by 
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requesting or recommending that a service user be taken off a specific 
psychotropic medication (26.5%). 
 
3.1.2.2 Discrepancies 
Engaging in a collaborative discussion with a service user to support them in 
making a decision about their psychotropic medication was not voted as one of 
the most frequent options that participants had been engaging with during the 
last six months. However, 89.1% reported they would do this given opportunity, 
and was also ranked as one of the most important forms of involvement.  
Being involved in the decision making process to prescribe a service user 
psychotropic medication was ranked as one of the most important forms of 
involvement (38.8%) but wasn’t one of the most frequently selected in regards 
to recent involvement, and options that would be done given opportunity. 
Logistic regression analyses were used to explore any relationships between 
type of service worked in and options for involvement within the last six months 
selected.  
 
3.2 Interview Results 
The themes and subthemes will be expanded on in order to provide additional 
quotes to support themes and increase representation of participants. In 
addition to providing further examples, a further critical approach will be taken to 
the results to add further speculation and consider findings from an alternative 
perspective. 
 
3.2.1 Conflicts and uncertainties.  
There was acknowledgment from participants that dominant medical-model 
narratives towards understanding and treating mental health difficulties 
prevailed in society: - 
 
“I think there is a lot of, you know, I think medication, psychotropic 
medication, but I think medication in general, there’s probably an over 
reliance in our society on that.” - Kate 
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This initially creates a conflict for psychologists, whereby psychological 
approaches in understanding aetiology of human distress is at the root of the 
profession. Alice describes this conflict as a “battle” as “people take at face 
value what medics say about this assumed kind of within person disorder, 
disease”. A paradigm conflict exists wherein participants are working in 
structures that potentially do not align with both their personal and professional 
views about the experience of human distress.  
 
In addition, the majority of participants recognised that their clinical training 
course adopted a critical stance towards the medical model, with expectations 
highlighted that clinical psychologists will take this view forward in practice. 
Whilst some welcomed a critical ethos, there were mixed views as to whether 
encouraging such a critical position during training was in fact helpful. Lucy 
believed that “a lot of psychologists views are perhaps a little bit ill informed”, 
and challenged her course’s critical approach: -  
 
“So I ended up approaching our course director and just kind of saying, 
look, I’m feeling a little bit uncomfortable that we’re sort of supposed to 
be learning how to treat people as individuals and not kind of, you know, 
fit people into predefined categories. And yet, all psychiatrists and 
psychiatry is evil, and it just didn’t sit well with me.” - Lucy 
 
Lucy makes the interesting point that being “antipsychiatry” in itself is actually at 
odds with the idea of removing classification, and highlights that negative 
blanket views towards another profession are unhelpful. Nicole echoes this 
sentiment, stating “And we’re not going to be so damning that we’re not going to 
be prepared to be open minded about the fact that it [medication] can be 
beneficial to people”, suggesting that sweeping negative views may do clients a 
disservice. 
 
Furthermore, Saffron acknowledged that a medical narrative around the 
understanding of mental health is indeed helpful for some clients, and this is 
how they choose to understand their difficulties: - 
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“So it is, for some people, it’s more helpful to think that they’ve got an 
illness and they need medication. And they take comfort in the fact that, 
in knowing that this is something that’s recognised, that other people 
have had and have coped with. And so in that way they might find it quite 
a comfort.” - Saffron 
 
Conflict arises between expectations set during training to minimise medical 
understandings, whilst working to maintain personal meanings and narratives 
for the client. Additionally, Saffron suggests that offering alternative 
understandings might just serve to cause confusion: - 
 
“I’ve seen people saying, it is really confusing when people have such 
different stances and I don’t know what’s right and what’s not right.” - 
Saffron 
 
Saffron continues to say “I guess it’s, there isn’t a right and not right, there’s just 
a, what you think and what’s most helpful to you”.  Acknowledgement that 
psychological approaches are an alternative and not a fundamental answer may 
serve to increase uncertainty and trepidation around challenging medical 
frameworks, given that both might be viewed as plausible frameworks for clients 
in understanding their distress. In addition to the risk of causing confusion, 
going against societal dominant understandings was noted as a difficult act: - 
 
“Well I suppose it feeds into bigger narratives about kind of like, in 
society, about what mental illness is and the fact that, you know, it’s a 
very medical model all the way through, isn’t it? You know, it’s built into 
the structures, it’s built into our laws and things like this, you know… 
you’re kind of coming right up against this challenging view, which is 
widely held in the rest of society. It can make you feel like you’re the odd 
ball.” - Bradley 
 
Overall, ‘conflicts and uncertainties’ captures the disparity between perceived 
expectations of the role and feasibility of meeting these expectations in practice. 
Participants are caught between feeling a responsibility to advocate a shift away 
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from the dominant medical model, but are left feeling uncertain about doing this 
due to acknowledgement that medical approaches have a place in mental 
health, and going against the grain can be very challenging. 
 
3.2.2 Weighing up.  
‘Weighing up’ refers to the process of decision making whereby participants 
consider a variety of factors prior to deciding whether to become involved with a 
client’s medication. Certain factors were found to either encourage or 
discourage involvement, and also impacted on the type of involvement. 
 
3.2.2.1 Values driven responses to clients.  
During the weighing up process a common rationale for a decision to be 
involved was based on the value of supporting informed consent, due to this 
being considered in line with clients’ best interests. Responses based on this 
value were commonly reflected in terms of feeling a pull to provide information 
due to clients appearing ill-informed or misinformed about their medication: - 
 
“I don’t think it should be my role but because I don’t feel like, maybe 
GPs don’t have the time and stuff for all the literature up to date at hand, 
then I think, obviously, now, in these days, it’s really easy to find 
information about drugs on the internet. And that most of the clients 
probably haven’t got access to printers, some of them aren’t allowed to 
look at the internet.  So I feel like then we do have a duty of care really to 
inform them about stuff.” - Jessica 
 
Despite acknowledgement that searching for and giving information is outside of 
her role, Jessica feels a pull to respond based on a self-defined “duty of care”. 
Hayley similarly describes how she feels a duty to ensure clients are well-
informed of medication side effects: - 
 
“I do think it’s important for clients to be aware that they could experience 
some side effects, you know, because it’s making an informed choice 
and deciding, you know, do you want to put up with possibly feeling more 
low and more suicidal over the first month? Do you want to put up with 
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feeling sick or having an upset stomach or having really vivid dreams?” - 
Hayley 
 
Hayley rationalises involvement based on values of supporting informed 
consent with a view to protect clients who may be ill-informed of side effect 
risks. There appears to be a sense of taking on the unpleasant job that has 
been missed by the prescriber in supplying some of the undesirable information. 
Indeed, Hayley states: - 
 
“I think one of the things I’ve seen in the medical reviews I attend, is that 
the medics don’t really talk too much about how it might not help or, do 
you know what I mean? They don’t seem to talk about the negatives.” - 
Hayley 
 
Hayley suggests that remaining loyal to values overweighs the avoidance of a 
potentially negative conversation about unpleasant side effects. This raises the 
interesting reflection of whether providing negative information is genuinely 
delivered to support informed consent, or perhaps driven by an alternative 
agenda to critique and reduce medication.  
 
A lack of clear rationale or observable benefit for the client was a factor that 
seemed to pull on ethical values for participants to become involved. Bradley 
voiced his frustration towards long-term use of medication with little clinical 
need: - 
 
“I guess something that kind of gets my goat a bit is, we’ve got a small 
population of service users who have been on depo medication for years 
and years and years, and just been lost in the midst of time, kind of like 
why they’re on it, what it’s supposed to be for.” - Bradley 
 
Jessica describes how she feels a pull to become involved and raise the issue if 
medication appears ineffective: - 
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“Because I feel, ethically, that that’s part of my role really, in terms of if 
they’re still very distressed, things aren’t working.” - Jessica 
 
However, with no apparent unhappiness on the client’s front and a beneficial 
medication effect, there is no need to act as Jessica’s values are not 
impeached: - 
 
“…like I say, they’re happy with it, if it seems to be having the desired 
effect for them, then fine, there’s nothing that I would, I don’t feel like I’ve 
got a duty then to kind of highlight anything to them.” - Jessica 
 
Evidence of beneficial outcomes and client satisfaction are, therefore, factors 
weighed up based around ethical values of ensuring clients aren’t taking 
medication by virtue of habit, and potentially experiencing side effects with no 
positive results. Saffron goes one step further by suggesting that withholding 
medication might be considered unethical if it might have beneficial effects: -  
 
“And, you know, some people think that’s a little bit unethical because it’s 
like, well if this, if increasing the medication could alleviate some of this 
distress, then why aren’t we doing it?” - Saffron 
 
This raises an interesting point of how participants largely consider it an ethical 
obligation to intervene in ways that might reduce medication use, but in fact, 
Saffron highlights how deterring medication could be unethical by denying 
access to distress-reducing treatment. 
 
Other than situations of high risk and distress, medication use might also be 
prompted by belief that it could help a client better access therapy: - 
 
“We’d had twelve sessions of CBT, there hadn’t been any kind of shift at 
all. And I was wondering, is that just because her anxiety is so, so high, if 
we sort of are able to reduce that slightly on a chemical level or try to do 
that, would that mean that she could do some of the exposure 
exercises?” - Hayley 
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Lucy described one situation in particular whereby she felt prompting a 
medication referral resulted in better therapy outcomes: - 
 
“I remember, in particular, one lady who was really struggling to engage 
with therapy. So we had conversations around, actually, would 
medication be helpful, in terms of giving her a little bit of a lift, in order for 
her to then engage? So I then referred her onto psychological medicine 
and they had some discussions there… she reflected at the end that 
actually, the medication was the most helpful way of her engaging in 
therapy. She was sort of saying, that without that, she felt that she would 
have just continued to see herself as failing because she wasn’t able to 
just engage fully.” - Lucy 
 
In such circumstances, prompting medication (or choosing not to challenge its 
use) can be viewed in terms of participants feeling it is in clients’ best interests 
in order to access therapy. From a critical point of view, it might be argued that 
participants use values-based practice in order to justify a variety of actions to 
best suit their agenda in a given situation. As clinical psychologists, client 
engagement with therapy is very likely to be considered priority. In order to 
enhance engagement, it appears that medication use is willing to be tolerated, 
and encouraged, justified by acknowledging that accessing therapy is in clients’ 
best interests.  
 
Finally, there seemed to be an increased pull to advocate on behalf of clients 
who may lack capacity, such as individuals with an ID. Nicole makes 
comparisons between working with individuals who have capacity to make 
decisions about medication, and those who may not: - 
 
“And it’s going to be very hard, unless a client is saying themselves, I 
don’t want to be on this, for you to advocate on their behalf as a 
capacitous adult that, you know, you shouldn’t be on antidepressants 
really, should you? You don’t need these. That’s going to be very difficult 
to influence that individual. You’ve got to respect what their viewpoint is 
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on the medication they’re taking. Whereas, in LD, we are advocating a lot 
of the time for that individual, for a lot of our clients.” - Nicole 
 
Nicole appears to adopt the role of benevolent protector advocating on behalf of 
clients to influence medication reduction, with what seems an underlying 
assumption that the psychologist knows best. Terminology used suggests it is 
easier to influence clients who have an ID, raising the question of whether 
personal views towards medication are actually imposed, but framed as being in 
clients’ best interests.  
 
3.2.2.2 Team context.  
When a team was already highly involved with medication and minimising use 
where possible, there was often little need to be involved: - 
 
“I think because in our sort of, the culture in our team is to generally, if it’s 
deemed to be unnecessary medication or too much of a certain 
something, then generally, it would be kind of done anyway or we would 
generally try and work with the patient to sort of decrease the medication 
as much as possible…. So yes, it’s rarely that I need to sort of, feel that 
it’s down to me to kind of intervene, let’s say, with something.” - Kate 
 
Kate appears to monitor and weigh up situations as to whether she needs to 
become involved by judging if she feels comfortable that the team are already 
acting in line with her values. Having said that, Kate also places a lot of trust 
within her team about medication decisions reducing the likelihood of 
involvement: - 
 
“So I think, you know, if the rest of the team feel that it’s important or 
necessary for the client to be on it, then, you know, that would be, you 
know, that would be sort of fine with me. And if that’s, you know, I 
wouldn’t necessarily intervene in any way in those kind of cases.” (Kate) 
 
Kate’s trust in her team’s judgement may be strengthened by belief that they 
hold similar values around reducing medication, and so she regularly decides 
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that there is no reason to be involved. Although, there does also appear to be a 
sense of relief for Kate in not needing to intervene. As such, there may be an 
element of justifying inaction by framing the teams’ values as consistently in line 
with her own. Louse similarly describes relief from feeling that she needs to 
intervene: - 
 
“And again, if somebody is prescribed say, four Diazepam a day and 
they’re taking it every day, four times, you know, I would say, what’s 
going on there? But again, usually, the teams that I work with are really 
hot on that as well.” - Louise 
 
This relief from feeling a need to become involved appears accompanied by a 
sense of fortune of working within a psychologically minded team, with 
suggestion that this does not reflect the norm. Having good relationships with 
prescribers, who are also receptive to psychological input, was reflected as 
important in being able to become involved and broach conversations around 
medication. Feeling influential and able to become involved within the team felt 
like a privileged position: - 
 
“I guess I’m pretty fortunate with the team I’m at, you know, the 
psychiatrists, they don’t throw their weight around too much, you know, 
they are fairly kind of like receptive to different points of view.” - Bradley 
 
Bradley reflected that he feels fortunate that his team context allows him to 
raise issues and offer psychological points of view, despite having previously 
acknowledged that doing so is important in his role (“If the psychologist isn’t 
speaking up and offering a non-medical explanation, then no one else will kind 
of thing”). Saffron expresses a similar level of freedom and acknowledges that it 
is not a given for all psychologists: - 
 
“I’ve just been in a meeting with some of the psychologists, who feel so 
undervalued and not respected by psychiatry and by other professions, 
that I actually felt quite privileged and quite lucky that I’m taken 
seriously.” - Saffron 
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Saffron’s point highlights the impact of the team context in feeling comfortable 
and influential on weighing up decisions to become involved.  
 
Two additional examples demonstrate the impact of team set up on decisions 
about involvement. Lucy works in a cancer service and explains how the 
physical healthcare element reduces opportunity for her to weigh up a need to 
be involved: - 
 
“So our team is all psychologists. So we, we’re embedded within the 
hospital but we are separate from kind of the medical sides of care, and 
all the medical side of care is cancer. So it’s normally the GP or 
psychological medicine that would prescribe psychotropic medication. So 
from that point of view, we don’t really have any contact with a kind of 
wider MDT, to be having discussions about medication”. - Lucy 
 
In contrast, Kristy works in a service with no co-located prescriber and regularly 
has to weigh up decisions about medication given her sole responsibility to 
prompt medication referrals: - 
 
“Well it’s still an MDT, so, obviously, I have a nurse colleague and an OT 
colleague, so we do discuss clients, you know, in our weekly team 
meeting. So one of them might suggest medication might be useful. But, 
obviously, as the care coordinator, you know, it would be my position to 
request or not request.” - Kristy 
 
Overall, participants identified how the team context and service set-up has 
large influence over opportunities, authority, and requirement to become 
involved with medication. 
 
Lastly, working in physical health services appeared to add an additional 
element to which clients might expect the clinical psychologist to adopt a similar 
role of other medical clinicians. Lucy described how this could potentially deter 
discussing medication with a client: - 
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“I’m cautious of not wanting to introduce that kind of expert stance or that 
sort of continuing that sort of experience that people will have had, where 
they present with a problem and then the doctor fixes them. So that’s, I 
don’t think I’ve broached it with anybody myself.” - Lucy 
 
There was also felt to be minimal need for a role in physical health (cancer) 
services, whereby the use of psychotropic medication risks medicalising normal 
reactions to a substantial life event.  
 
3.2.3 Strategy re: agenda.  
A decision to become involved was underpinned by psychologists’ agendas 
towards medication and strategy by which agendas were expressed ranged on 
a continuum from neutral (dropping agenda), to tentative, to challenging. 
 
Despite generally considering herself to be ‘pro-medication’, Lucy felt it was 
important to represent balanced and neutral views towards medication for 
clients: - 
 
“…I think, you know, people, people need to make an informed decision 
about what’s right for them. And I think it’s difficult for them to make an 
informed decision if the information isn’t being presented neutrally and 
they’re not being given the pros and cons and different alternatives.” 
Lucy 
 
Lucy highlights how expressing personal opinions or attempting to sway a client 
one way or the other is not conducive to supporting informed decision making. 
This is interesting in comparison with other participants who advocate that the 
need for offering potential negative side effects is important for informed 
decision making. Hayley also reflects on her adoption of neutral strategies: - 
 
“Yes, I think I try not to think about my own experiences of that when 
we’re having conversations about medication. I’d sort of be thinking more 
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about what I’ve seen for other young people, what’s been discussed on 
training…. So I try and be relatively neutral if I can be.” - Hayley 
 
Hayley describes actively attempting to not allow her personal opinions and 
experiences to influence her conversations about medication with a client. 
Instead she draws on professional experiences and her knowledge base to try 
and offer a neutral perspective.  
 
Strategies whereby the agenda was expressed moved along the continuum 
from tentative, towards more directive and challenging. Hannah explains how 
she would adjust her approach in relation to the context: - 
 
“…ward round was quite fast paced, so some conversations outside of 
ward round would be very gentle, very psychologically kind of guided.  
Whereas, sometimes more, in ward round, it would be, no, I completely 
disagree with what you’re talking about, this is what I think we should do, 
and it was a really direct conversation.” - Hannah 
 
Hannah judged the most suitable approach by considering which would be best 
received by her team, alongside other factors such as which would be the most 
influential within time constraints: - 
 
“I think sometimes, it’s knowing the dynamic of your MDT as well, and 
working with a particular group of people. You kind of know how much 
time you’re going to have, how direct you need to be, or can you be a bit 
more subtle and gentle?” - Hannah 
 
Whilst all were flexible, some participants favoured one strategy over the other 
based on past experiences of strategy selection. Alice had been shut down from 
expressing her opinion historically, and had seen others attempt challenging 
approaches with limited success: - 
 
“In fact, other psychologists have tried a more direct approach and 
written reports that then they take to this clinic appointment, as if they’re, 
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you know, going into battle. That doesn’t work at all, that doesn’t work at 
all, literally, that doesn’t work. And, of course, it won’t work at all, will it?  
Because it’s too direct.” - Alice 
 
Consequently, Alice generally reported using tentative strategies such as being 
“playful” and “then start getting them to unpick the story” in order to challenge 
the use of medication. Hayley also gave examples of tentative strategies she 
tended to use: - 
 
“I don’t know that I’ve ever sort of stepped in and said, oh why are you 
prescribing this or sort of being, I can’t think of the word, like 
confrontational about it. But I might have sort of just said, oh, you know, 
I’m not sure whether medication is going to have any impact on this or I 
feel like it could be more to do with this type of thing.” - Hayley 
 
In contrast to a gentle and curious approach, Hannah often found using a more 
challenging approach to be reinforced and so would lean towards this strategy 
where possible: - 
 
“And sometimes, yes, with a number of people, I remember being told, 
oh OK, well if you’ve got an idea, go with that then. So actually, it kind of 
reinforced my behaviour to be that direct because it was really helpful.” - 
Hannah 
  
Saffron also reflected the need to be firm to in order to ensure an opinion was 
counted: - 
 
“And you do need to be a bit more, not feisty, you don’t want to cause 
arguments, and I have actually got good working relationships, but, you 
know, I’ve got strong opinions about things and I will say if I disagree with 
something.” - Saffron 
 
Overall, neutral strategies reflected a decision not to become involved, or to 
impart information in a neutral way. Tentative and challenging strategies reflect 
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the expressing of an agenda to influence a clients’ medication in some capacity. 
Participants judged the strategy by which agenda was expressed (or not) based 
on prior values (acting in clients’ best interests), and most suitable strategy in 
the context of the situation. Flexibility appears to represent participants judging 
which strategy will be most successful in terms of influence. 
 
3.2.4 Strategy of action.  
The process of involvement with medication broadly fell under two subthemes: 
direct work about medication, and psychological alternatives.  
 
3.2.4.1 Direct work about medication.  
Many examples of direct work about medication are demonstrated in previous 
themes including prompting the idea of medication, supplying information about 
medication, considering the pros and cons of medication with a client, and 
discussing a client’s medication with the team. Additional examples not already 
covered will be provided. 
 
In her CAMHS position Alice describes taking on a reflective role by listening to 
and validating parents’ concerns about medication: - 
 
“…with parents then, their child might be on medication or might have 
been in the past or might become in the future. So, you know, you act as 
a kind of, a bit of a sounding board.” - Alice 
 
Lucy takes on a reflective role by feeding back information in an attempt to 
normalise side effect experiences: - 
 
“And if people sort of mention side effects and I have had prior 
experience of other patients saying the same, I might reflect that back, 
but I wouldn’t normally kind of go into, I wouldn’t normally go into much 
detail about that sort of thing.” - Lucy 
 
By drawing on her professional experience Lucy provides the client with 
information about side effects from an anecdotal position. Louise similarly 
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discussed taking a reflective position, however, gave examples of reflecting on 
positive effects of medication: - 
 
“I have lots of people say, well I quite like that little blue pill, which is the 
Lorazepam. And I go, yes, I bet you do, and we talk about that and how 
reinforcing it is to take it.” - Louise 
 
Whilst much direct work about medication occurred with clients, many examples 
of involvement were with the psychologist’s team. Kristy would interpret the 
reason behind a certain prescription for other team members working directly 
with a client: - 
 
“So it’s more about, I guess, being able to interpret the information from 
an assessment point of view, and being able to help staff to understand 
why different things have been prescribed, rather than giving information 
themselves. I guess, so yes, this is, you know, it’s usually used for this 
purpose, but, you know, I can find out, you know, more about why for this 
particular patient.” - Kristy 
 
Kristy comfortably adopts this information giving role, seeing it as important that 
a client’s team are informed about the client’s medication. Jessica echoes this 
sentiment, similarly describing how she will take the time to look up information 
to share with the team: - 
 
“And this guy went to the doctor, I’d never even heard of the medication, 
a staff member went with him, because he was saying he’s not sleeping, 
he’s the one who’s kind of got some symptoms of psychosis. And it might 
just be from not sleeping and she’s giving him something, I don’t even 
know what it is, but once we get the name of that, I will definitely look it 
up and share that, you know, kind of share that with the team.” - Jessica 
 
Direct work about medication that participants regularly engage in 
encompasses a wide variety of forms both with clients and the team.  
 
 Page 157 of 272 
3.2.4.2 Offering psychological alternatives.  
Offering psychological alternatives for both understanding and treating distress 
was felt to be a key part of the role for clinical psychologists. Hannah 
summarises how this is a key part of her role: - 
 
“I feel like I’ve got a bit of a role to, certainly, to advocate psychological 
approaches in the first instance. And without doubt, that’s my kind of 
profession, so why wouldn’t I do that?” - Hannah 
 
Bradley spoke about how using formulation offered a method for shifting away 
from the medical model without directly addressing medication: - 
 
“You know, just even something like introducing like a common shared 
language of formulation in the team, you know, just the simple fact that 
you’re formulating, enables people to talk about the psychosocial factors 
and not just the medical factors that would be talked about otherwise, 
yes.” - Bradley 
 
In this way he supports the team to consider wider factors and not focus on a 
medical disorder. In a more specific example, Alice can be seen to offer a 
psychological formulation to challenge a young client’s diagnosis of Attention 
Deficit Hyperactivity Disorder (ADHD): - 
 
“And so I had a view and I talked to the parent about this and I’ve given 
her stuff that she can read that’s about developmental trauma. Because 
the way he presents isn’t about ADHD, it’s about developmental trauma. 
This is a boy that seeks, you know, seeks kind of reassurance on such a 
high level because he also has a development disability.” - Alice 
 
Alice opens up a new way of thinking for the client’s parents by encouraging 
them to view his difficulties from a developmental perspective, and further 
encourages this by providing them information to take away and read. In many 
cases, offering a psychological formulation served to challenge a client’s 
diagnoses and negate the need for medication: - 
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“She had kind of a diagnosis of all sorts of whacky and wonderful things 
that actually, when we kind of put them into a psychological formulation, 
yes, it was very complex, but it was all stuff that we could manage in a 
more psychological way. And it was all things to do with her autism, to do 
with her sensory needs.” - Hannah 
 
Hannah’s formulation allowed an alternative approach to be undertaken with the 
client, and also functions to shift staff thinking in considering environmental 
factors for clients. Louise similarly spoke of how she regularly prompted staff to 
consider alternative strategies in the context of an overreliance on medication: - 
 
“So I sometimes talk to staff members about, you know, what are you 
doing instead of giving medication?  Because that is something that 
everyone should be thinking about anyway but it often, depending on the 
culture of the ward or the person themselves, if they really like it and 
haven’t got any other coping skills, their first port of call would be to ask 
for that PRN.  Whereas, I might suggest, have we got other ways that we 
can help someone cope with this in the moment, if that makes sense?” - 
Louise 
 
Hannah and Louise can be seen to actively take on the role of promoting 
psychological thinking within the team with the agenda of reducing the need for 
medication by allowing difficulties to viewed through a psychological lens.  
In addition to working with the team, Hannah also described offering 
psychological alternatives directly with clients: - 
 
“What I have done with quite a few people who’ve raised it with me, is 
talk about, when they’ve said to me, they didn’t want to be taking it 
anymore or they don’t think it’s useful, I guess I have encouraged that 
conversation because then I’ve been able to kind of offer, I guess, the 
psychological approach.” - Hannah 
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An example of this in practice can be seen by Kate, below, who offered an 
account of working jointly with the psychiatrist and client for medication to be 
reduced and alternative coping skills to be used in its place: - 
 
“So I think, so then it was, there was a sort of work on two fronts, the 
psychiatrist sort of was working with the client directly, and then I was 
working on trying to help her, you know, use other techniques more, you 
know, to not go straight to the medication as a first sort of instance. But 
sort of think, could I, you know, could I use something else, could I do 
something else first?” - Kate 
 
This joint approach appeared to work well in empowering Kate’s client to utilise 
new techniques in lieu of medication: - 
 
“So I think, so kind of the medication was reduced and we actually 
managed to work kind of really well in our sessions, to try and sort of 
decrease her reliance on the medication and improve her sort of ability to 
use other techniques to kind of, to manage what she was facing.” - Kate 
 
Kate’s example also highlights the importance of supplying psychological 
alternatives in the first instance, or alongside the reduction of medication. As 
Louise points out, “we sort of expect people to take drugs until they can rely not 
on them”, acknowledging the need to supply alternative coping strategies before 
attempts are made to reduce the strategy of medication.  
 
3.2.5 Reflection on strategy.  
Following involvement, participants reflected on their strategy adopted and how 
this might influence future involvement. Bradley said he felt he had only been 
able to influence medication a handful of times, however, on reflection noticed 
that he had in fact influenced his team’s approach: - 
 
“I guess, you know, being in one team for so long, then I guess, you 
know, over time, then you do notice that people are starting to challenge 
things themselves without you there.” - Bradley 
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By tentatively challenging medication and consistently offering alternatives it 
appears that his approach has transferred into the wider team and his presence 
was not always required to continue his work. This influence was not consistent 
across participants, however. Saffron found that her stance was not maintained 
in her absence: - 
 
“I’ve seen slight shifts in the nursing staff’s approach. I don’t really think 
I’ve seen much of a shift in psychiatry. I think when I’m present there’s a 
definite shift.” - Saffron 
 
These outcomes can be seen in light of how they may challenge or maintain the 
initial conflicts and uncertainties at the beginning of the process. Bradley may 
experience reduced uncertainty as a result, with increased confidence that he 
has an influential role with medication in his team. Saffron, however, may 
continue to navigate her decisions within a framework of challenges when 
deciding whether to become involved. 
 
Other reflections included considering suitability of the strategy adopted in light 
of its perceived effectiveness. Nicole reflects on adopting an intermediary role 
between a client and psychiatrist, and whose benefit her involvement served: - 
 
“So yes, often, in hindsight, you’ll still reflect on, is that the best 
approach, is there other approaches? Was that just the easy option for 
that person and you’ll, you know, I’ll be quick to say, yes, that’s fine, I’ll 
do that.  But actually, does that help my role with that client?” - Nicole 
 
Nicole’s uncertainty seems to stem from conflict arising from the weighing up of 
her decision; in this instance she became involved at the request of the 
psychiatrist, however, later reflected on whether this was at the expense of her 
client. This highlights an ongoing reflective process about whether involvement 
is fundamentally always in clients’ best interests, or to serve underlying 
agendas. 
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In regards to strategy adopted, Alice reflects on her use of tentative approaches 
to challenging medication: - 
 
“And I just think, what are we doing, you know, tinkering around and tip 
toeing and avoiding conflict? But the point is this, we work in a social 
system and there’s a hierarchy, that’s how these systems work. So you 
don’t want to get a reputation of being the one that’s doing all the 
challenging, you don’t get very far.” - Alice 
 
Alice appears to feel somewhat stuck with frustration of wanting to act on her 
values, but acknowledging this can be difficult in her team context. This leaves 
her reflecting on how her approach might feel ineffective at times, but feels 
appropriate in the wider context of slowly bringing about change. Alternatively, 
Hannah reflects on her use of a challenging approach: - 
 
“So I guess one of my reflections has been that I feel I can be really 
passionate and sometimes that comes across wrong. So I’m trying, I 
have been trying for a long time, to be a little bit more curious and a little 
bit more kind of psychologically, you know, that kind of circular 
questioning type stuff. And thinking about that kind of approach, rather 
than the more direct approach.” - Hannah 
 
Hannah considers whether using a tentative approach is more helpful in her 
concerns being taken seriously by her team. Indecision remains as to the ideal 
strategy for becoming involved with medication, perpetuating uncertainty about 
the role that clinical psychologists’ have with medication.  
 
3.3 Involvement Process Case Examples 
The process of involvement is outlined sequentially for Nicole and Kate to 
demonstrate the process using case examples.  
 
3.3.1 Nicole. 
Nicole works in an ID service and was considered to engage in high levels of 
involvement. 
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3.3.1.1 Conflicts and uncertainties.  
Similar to others, Nicole reported that her clinical training adopted a critical 
stance towards medication. Despite experiences during training, she felt that it 
was important not to be overly critical of medication: - 
 
“I try and be open minded about what people think about it, even though I 
am mindful that, as a psychologist, I don’t value it at the top of my list of 
treatment options because, you know, that’s not my professional 
standpoint, in terms of, medication isn’t the answer. But, unfortunately, 
it’s very powerful in society, the narrative around certain treatments and 
medication is seen as a go to for a lot of people to a kind of cure or a 
panacea to resolve problems.” 
 
Nicole seemed to find a place of acceptance and balance of working with 
dominant medical narratives given their tenacity. Nicole felt that clinical 
psychologists have a definite role with medication, however, admitted 
uncertainty in what this looks like in practice: - 
 
“So that is, it’s quite a big grey area generally, in psychology, in our 
profession in the UK. That we aren’t prescribers but we do clearly, have 
a lot of cross over, in terms of thinking about medication, talking about 
medication and the impact on a client.”   
 
This translated into some uncertainty about the extent of knowledge clinical 
psychologist require, and indecision regarding the impact of an increasing role 
on professional identity: - 
 
“And sometimes I probably think to myself, I should be more 
knowledgeable about medication treatments, but then on the flip side, do 
I need to be? Because I’m not an expert in that and that isn’t my 
professional, you know, my subscription and my professional identity.”   
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Overall Nicole accepts having a definite role with medication, but uncertainty 
remains regarding definition of this role, particularly in how this fits with a sense 
of psychological professional identity.    
 
3.3.1.2 Weighing up.  
3.3.1.2.1 Values driven responses to clients.  
Nicole describes commonly adopting an advocacy role on behalf of her clients, 
demonstrating a pull to respond and intervene given clients’ vulnerability and 
possible lack of capacity. Her value of advocating in clients’ best interests 
appears to be a strong driver when weighing up decisions to become involved: - 
 
“…if we’re going to support this individual or from a, you know, positive 
behaviour support perspective, or get the, this person’s distress levels 
down, then I need to have a responsible conversation about the fact that 
just taking a tablet isn’t going to necessarily eradicate this or reduce this.” 
 
Nicole also feels pulled to intervene when noticing that important information 
about medication has been missed: - 
 
“And sometimes we’ve had to step in if side effects haven’t been talked 
about. There might be those times when you think, well hang on, has the 
person talked through the risks of this? And then they’re like, no. And you 
think, right, I need to get somebody back involved here, because they 
are actively saying, there’s a lack of information here.”   
 
She does this confidently without hesitation, identifying this as an element of her 
role. Whilst it may feel clear that missing information needs to be provided, 
there is an element of weighing up as to whether it falls within her remit: - 
 
“And we’re very clear of not dishing out advice or information that you 
don’t actually have, you know, the professional knowledge, to be 
asserting more of an information giving, about signposting to where they 
might be able to find further information about treatment options… So I 
think it’s, I think that’s sometimes quite easy, in terms of, that isn’t my 
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role and I don’t know the answer to that question, but I can certainly 
signpost you to who could.” 
 
Nicole again appears to navigate this decision with ease. It may be that the 
weighing up process is somewhat less complex, as Nicole appears acceptant 
that she will definitely have a role due to her perceived need to advocate in her 
clients’ best interests. The weighing up process is more focused then on 
whether she feels she has the knowledge to directly intervene, or not: - 
   
“So yes, I think it has its challenges but I think it’s knowing your 
professional identity, isn’t it? And knowing your, I suppose your duty of 
care, where your competencies stop.”   
 
Despite acknowledging that the topic can be a grey area, Nicole appears 
relatively comfortable in her positioning. Consequently, strong values-led 
practice means Nicole appears to navigate the weighing up process with 
relative ease. 
 
3.3.1.2.2 Team context.  
Nicole identifies increased opportunities for involvement with medication due to 
the nature of the service and the MDT working closely together: - 
 
“You know, if your client group predominantly goes to a GP and 
psychiatry is not that available and you don’t have a dedicated psychiatry 
team, then you’re probably going to have a lot less opportunity to make, 
you know, influence those decisions about medication.” 
 
Whilst service context offers increased opportunity, strong MDT relationships 
appear to influence the extent of involvement for Nicole. She describes having 
good relationships with the prescribing medics in her team, who also value 
psychology and regularly request input. In addition, Nicole’s opinion on 
medication specifically is also requested: - 
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“And they will come to us and ask our opinion on diagnosis and 
medication and whether we agree that, you know, a change is needed.” 
 
This appears to permit Nicole increased authority over having involvement with 
medication, influencing the ease of the decision making process as to whether 
she should be involved. Nicole explains how the team context allows her to feel 
safe to broach medication issues and offer her opinion: - 
 
“I think maybe you probably feel less anxious about having those 
conversations with people, if you know that’s not going to have negative 
connotations, or negative repercussions, sorry, or that psychiatry are 
going to be angry in some way, that you’ve delved into something that 
they feel is very much their domain. …I think that enables you to be more 
open with how you involve yourself in it because you know that’s going to 
be received positively from an MDT perspective, that you’ve had those 
conversations.” 
 
The positive relationships and lack of power dynamics support Nicole to feel 
comfortable having involvement. Being open to involvement and facilitating 
requests from psychiatry does appear to create some challenges, however, in 
weighing up whether to opt out of a role: - 
 
“And sometimes I’ve actually been asked by psychiatry, because the 
client’s not engaging with them, for me to ask them what their thoughts 
are on their medication, to feed back to psychiatry, if they’re saying they 
want any medications changed. So sometimes, that’s quite interesting 
because you think, oh, in some ways you think, oh I’m not sure I’m 
comfortable with having a conversation about medication.” 
 
Nicole reports tolerating discomfort at times in order to maintain working 
relationships, highlighting that whilst close working relationships permits greater 
levels of involvement, it also risks blurring role boundaries. Nicole felt it was 
important to be clear on where roles end: - 
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“So I think it’s about kind of how you manage that yourself and how you, 
how you have those relationships with colleagues, that you are prepared 
to support them in their work, but still having a clarity of where your role 
ends. And there, obviously, are grey areas, where sometimes you do feel 
you are getting more pulled into doing jobs that aren’t ours, and I think 
that’s wider than just medication.” 
 
This appeared difficult to manage in practice, particularly when involvement 
invited by the psychiatrist whom it appears important to maintain a good 
relationship with in order to continue authority around medication decisions. It 
seemed somewhat easier to weigh up decisions on boundaries when tasks 
involved a practical element, or it was easier to define the associated 
professional for the job. Nicole discusses preparing medication for a client’s 
discharge: - 
 
“So sometimes I’ve had to really take a step back, and even though, 
obviously, I’m mindful of the risks and I’m involved in risk assessing 
around how they’re going to have those tablets, I had to let other 
professionals take a lead, particularly our LD nursing colleagues or the 
medics here, around how they’re going to get those medication packs in 
place ready for that discharge plan and that. Because I just feel that 
that’s well outside of my area of what I should be doing.” 
 
Nicole appears relatively confident in weighing up decisions regarding 
involvement with clients, however, there appears to be increased difficulty in 
navigating the role remit with team members.  
 
3.3.1.3 Strategy re: agenda.  
Nicole appears comfortable in generally adopting challenging strategies towards 
medication due to the receptiveness of her team. She confidentially and directly 
expresses her opinion on medication to her team: - 
 
“So that was really helpful, to say to the psychiatrist, yes, don’t prescribe 
anything because that really is going to affect our behaviour interventions 
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at the moment, and we want to be able to prove behaviourally, with the 
monitoring, that what we’re putting in place is having a positive impact.” 
 
Nicole also states that the team “have some quite frank conversations at 
professional meetings about medication” suggesting there is a general level of 
acceptance in adopting challenging positions within the MDT. 
 
3.3.1.4 Strategy of action.  
3.3.1.4.1 Direct work about medication.  
A large component of Nicole’s role includes direct work with medication. Nicole 
spoke of using information collected from discussions with clients to map onto 
behaviour charts: - 
 
“So I think that gives us that opportunity, because a lot of time we get 
feedback about medication, you know, directly, in those conversations, in 
sessions, or we hear, that someone says, oh their medication’s changed 
and this has helped.  So if we’re, you know, reviewing and looking 
behaviourally at things within our behaviour charts, we’d be capturing 
whether any medication has been changed, whether any PRN’s been 
administered. So we’d be mapping some of that behaviourally on 
behaviour charts.” 
 
Awareness of the medication clients take seems vital to Nicole’s role in her ID 
service in terms of behaviour-mapping. As noted above, Nicole also frequently 
adopts a role in providing information about medication when this has been 
missed, and deciding when to signpost to a prescriber: - 
 
“So I might be able to have an open conversation about some of the 
potential side effects, or advocating that what they’re telling me may be a 
side effect, therefore, we need to talk to psychiatry about this and make 
more of an assessment of what’s going on.” 
 
As a final example, Nicole facilitates assessments about medication in order to 
feed information back to the psychiatrist: - 
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“So I have actually, you know, had to do a bit of an assessment 
sometimes with a client, saying, how do you feel about your medication, 
do you want it to change, do you want to see psychiatry, what are your 
thoughts? Because they’re not engaging with psychiatry.” 
 
As shown in the examples, direct work about medication forms a core part of 
Nicole’s role, perhaps emphasised by the nature of the service and 
collaborative relationship with the psychiatrist.  
 
3.3.1.4.2 Offering psychological alternatives.  
Nicole introduces alternative thinking by supporting others to consider the limits 
of medication, and offering formulation to think about the impact of the wider 
environment: -  
 
“...we have a duty of care really to think about the wider formulation and 
to help somebody think about, well if we’re going to support this 
individual or from a, you know, positive behaviour support perspective, or 
get the, this person’s distress levels down, then I need to have a 
responsible conversation about the fact that just taking a tablet isn’t 
going to necessarily eradicate this or reduce this.”   
 
In addition to offering psychological formulation, Nicole gives examples of 
activities such as training to support the implementation of psychological 
techniques. Given the nature of the client group, offering alternatives generally 
appears to be supporting staff or carers to adopt different approaches to 
working with the client: - 
 
“And we need to think about, you know, other solutions, or other, you 
know, other skills or options that the care team can put in place, so they 
feel more equipped to deal. And sometimes that comes down to training 
and saying, well we need to offer some support training here or 
challenging behaviour training, because they, you know, they are heavily 
reliant on a PRN, you know, type protocol, rather than actually actively 
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thinking about internal or external factors that might be contributing to 
that person’s presentation.” 
 
A role in supporting others with psychological techniques in lieu of medication is 
clearly considered an important aspect of the role for Nicole. She suggests that 
it “can be very disempowering… for people just to be taking tablets and not feel 
they’ve got any other way to cope with the distress”. Nicole spoke positively of 
offering alternatives and did not highlight any barriers in doing so, perhaps 
facilitated by her status within the team context. 
 
3.3.1.5 Reflection on strategy.  
Nicole reflected that she would not change the role she currently adopts with 
psychotropic medication, although felt ambivalent about whether she would like 
to gain further knowledge to inform practice. It was discussed how additional 
training may enable increased confidence with involvement in some instances: - 
 
“I suppose sometimes I’ve been mindful about how much to delve, if I 
think I don’t, it’s making me sound unknowledgeable about treatments or 
medication, or I suppose if it links to certain conditions that I think, we 
should know more about that.”  
 
This suggests Nicole is considering opportunities for increased involvement, 
however, she also appeared reflexive of whether at times her active role was 
perhaps not always most appropriate. This is particularly the case when working 
in an intermediary role for the psychiatrist: - 
 
“But then, yes, on the flip side you think, should I be doing that? Should I 
be delving into asking a client about their medication because does that 
confuse the issue for them?  So yes, often, in hindsight, you’ll still reflect 
on, is that the best approach, is there other approaches? Was that just 
the easy option for that person and you’ll, you know, I’ll be quick to say, 
yes, that’s fine, I’ll do that.  But actually, does that help my role with that 
client?”   
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Nicole can be seen reflecting on whose benefit her involvement is for, 
questioning whether the function is to support her colleague or her client. These 
reflections lead back into ‘contexts and uncertainties’, whilst ambiguity around 
the definition of the role remains. Despite continued uncertainty, it is evident 
how engaging in reflective practice on involvement might influence Nicole’s 
practice in future.  
 
3.3.2 Kate. 
Kate works in an eating disorder service and was considered to engage in low 
levels of involvement. 
 
3.3.2.1 Conflicts and uncertainties.  
Kate began by stating that she felt there was a general reliance on medication 
within society, and it was often prioritised over psychological therapies: - 
 
“…and, you know, and I think there is a lot of, you know, I think 
medication, psychotropic medication, but I think medication in general, 
there’s probably an over reliance in our society on that. And I think, you 
know, as a psychologist, I would like to see kind of more people being 
able to use other methods, you know, other techniques and all 
psychological therapies instead of medication.”   
 
This hope for therapies to be used instead of medication suggests potential 
opportunity for involvement, however, Kate expressed uncertainty around 
clinical psychologists having involvement with clients’ medication due to being 
trained in an alternative role: - 
 
“We, you know, we are trained in sort of other ways of working and I 
think if we, let’s say, if we kind of delve too much into conversations 
about medication, it kind of dilutes, maybe not necessarily dilutes, but, 
you know, it kind of, it might be a bit confusing, if that makes sense.” 
 
Kate expressed concern that role blurring could be confusing for others and 
appeared to err on the side of caution. She admitted that a role with medication 
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was “hard to define” and seemed undecided about whether there should be a 
distinctive role even with further training: - 
 
“I mean I think generally, as psychologists, I think we don’t, I kind of 
wonder whether it’s important for us as psychologists to do that, well to, 
to engage too much with, because I think we would have to either be 
psychiatrists or, you know, I’m not sure how much, you know, how much, 
we would have to have a huge amount of training. But then a little bit of 
training, again, I think might be problematic… although on the other 
hand, maybe a little bit of training would, yes, might help.” 
 
Despite acknowledging that medication can be overused and she would like to 
see increased use of psychological therapy, Kate expresses ambivalence as to 
what a clinical psychologist’s role with medication should look like.  
 
3.3.2.2 Weighing up. 
3.3.2.2.1 Values driven responses to clients.  
Kate states that she would be inclined to query medication use if she felt that it 
was not required: - 
 
“I wouldn’t necessarily, you know, unless I sort of, I think that they 
definitely shouldn’t have that or they definitely don’t need to be on a huge 
amount of medication, let’s say, because they’re doing quite well.”  
 
Whilst she states that in certain instances she would query its use, overall Kate 
appears to take a cautious approach in weighing up her decisions to become 
involved and carefully considers where her remit ends. She explains the extent 
to which she considers her role: - 
 
“I don’t think it’s, you know, it’s within my role to discuss medication in 
any detail. I could, you know, I can sort of emphasise and, you know, do 
all our sort of soft psychological skills around it, but I wouldn’t advise or I 
wouldn’t, you know, talk about what they should do, you know, apart 
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from… it’s best to discuss it with your GP if it’s an outpatient or with our 
psychiatrist if it’s an inpatient.”   
 
Kate weighs up her decision based on what seems to be an empathic pull to 
respond in some way, with boundaries she has defined. Despite holding firm 
boundaries, Kate is inclined to find a way to become involved and engage her 
client in a discussion about medication, suggestive of a values based response 
of care and responsibility for the client’s wellbeing. Kate also described an 
incident of intervening due to risk: - 
 
“There was this one case when I needed to sort of intervene because the 
patient had expressed some suicidal ideation, and I knew that they were 
on a lot of medication. And it wasn’t, there wasn’t a sort of, you know, 
they didn’t have, it wasn’t sort of, it was a risk but it wasn’t a sort of, they 
didn’t have a concrete plan. But they sort of said, that if they were to act 
on their thoughts they would use the medication that they had.”   
 
In this instance Kate was driven to respond by her values of maintaining client 
safety, and consequently telephoned her client’s GP in order to communicate 
her concerns.  
 
3.3.2.2.2 Team context.  
Kate described her team as having a focus on medication reduction, primarily 
due to the additional health risks when working in eating disorder services: -  
 
“…the culture in our team is to generally, if it’s deemed to be 
unnecessary medication or too much of a certain something, then 
generally, it would be kind of done anyway or we would generally try and 
work with the patient to sort of decrease the medication as much as 
possible. It might be because it’s, you know, the physical health of our 
clients as well, you know, it can be hugely affected by it. So I think it’s 
sort of, naturally, the drive is to kind of bring that down anyway.”   
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This alleviates Kate from having to make a decision about involvement, given 
that the team ethos is dominantly in alignment with values about minimising 
medication use.  
 
Kate expresses a general sense of hesitancy in regards to weighing up 
involvement: - 
 
“So a lot of the meetings, I’m there when the medication is discussed, 
although I wouldn’t, I wouldn’t really comment very much on that 
because there are psychiatrists, prescribing nurses there, that know a lot 
more about medication than I do.” 
 
When weighing up her decision it seems that Kate is often more swayed by the 
anxiety around having little knowledge in comparison to her team. Kate justifies 
regularly not being involved by trusting her team’s judgement: - 
  
“So I think, you know, if the rest of the team feel that it’s important or 
necessary for the client to be on it, then, you know, that would be, you 
know, that would be sort of fine with me. And if that’s, you know, I 
wouldn’t necessarily intervene in any way in those kind of cases.”   
 
As such, Kate often appears to decide not to become involved based on belief 
that the rest of her team are already working in client’s best interests, and there 
is no conflict with her values. The set-up of her team, and the reliance on other 
professionals to address medication issues reduces opportunity for Kate to 
have involvement: - 
 
“I think if, let’s say, I think it’s because, it’s probably more important for a 
psychologist if they are the only people that see a patient… if I would be 
the only person seeing somebody, then, obviously, I would be bringing 
that probably more frequently.” 
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It is unclear on how Kate would respond should she face a situation that 
provoked a strong reaction in line with her values, as Kate is often relieved from 
involvement due to the nature of her team context. 
 
3.3.2.3 Strategy re: agenda.  
Whilst Kate initially stated that she felt medication was often used over and 
above psychological therapy, she does not often express this agenda and if she 
does, a tentative strategy is used. Kate describes her reaction to perceiving that 
a client was taking a lot of medication: - 
 
I think sometimes, I mean sometimes I think, I mean there is generally, 
you know, if somebody’s on a lot of medication, I might, you know, I 
might sort of say that, but yes, I think, it’s difficult.  
 
Kate’s tentative language is suggestive of wishing to query medication use but 
perhaps not feeling confident enough to take a challenging approach. Kate 
gives a further example of attempting to postpone prescribing: - 
 
“I mean sometimes there might be cases when, let’s say, we’re thinking 
about starting psychological therapy with a patient and, you know, I have 
assessed them, and they seem sort of very, very poorly still. So I would 
say, maybe it’s not quite the right time yet because they don’t seem to be 
able to sort of concentrate or, you know, they’re kind of, they’re not 
engaged, they’re kind of too withdrawn or something like that, for that 
particular type of work.”  
          
Kate describes how she gently proposes reasons as to why it is not an 
appropriate time to prescribe medication for a client. In doing so she expresses 
her agenda in a tentative manner. 
 
3.3.2.4 Strategy of action. 
3.3.2.3.1 Direct work about medication.  
Kate described how she would sometimes bring medication related issues to 
her team for discussion: - 
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“I mean sometimes if I, let’s say, I’ve got, if a patient would sort of tell me 
that they’re struggling with something, some medication or something 
like that, then I would sort of pass it on to the team and then they sort of 
discuss it in that manner.” 
 
As such, much of Kate’s direct work with medication was in passing on 
concerns rather than directly addressing issues with clients. Kate did provide 
some examples, however, of direct work that influenced medication a client was 
taking. One example was with a client in her practice: - 
 
“So we had a chat with, I had a chat with our psychiatrist about that and 
the use of medication, and encouraged her to discuss the medication 
with our psychiatrist…. so kind of the medication was reduced and we 
actually managed to work kind of really well in our sessions, to try and 
sort of decrease her reliance on the medication and improve her sort of 
ability to use other techniques to kind of, to manage what she was 
facing.” 
 
In this case Kate prompted the idea of medication reduction and worked jointly 
with the psychiatrist and client to manage this. On another occasion, Kate 
contacted a client’s GP to offer medication-related advice: - 
 
“So then sort of I did contact the GP to let them know about the sort of, to 
kind of lower the risk and, you know, the problem that, potentially, it’s 
either that, you know, they really, they didn’t necessarily need the 
medication, or maybe they did need it but they weren’t using it properly, 
so that’s why it wasn’t working anyway.” 
 
Despite lower levels of involvement, there are still clearly situations whereby 
Kate feels a pull to respond and works to influence prescribing. 
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3.3.2.3.2 Offering psychological alternatives.  
Kate felt that offering psychological alternatives was an important role, not just 
for herself, for the psychologists in general: - 
 
“Yes, I mean I think in terms of, I think, yes, I think as psychologists 
probably we do have a role in, we have a big role in promoting 
psychological approaches to mental health. And sort of thinking, sort of 
maybe showing examples of when it can be used as an alternative to 
medication.” 
 
Despite considering offering alternatives as important, Kate actually perceives 
her contributions as being an addition to medication rather than alternatives per 
se: - 
 
“I think what I usually do in a sort of, in this kind of setting, is generally 
sort of provide an alternative, I guess, to medication, and think, sort of 
say, OK, well on top of that, maybe we could do this and this and this, 
let’s say.” 
 
Offering additional ideas appears in line with the tentative strategies Kate 
commonly appears to adopt, ensuring that psychological ideas are proposed 
without directly challenging use of medication. Kate regularly considers 
medication use from a psychological point of view: - 
 
“It’s more about the meaning of the, let’s say, if they need to be on the 
medication but they sort of question how, you know, how it impacts them.  
And it can maybe have a, you know, it might have a bearing on the 
formulation. So I would kind of think about how they feel about this from 
the sort of psychological point of view.” 
 
Kate engages with her clients in terms of thinking about the impact that taking 
medication has on their identity, offering a unique reflective space without 
necessarily challenging or influencing its use: - 
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“Because sometimes that affects a lot, you know, the identity of people.  
Like I’m somebody who needs to be on a very strong sort of medication, 
let’s say, and, you know, and often, they can want to talk about, they may 
want to talk about that. So I can help them with that, to think about how it 
impacts sort of them as people.” 
 
Furthermore, Kate formulates medication use in terms of the impact that it might 
be having on a client’s ability to progress and engage in therapy: - 
 
“I can think about, is somebody who’s been an outpatient in the sort of 
service, and she was on a lot of anti-anxiety medication.  And she sort of, 
she mentioned to me that she really needed the medication, she felt she 
needed the medication because it sort of made her sort of more able to 
sort of resist the sort of negative thoughts from directly about sort of 
eating… from a psychological point of view, I was worried about the sort 
of completely external loss of control, in terms of being able to manage 
her thoughts.” 
 
By offering an alternative understanding for the client’s difficulties Kate was then 
able to engage in some of the direct work about medication discussed above, 
whilst supporting her client to use alterative coping strategies whilst reducing 
their medication. 
 
3.3.2.4 Reflection on strategy.  
Kate reflects by considering how despite having strong opinions, she feels 
comfortable adopting tentative strategies given the knowledge she currently 
holds: - 
 
“I think I do have a strong sort of opinion that it’s, you know, I try not to 
kind of get too much into it. Because I think it’s, you know, the different 
things will be right for different people, and I think if I’ve, without sort of 
too, without too detailed knowledge, I think I wouldn’t want to, you know, 
say, oh, you know, this is right or wrong. Because I think it really 
depends on who it is and for some people, you know, some people will 
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need medication, some people won’t necessarily. But it’s not up to me 
really to decide which is which really.” 
 
Kate’s reflections express continued ambivalence about her role with 
medication; she clearly feels strongly about its use and becomes involved on 
occasion, but does so cautiously due to ongoing conflicts and uncertainties 
about the suitability of this role. 
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4. Extended Discussion 
This section elaborates on the discussion provided in the journal article. Study 
finding are considered in context to relevant literature and theory, strengths and 
limitations of the study are discussed, before outlining clinical implications and 
recommendations for future research. 
 
4.1 Findings in Relation to Previous Literature.  
VandenBos and Williams (2000) found that almost all psychologists in their 
study were involved with medication in some capacity, a finding that was also 
reflected in the current study. The most common forms of involvement 
psychologists were undertaking did differ between studies, however, it is 
important to note that options available within both surveys varied. In the 
previous study, psychologists were most frequently referring a client to a 
prescriber, recommending a medical evaluation following assessment, and 
discussing changing a client’s medication with their prescriber. These actions 
predominantly serve an agenda of supporting medication use, however, in the 
present study roles of a more reflective and discursive capacity were assumed. 
Most frequent forms of involvement in the current study were reflecting with a 
client on their general experience of taking medication, discussing medication 
within individual sessions, and supporting clients to discuss medication with 
their prescriber. It is important to consider differences in cultural and healthcare 
context when comparing results. Prominent difference in the treatment patterns 
of psychotropic medication exists between the US and Western Europe, with 
increased use in the US (Zito et al., 2008). Divergence in rates can be 
accounted for by difference in healthcare funding (King, 2001), policies 
regarding drug advertising, diagnostic classification systems, and cultural 
beliefs regarding the role of medication for emotional and behavioural treatment 
(Zito et al., 2008). Despite cultural differences, only a small proportion of UK 
psychologists felt it would be inappropriate to refer a client for medication 
(6.1%) or discuss changing a client’s medication with their prescriber (3.4%) 
with many reporting they engage in these roles.  
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Within context of emerging professional critical publications towards the medical 
model, it was anticipated that findings might represent a largely critical stance 
erring away from supporting its use. Indeed, the recently published PTM 
framework advocates the movement of mental healthcare beyond 
medicalisation and diagnostic assumptions (Johnstone & Boyle, 2018). 
Declining to support medication use was, however, not found to be the case. 
Just under half (49.7%) of survey participants reported making referrals to a 
prescriber for medication, and slightly fewer were involved in the decision 
making process in prescribing a client medication (44.2%). Vandenbos and 
Williams (2000) offer little speculation of psychologists’ agendas driving their 
involvement other than suggesting that knowledge of medication may help in 
understanding the whole person, and support career progression into new roles. 
Interview data from the current study allows insight as to clinical psychologists’ 
decision making, revealing that whilst medication was not valued as a first-line 
treatment, prompting its use was driven by responses to client risk and distress, 
and with hopes of supporting engagement with therapy. These findings also 
demonstrate the value of the mixed methods approach in providing context and 
understanding to participants’ rationales behind involvement. 
 
Study findings were also congruent with roles proposed by Houghton (2016) 
who articulated that clinical psychologists were well placed to hold discussions 
about medication with clients, provide balanced perspectives to medical 
discourses, and explore the psychological meaning of taking medication. 
Thematic analysis identified that the sampled clinical psychologists are already 
engaging in these practices. A form of involvement perhaps unique to clinical 
psychologists was in using knowledge about a client’s relationship with 
medication to aid formulation and understanding as to how this impacts on 
client identity and coping styles. These findings support the notion that clinical 
psychologists are well placed to offer such reflective conversations, an aspect 
that seems unique to the role.  
 
4.2 Findings in Relation to Theory.  
There is limited research with which to compare study findings with. 
Nevertheless, considerations can be made with regards to previous theories 
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discussed in the extended background. It was anticipated that clinical 
psychologists may not traditionally identify themselves as having a role with 
medication. Role ambiguity was hypothesised due to encouragement from 
professional networks to work beyond the medical model, but a lack of clarity 
about expectations on how to manage this. Role ambiguity was extensively 
expressed, as participants acknowledged that they perceived themselves as 
having a role, but found this difficult to define and described many ‘grey areas’. 
Role blurring was also apparent, evidenced by many participants engaging in 
roles they considered beyond their remit, but felt were missed by other 
professions. This included acting on behalf of a psychiatrist to question a client 
about their medication when the client disengaged from psychiatry, and seeking 
information to supply to a client when a GP had not provided this. Concerns 
associated with role blurring have been highlighted as losing a sense of 
professional identity (Brown et al., 2000) and a loss of efficiency due to 
operating outside areas of expertise (Wall, 1998). During the weighing up 
process concern was expressed about the risk of being perceived too closely to 
psychiatry and blurring role boundaries. Participants attempted to balance 
maintaining professional identity as a psychologist, alongside a pull to respond 
and become involved with medication to support clients’ care. This role blurring 
resulted in feelings of discomfort and uncertainty for some, with little strategy 
available for managing and alleviating this. 
 
 4.2.1 Triangle of responsibility.  
The triangle of responsibility model highlighted the uncertainty clinical 
psychologists’ face when making a judgement about becoming involved with a 
client’s psychotropic medication (Schlenker et al., 1994). Due to professional 
identity, perceived limits of control, and ambiguity about a connection to 
medication, conflicts around existence of a role were evident. The model 
proposes that responsibility is the adhesive that connects an individual with an 
event and a set of prescriptions for conduct, and responsibility increases via 
strengthening of the three linkages of the triangle. Prior to conducting the 
research, it was anticipated that the linkages were likely to be weak, resulting in 
decreased responsibility for involvement with clients’ medication. Study findings 
contradicted this hypothesis, however, with many participants reporting high 
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levels of responsibility to intervene and considered many actions to be within 
their ‘duty of care’. The triangle will now be considered again in light of findings. 
 
 4.2.1.1 Identity-prescription link.  
The identity-prescription link refers to the extent to which the prescriptions are 
perceived as applicable to the individual by virtue of their characteristics and 
roles. Role ambiguity and lack of clarity about the relevance of involvement to 
psychologists’ identity serve to weaken the link. Schlenker et al. (1994) suggest 
that the link is strengthened by a sense of purpose and direction. This may 
account for participants’ involvement given that actions were driven by a strong 
sense of values. A sense of purpose and agenda for involvement may 
strengthen clinical psychologists’ perceived identity with medication, thus 
increasing responsibility to become involved. 
 
 4.2.1.2 Identity-event link.  
The identity-event link is the degree to which an individual appears connected 
to the event; this may simply be due to their group membership, or the extent to 
which they have personal control over the situation. The extent to which 
participants felt they had influence and personal control over decisions 
regarding clients’ medication varied. However, little control also did not seem to 
deter participants from continuing to become involved. In situations whereby 
participants did not feel they had influence, an alternative strategy would be 
adopted following reflection on outcome of prior strategies used. As such, a 
degree of personal control remained even if this was to influence change in 
smaller, or different ways than previously considered. Additionally, when 
involvement is validated and met favourably, this may serve to increase 
perception of personal control and strengthen this link. 
 
 4.2.1.3 Prescription-event link.  
The prescription-event link refers to the extent to which clear rules and 
expectations governing the prescription exist. Despite lack of clear guidance, on 
the whole participants were not deterred from involvement. This link presents as 
most difficult to account for in regards to study findings. One explanation is that 
responsibility is increased via the other linkages, and so action is taken despite 
 Page 183 of 272 
a lack of clear rules. Alternatively, self-confidence as a result of certainty about 
goals is suggested to increase this link (Schlenker et al., 1994). Although there 
may be no rules governing actions, participants did appear to have goals in 
mind as a result of their involvement; often to influence prescribing in some 
capacity. Such goals may increase a sense of responsibility, and actions are 
then weighed up and navigated in absence of clear rules. 
  
4.2.1.4 Triangle of responsibility summary.  
Study results identified that participants do view involvement with clients’ 
medication as part of their role. Goals that are driven by values appear to 
strengthen the links within the triangle, and create a sense of responsibility that 
leads to action, despite role ambiguity.  
 
4.3 Discussion of Issues Arising from Results 
4.3.1 Online survey.  
There were some discrepancies within the online survey that are important to 
consider. Engaging in a collaborative discussion with a service user to support 
them in making a decision about their psychotropic medication was not voted as 
one of the most frequent options that participants had been engaging with 
during the last six months. However, 89.1% of participants reported they would 
do this given the opportunity, and this was also ranked as one of the most 
important forms of involvement. In addition, aiming to support informed decision 
making was identified as a key driver for involvement within interviews. This 
may not be occurring as frequently in practice due to a lack of perceived 
knowledge or confidence in supplying information. Indeed, fears of appearing 
unknowledgeable and overstepping boundaries were noted within the weighing 
up process.  
 
Additionally, involvement in the decision making process to prescribe a service 
user psychotropic medication was ranked as one of the most important forms of 
involvement (38.8%) within the survey, but wasn’t one of the most frequently 
selected in regards to recent involvement, or if given the opportunity. This again 
may reflect similar concerns around knowledge, or difficulties within the team 
context in the practicality of being involved in such decisions due to power 
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dynamics. These results suggest that many clinical psychologists believe there 
is an important role to help clients consider medication decisions, and in being 
part of the decision making process. However, factors are impeding action 
during the weighing up process, leaving many feeling unable to adopt a role in 
these circumstances.  
 
It was found that participants working in CAMHS, ID, and services which fell 
under ‘other’ were statistically more likely to have been involved in the decision 
making process to prescribe a service user psychotropic medication, compared 
with participants working in alternative services. Consideration as to this 
phenomenon for participants working in CAMHS and ID services has been 
considered in the journal paper. Reasons behind these differences are difficult 
to account for with participants working in ‘other’ services, given the diversity of 
services noted (eating disorders, neuropsychology, forensic, perinatal, early 
intervention in psychosis, military mental health, and occupational health). 
Participants working in services which fell under ‘other’ were also statistically 
more likely to have used psychological and/or neuropsychological tests to 
monitor and measure psychotropic medication effects. This was not a form of 
involvement discussed in interview, but may well reflect participants working in 
neuropsychology services.  
 
 4.3.2 Interviews.  
Rationale for involvement was commonly reported to be due to working in 
clients’ best interests. By virtue of its true definition, best interests refer to the 
requirement of making a decision on behalf of an individual who lacks capacity 
(British Psychological Society, 2010). Participants are not describing the act of 
conducting formal capacity assessments, however, but assuming that they 
know what is best for the client. More specifically, an assumption is usually 
being made that medication use is not best for them. It is questionable, 
therefore, whether utilising opportunity to provide potential negative 
consequences of medication, or challenging medication use, is precisely 
working in clients’ best interests or in the interest of the psychologist’s agenda. 
This may potentially stem from assumptions that psychological agenda cannot 
do any harm, but medication can.  
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4.4 Strengths and Limitations 
A key strength of the study was the mixed methods approach used to gather 
and analyse the data. The online survey is the first attempt to gather data about 
clinical psychologists’ involvement with clients’ medication within the UK. The 
mixed method approach is considered a strength given that the survey data is 
limited to descriptive information with minimal inferential analysis, which would 
have been a limitation of using only the survey. The qualitative analysis 
provided context and understanding behind reasons for involvement (or no 
involvement) and is the first known study to ask clinical psychologists about 
both their views towards, and involvement with medication. This study has 
revealed some insights into how clinical psychologists perceive their roles. This 
is important in context of the changing profession, particularly with recent 
movements towards the prospect of psychologists prescribing (British 
Psychological Society, 2018).  
 
The recruitment strategy for the online survey aimed to sample a representative 
proportion of clinical psychologists. It was not possible to attain figures depicting 
the percentages of clinical psychologists working across different service setting 
within the UK. Consequently, it is difficult to ascertain sample 
representativeness. The largest proportion of participants worked in adult 
mental health, which may be representative of a higher frequency of such 
services in the UK. The survey did not aim to recruit a minimum number of 
participants; it is unclear as to whether extended recruitment may have added 
value to the results, however, no strong evidence to suggest this would be the 
case. Restrictions on recruitment sampling times were required to be made for 
practicality reasons.  
 
Due to the nature of the topic it is important to consider the potential impact of 
self-selection bias. Attempts were made to minimise this by encouraging all who 
met selection criteria to take part regardless of views and experience. The 
spread of responses and balance of views suggests that this was at least in part 
successful. The sampling strategy for interviews was devised to represent a 
variety of opinions, services, and reported levels of involvement with 
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medication. Interview data largely supported survey findings, suggesting that 
participants interviewed were likely to be reflective of the wider sample.  
 
It is important to consider the strengths and limitations of the instruments used. 
The online survey was in part based on one used a previous study which was 
not created with rigour (VandenBos & Williams, 2000), and was largely adapted 
by the researcher. The online survey appears to hold face validity due to 
generating responses relevant to the research question, plus additional 
information within the free-text responses alleviating restriction. The survey 
appeared to have fair accessibility, evidenced by the response rates. The 
interview schedule was created solely by the researcher; piloting its use 
provided insight as to whether questions were appropriate and sought 
responses relevant to the research aims.  
 
One limitation of the study was lack of a second coder when analysing the data, 
which is considered good practice (Braun & Clarke, 2013). Although only one 
researcher coded all of the data, excerpts were checked by a research 
supervisor multiple times during research supervision. The process has also 
been made as transparent as possible (see quality assurance section 2.7) in 
order to enhance validity.   
 
4.5 Clinical Implications 
The study findings have several clinical implications, and are timely in relation to 
the recent advancements of the BPS proposing a task group for considering 
prescribing rights for clinical psychologists. Whilst this study did not focus on the 
issue of psychologists gaining prescription privileges, it adds to the debate by 
uncovering clinical psychologists’ views towards use of psychotropic medication 
generally, and roles that are already being adopted in practice.  
 
Professional guidance and/or a position statement are suggested based on 
current study findings. This would provide greater clarity on roles with 
medication for clinical psychologists, other professionals, and the public. The 
reality of what such guidelines would look like in practice, and the challenges in 
creation need to be considered. Currently, there is divergence in training on 
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psychotropic medication delivered on clinical training programs and, therefore, 
inconsistency in pharmacology knowledge held. There is propensity to consider 
the level of knowledge considered appropriate for clinical psychologists to hold, 
and for training programs to account for this. Study findings suggest that despite 
little or no training, clinical psychologists are involving themselves with issues 
relating to clients’ medication. Increased focus during training could serve to 
support in making these approaches better-informed and more consistent. If the 
BPS decide to move forwards with psychologists gaining prescription privileges, 
additional training will be required for those wishing to gain this status. This may 
reflect an acceptance that the profession as a whole should be more informed 
about medication, and training programs may incorporate increased teaching in 
line with the development of the profession.  
 
Similar to the published recommendations on moving beyond diagnosis, over-
arching guidelines on working with issues related to medication may help 
provide clarity for clinical psychologists on roles with medication. This may have 
the advantage of backing the roles that some clinical psychologists are already 
undertaking, or helping others re-revaluate their role and increase confidence in 
involvement with medication. Many weighed up decisions about involvement 
based on team context amid concerns of not being taken seriously by other 
clinicians, or power dynamics that may prevent involvement. Greater clarity on 
role has potential to improve team working and promote consistency in 
approach. Randall-James and Coles (2018) explored clinical psychologists’ 
accounts of working beyond diagnosis and found that many faced challenges in 
the implementation of working towards a paradigm shift. The authors 
speculated that this may relate to uncertainties about how to offer alternatives to 
diagnosis, and highlighted a danger that such a shift may remain aspirational 
rather than applied in practice. Guidelines outlining how clinical psychologists 
may become involved with medication may, therefore, be helpful, as opposed to 
non-specific recommendations that involvement may form part of the role. 
 
4.6 Recommendations for Future Research 
The current research explored clinical psychologists’ views towards 
psychotropic medication to an extent, but did not focus specifically on how 
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views develop and change over time; an area which may be explored in future 
research. The majority of participants discussed how professional experiences 
had shaped their views and involvement, however, little is known about 
personal use of psychotropic medication and how this may influence views and 
involvement. Within the current study sample one participant reported using 
psychotropic medication in the past, and a second reported a family member 
being prescribed psychotropic medication. Future research may wish to 
consider how personal experiences affect involvement, particularly if personal 
experience causes a shift in views.  
 
Future research may aim to expand on the current research findings by working 
towards proposed guidelines to support clinical psychologists in navigating 
issues relating to medication in practice. One proposed method of working 
towards establishing guidelines is by use of the Delphi expert consensus 
method. The Delphi method is a systematic way of determining expert 
consensus on a given question, determining collective values, and defining 
concepts (Jorm, 2015). Furthermore, consensus methods have utility in 
developing clinical guidelines within healthcare (Murphy et al., 1998). This 
would provide opportunity for a panel of clinical psychologists to have input and 
reach consensus on appropriate guidance to aid working with psychotropic 
medication.  
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5. Critical Reflection 
This section critically discusses some of the issues and challenges raised by 
this research study. Extracts from the reflexive diary are included to 
demonstrate decision making and offer reflections that occurred throughout the 
research process.  
 
5.1 Conceptualising the Research 
The research project was an idea proposed by the service user panel who work 
with the Trent Doctorate in Clinical Psychology. I was drawn to the idea based 
on a personal interest in critical literature towards psychotropic medication, 
stemming from working in a secure mental health hospital. As an assistant 
psychologist I began in what I now consider quite a naïve position, accepting 
psychotropic medication as being somewhat of a cure, given my past support 
worker experiences of seeing it used as the sole method of treatment. I saw 
many of the clients in the hospital being prescribed various medications and the 
frequent use of PRN12. On some occasions second opinion doctors sought to 
prescribe medication against a person’s wishes. I began taking an interest in 
critical reading about psychotropic medication, particularly written by other 
psychologists such as Lucy Johnstone and Peter Kinderman. I started to 
wonder about whether psychologists should have more of a role in challenging 
the medically dominant model of mental health. Following selection of the topic 
idea, I spoke with some of the service user panel members to ascertain their 
reasons behind suggesting the topic. They suggested that the idea stemmed 
more from ideas around convenience, due to the increased frequency of contact 
with a clinical psychologist compared with a psychiatrist. It was also felt that 
better-quality therapeutic relationships were built with psychologists, and it 
would be helpful to be able to discuss issues with medication in this forum. This 
helped me to widen my thinking around all kinds of possible roles clinical 
psychologists might adopt with psychotropic medication, and not necessarily a 
solely critical or challenging stance.  
 
 
                                            
12 Medication use that is proportionate, reasonable, and necessary 
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5.2 Decisions about the Research 
Decisions about the research design were developed through research 
supervision, and feedback from research panel presentations and protocol 
submission. The project was initially designed to be an interview study, but 
following feedback from research presentation panels it was decided to 
incorporate an online survey and use a mixed methods approach. This was due 
to a lack of previous research in the field, and reflection that an online survey 
would be helpful in giving a ‘flavour’ of wider current involvement. I decided to 
seek only university ethical approval and not recruit via the NHS in order to 
save time on the ethical application process. I reflected in my diary that “I’m 
worried in case I get a poor response rate and should have taken the time to try 
and get NHS ethics sorted”, however, the recruitment strategy proved 
successful in gaining a suitable number of participants.  
 
5.3 Reflections on the Recruitment Process 
Overall, I feel that my recruitment went very smoothly and I did not encounter 
any problems in attaining a suitable sample size. I felt very lucky, especially with 
knowledge that fellow colleagues were having increased difficulty with 
recruitment, yet continued to experience some anxiety in a ‘it’s too good to be 
true’ sense. Despite having a research plan, I came to realise at many points 
along the way that perhaps I had not thought certain aspects through in the 
detail required. I struggled with the concept of feeling anxious that I was not 
rigorous in my research skills, but remaining flexible where appropriate. Much of 
my anxiety stemmed from limited confidence in my research abilities, feeling 
relatively inexperienced in this area: - 
 
“My survey has now been live for over a month. I have 98 responses 
currently which is amazing! I still have another two months to go, too. 
Lots of people have consented to follow up interviews also which is 
fantastic. I had a research meeting the other day and discussed how 
things are going so far, and some of the decision making regarding the 
sampling for interviews. I reflected on my worry that I felt like I was kind 
of making it up as I go, and my plan was a bit woolly. My supervisor 
helped me realise that it’s OK to be open minded about things at this 
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stage, and as long as I have a rationale behind all of my decision making 
then it’s OK.” (26th February 2017) 
 
I continued to recruit participants for interview, again without facing any 
difficulties. I felt that the interviews went well and I became more comfortable 
over time in engaging with participants, and following up on details they had 
said. Reflection on the researcher role in the generation of data is crucial due 
the inevitable power dynamic created between researcher and participant. As 
the researcher, I hold power due to controlling the topic of research, direction of 
questionings, and consequent analyses. However, participants were qualified 
clinical psychologists, whilst I am a trainee and so in regards to relational 
dynamics increased power could be considered to lie with the participants. This 
may have enabled participants to feel safer in expressing their thoughts and 
views due to feeling safer in the knowledge that they had greater knowledge 
than the interviewer. Additionally, my role as a trainee clinical psychologist may 
also have afforded me ‘inside status’ (Given, 2008) due to myself being part of 
the same system being explored with participants. This may have facilitated 
participant openness due to unspoken assumptions that we position ourselves 
similarly with regards to psychotropic medication, and due to mutual 
understanding and knowledge about the research topic. In an attempt to remain 
neutral, I did not share any of my personal beliefs prior to interviews, however, a 
few participants asked me about my opinions afterwards. This possibly 
suggests inside status reflected in a desire to exchange views about a topic 
relevant to our professions. 
 
5.4 Reflections on Analysis 
The interviews were initially coded inductively prior to using the deductive 
framework. It is important to bear in mind, however, that due to the mixed 
method nature of the study I approached the transcription analysis with 
knowledge of data from the online survey. I was also wary of minimising bias, 
and personal beliefs leading me to focus on certain aspects of the data at the 
expense of others. This was particularly important given my background interest 
in critical literature on psychotropic medication; I did not want to become 
engrossed in participant’s critical approaches and ignore other aspects and 
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roles. Being new to qualitative research, I found working with eleven 
transcriptions quite overwhelming and at times felt I was losing sight of my 
research aims, and struggling to really ‘see’ the data. I wrote in my reflective 
diary at this time to capture some of my anxieties: - 
 
“I don’t really feel immersed in my project at the moment and it feels 
more like a chore. I have begun coding the qualitative data and have 
research supervision to discuss this today. Given the diversity of things 
people have said, I’m finding it hard to remember and stick to my initial 
question looking at ‘current involvement’ and keep being swept away by 
people’s opinions and potential roles for psychologists.” (6th September 
2017) 
 
I used research supervision to discuss concerns, and found it helpful to have 
my research supervisors offer their insights. Themes were derived over several 
research supervisions, including input from an external supervisor in attempts to 
minimise bias and ensure themes made were coherent. Being new to qualitative 
research I found this process quite tiring and frustrating, the process taking 
much longer than I had anticipated. There were several times when I felt I finally 
had my themes, only to begin drafting and realise further refinement would be 
appropriate. Braun and Clarke (2013) acknowledge that researchers need to 
decide when they will stop refining themes, as this process can be ongoing. 
Analysis was concluded following external supervisory input, as all researchers 
were in agreement that the final conceptual thematic map was logical and 
represented the data.  
 
5.5 Theoretical Reflections 
An aspect of the research that proved both a positive and a challenge was the 
atheoretical nature of the topic area and research questions. This allowed for 
flexibility in considering the application of psychological theory to the 
phenomenon, however, I found this challenging due to its broad nature. 
Personally, I lean more towards constructivist ways of thinking about reality, 
focusing on individual experience rather than an existence of an objective truth. 
This is represented within my clinical practice, as I generally favour qualitative 
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feedback over quantitative measures, believing they can miss individual 
differences and lose sight of context. With this in mind, I appreciate that in order 
to organise and draw comparisons, the structure of such quantitative measures 
can be useful tools. This paradigm conflict presented difficulty in incorporating 
quantitative and qualitative components of the research, in understanding the 
epistemological position most appropriate to the research design, and my own 
way of thinking. I initially considered pragmatism due to its frequent association 
with mixed methods research, but upon further reading learnt of critical realism 
and felt this approach provided best fit. There is no denying of an objective 
reality, but accounts for researcher influence and participant’s constructions of 
reality.  
 
The following extract reflects some thoughts noted after interviewing a 
participant who identified as being a social constructionist, which are then 
related to epistemology and associated challenges: - 
 
“Just did my 6th interview, was a really interesting one because she had 
quite strong ideas around use of medication and how she works in 
practice. She started off by saying that she considers herself as a social 
constructionist, and so totally disagrees with the use of medication to 
treat mental health problems. I thought it was interesting because when I 
think about the way she described working, I’m pretty sure my online 
survey and the options presented wouldn’t really have captured that. She 
took more of a passive aggressive kind of approach in relation to her 
involvement with medication, she would share critical articles and gain 
allies to get others on board with her way of thinking. It was more about 
making small changes here and there, and try to stop clients being 
referred to the psychiatrist instead of taking people off medication when 
it’s too late. This made me think about just how complex ‘involvement’ 
can be, which I didn’t really consider when I first started designing the 
study. It also reflects forms of ‘involvement’ I had never really considered 
before.” (25th August 2017) 
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By allowing participants to talk openly they were able to discuss factors they 
perceived as most important and allow insight into how they construed their 
reality. Sole use of the online survey, coming from a positivist approach would 
have assumed that predefined options represented reality of practice. I feel that 
the benefit of using mixed methods allowed for previously undefined forms of 
involvement to arise, resulting in unexpected findings and new ways of thinking 
about the topic than were conceptualised in the online survey. 
 
5.6 Ethical Reflections 
My initial thoughts in regards to reflecting on ethical issues, is that I don’t feel 
my study encountered or raised any substantial ethical issues. I was mindful of 
time requirements made of participants, particularly as there was no incentive 
offered for taking part. As a trainee I am aware of the time pressures for clinical 
psychologists. Attempts were made to minimise demands by offering to travel to 
participant’s work base, or conducting the interview over Skype or telephone. I 
also ensured that interviews did not overrun an hour’s length, as specified in the 
participant information sheet. 
 
I felt somewhat of an obligation to represent all of the interview participants and 
do justice to their contributions. Due to such a large volume of data and limited 
word space, decisions had to be made regarding which data to include and 
leave out. Attempts were made to justify decisions by use of an audit trail, 
however, I have invariably had influence over which data is presented. By using 
reflection and supervision I have aimed to incorporate all views, not just those I 
may align with, and have hoped to fairly represent all participants across both 
papers.  
 
5.7 Reflections On Research Implications 
A key implication resulting from the study is that professional guidance on 
working with psychotropic medication may help to inform clinical psychologists’ 
practice. My initial reflections on the implications were that I worried they were 
somewhat vague, and also whether guidelines would in fact be helpful. This 
partly stemmed from the findings of Randall-James and Coles (2018) whereby 
clinical psychologists appeared to struggle to work beyond diagnosis, despite 
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professional guidelines being in place. This made me wonder the extent to 
which guidelines might impact practice or may remain largely uninfluential. 
However, on further reflection I considered how participants working in ID 
services felt an increased need to advocate on behalf of their clients, possibly 
backed by initiatives such as STOMP (Voluntary Organisations Disabilty Group, 
2017). Whist guidelines may not necessarily always be followed, this made me 
realise that having backing in terms of formal documents could serve to permit 
perceived authority to become involved. This may also help clarify some 
aspects of the weighing up process, and so I do think that guidelines could be 
useful. 
 
I would also like to think that the findings will be interesting to many clinical 
psychologists and continue the debate around involvement with psychotropic 
medication. I think this is especially timely given that the BPS are moving 
towards considering prescription privileges. Whilst prescribing was not a key 
aspect within the current study, I think the findings are still interesting within this 
context and demonstrate the extent to which clinical psychologists can have 
influence with medication without prescription privileges.  
 
Research Project Portfolio Word Count (excluding reference lists, tables, 
figures, appendices, and statements referring to Extended Paper): 37,681 
words 
 
 
 
 
 Page 196 of 272 
References 
 
American Psychological Association. (2018). About Prescribing Psychologists. 
Retrieved from 
http://www.apapracticecentral.org/advocacy/authority/prescribing-
psychologists.aspx?_ga=1.145102583.299816480.1443970138 
Antaki, C., Billig, M., & Potter, J. (2003). Discourse Analysis Means Doing 
Analysis: A Critique Of Six Analytic Shortcomings. Athenea Digital. Revista 
de Pensamiento e Investigación Social, 1(3), 14. 
http://doi.org/10.5565/rev/athenead/v1n3.64 
Attride-Stirling, J. (2001). Thematic networks: An analytic tool for qualitative 
research. Qualitative Research, 1(3), 385–405. 
http://doi.org/10.1177/146879410100100307 
Baldwin, L. J. (2008). The discourse of professional identity in child and 
adolescent mental health services. University of Nottingham. Retrieved 
from http://eprints.nottingham.ac.uk/10504/ 
Barker, C., Pistrang, N., & Elliott, R. (2002). Research Methods in Clinical 
Psychology. Chichester: John Wiley & Sons. 
Barker Caza, B., & Creary, S. (2016). The construction of professional 
identity[Electronic version]. Perspectives on Contemporary Professional 
Work, 259–285. http://doi.org/10.4337/9781783475582.00022 
Biddle, B. J. (1979). Role Theory: Expectations, Identities and Behaviors. New 
York: Academic Press Inc. 
Biddle, B. J., & Thomas, E. J. (1966). Role Theory Concepts and Research. 
Chichester: John Wiley & Sons. 
Bosely, S. (2018). The drugs do work: antidepressants are effective, study 
 Page 197 of 272 
shows. The Guardian. Retrieved from 
https://www.theguardian.com/science/2018/feb/21/the-drugs-do-work-
antidepressants-are-effective-study-shows 
Bowen, G. A. (2008). Naturalistic inquiry and the saturation concept: A research 
note. Qualitative Research, 8(1), 137–152. 
http://doi.org/10.1177/1468794107085301 
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. 
Qualitative Research in Psychology, 3(2), 77–101. 
http://doi.org/10.1191/1478088706qp063oa 
Braun, V., & Clarke, V. (2013). Successful qualitative research. London: SAGE. 
British Psychological Society. (2003). To prescribe or not to prescribe – Is that 
the question? The Psychologist, 16(4), 184–191. 
British Psychological Society. (2008). Generic Professional Practice Guidelines. 
Retrieved from 
http://www.bps.org.uk/sites/default/files/documents/generic_professional_pr
actice_guidelines.pdf 
British Psychological Society. (2009). Code of Ethics and Conduct. Leicester: 
British Psychological Society. 
British Psychological Society. (2010). Best Interests Guidance on determining 
the best interests of adults who lack the capacity to make a decision (or 
decisions) for themselves. The British Psychological Society, 1–45. 
Retrieved from 
http://www.briscomhealth.org.uk/files/Best_Interests_Guidance.pdf 
British Psychological Society. (2018). Unlocking the social cure. The 
Psychologist, 31(May), 28–31. 
 Page 198 of 272 
Brown, B., Crawford, P., & Darongkamas, J. (2000). Blurred roles and 
permeable boundaries: The experience of multidisciplinary working in 
community mental health. Health and Social Care in the Community, 8(6), 
425–435. http://doi.org/10.1046/j.1365-2524.2000.00268.x 
Bryman, A. (2007). Barriers to Integrating Quantitative and Qualitative 
Research. Journal of Mixed Methods Research, 1(1), 8–22. 
http://doi.org/10.1177/2345678906290531 
Carlson, J. S., Demaray, M. K., & Hunter-Oehmke, S. (2006). A survey of 
school psychologists’ knowledge and training in child psychopharmacology. 
Psychology in the Schools, 43(5), 623–633. 
http://doi.org/10.1002/pits.20168 
Cho, J. Y., & Lee, E. (2014). Reducing confusion about grounded theory and 
qualitative content Analysis: Similarities and differences. The Qualitative 
Report, 19(64), 1–20. 
http://doi.org/http://www.nova.edu/ssss/QR/QR19/cho64.pdf 
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, 
Y., … Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 
antidepressant drugs for the acute treatment of adults with major 
depressive disorder: a systematic review and network meta-analysis. The 
Lancet, 391(10128), 1357–1366. http://doi.org/10.1016/S0140-
6736(17)32802-7 
Clifford, C. (1996). Role: a concept explored in nursing education. Journal of 
Advanced Nursing, 23(6), 1135–41. http://doi.org/10.1046/j.1365-
2648.1996.01219.x 
Coulson, M. A. (1972). Role: A redundant concept in sociology? Some 
 Page 199 of 272 
Educational considerations. In J. A. Jackson (Ed.), Role (pp. 107–128). 
Cambridge: Cambridge University Press. 
Creswell, J., & Plano-Clark, V. (2011). Designing and Conducting Mixed 
Methods Research. London: SAGE. 
Creswell, J. W. (2009). Research design: Qualitative and mixed methods 
approaches. London: SAGE. 
Davies, C. (2003). Workers, professions and identity. In J. Henderson & D. 
Atkinson (Eds.), Managing care in context (pp. 187–210). London: 
Routledge. 
Deforge, R., & Shaw, J. (2012). Back- and fore-grounding ontology: Exploring 
the linkages between critical realism, pragmatism, and methodologies in 
health & rehabilitation sciences. Nursing Inquiry, 19(1), 83–95. 
http://doi.org/10.1111/j.1440-1800.2011.00550.x 
DeNelsky, G. Y. (1996). The case against prescription privileges for 
psychologists. American Psychologist, 51(3), 207–212. doi:10.1037/0003-
066x.51.3.207 
Division of Clinical Psychology. (2010). The core purpose and philosophy. 
British Psychological Society. Retrieved from 
www.bps.org.uk/system/files/Public files/DCP/cat-713.pd 
Division of Clinical Psychology. (2011). Good Practice Guidelines on the use of 
psychological formulation. British Psychological Society, (December), 1–36. 
Division of Clinical Psychology. (2013). Classification of behaviour and 
experience in relation to functional psychiatric diagnoses: Time for a 
paradigm shift. Leicester: British Psychological Society. 
Division of Clinical Psychology. (2014). Understanding Psychosis and 
 Page 200 of 272 
Schizophrenia. (A. Cooke, Ed.)The British Psychological Society. 
http://doi.org/10.1176/appi.pn.2017.5a13 
Elliott, R., Fischer, C. T., & Rennie, D. L. (1999). Evolving guidelines for 
publication of qualitative research studies in psychology and related fields. 
British Journal of Clinical Psychology, 38(3), 215–229. 
http://doi.org/10.1348/014466599162782 
Feilzer, M. Y. (2010). Doing mixed methods research pragmatically: 
Implications for the rediscovery of pragmatism as a research paradigm. 
Journal of Mixed Methods Research, 4(1), 6–16. 
http://doi.org/10.1177/1558689809349691 
Fisher, P., Chew, K., & Leow, Y. J. (2015). Clinical psychologists’ use of 
reflection and reflective practice within clinical work. Reflective Practice, 
16(6), 731–743. http://doi.org/10.1080/14623943.2015.1095724 
Fitzjerald, J. & Galyer, K. (2008). Collaborative Prescribing Rights for 
Psychologists: The New Zealand Perspective. New Zealand Journal of 
Psychology, 37(3), 44-54. 
Fusch, P. I., & Ness, L. R. (2015). Are we there yet? Data saturation in 
qualitative research. The Qualitative Report, 20(9), 1408–1416. 
http://doi.org/1, 1408-1416 
Given, L. M. (2008). The SAGE encyclopedia of qualitative research methods 
(Vols. 1-0). Thousand Oaks, CA: SAGE Publications Ltd. 
Green, J. (2000). Understanding social programs through evaluation. In N. 
Denzin & Y. Lincoln (Eds.), Handbook of qualitative research (2nd ed., pp. 
981–999). 
Guest, G., Bunce, A., & Johnson, L. (2006). How Many Interviews Are Enough ? 
 Page 201 of 272 
An Experiment with Data Saturation and Variability. Family Health 
International, 18(1), 59–82. http://doi.org/10.1177/1525822X05279903 
Hall, R. (2013). Mixed Methods : In Search of a Paradigm. Conducting 
Research in a Changing and Challenging World, 71–78. Retrieved from 
http://auamii.com/proceedings_phuket_2012/hall.pdf 
Hanna, P. (2012). Using internet technologies (such as Skype) as a research 
medium: A research note. Qualitative Research, 12(2), 239–242. 
http://doi.org/10.1177/1468794111426607 
Harper, D., & Thompson, A. R. (2012). Qualitative Research Methods in Mental 
Health and Psychotherapy: A Guide for Students and Practitioners. 
Qualitative Research Methods in Mental Health and Psychotherapy: A 
Guide for Students and Practitioners. West Sussex: Wiley-Blackwell. 
Health and Care Professions Council. (2015). Standards of Proficiency for 
Practitioner psychologists. 
Health and Care Professions Council. (2018). Registered practitioner 
psychologists - modality and gender. 
Health and Social Care Information Centre. (2017). Prescriptions dispensed in 
the community: England 2006-2016. http://doi.org/ISBN 978-1-78386-430-0 
Hewson, C. (2014). Conducting research on the Internet-A new era. The 
Psychologist, 27(12), 946–950. Retrieved from 
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=psyc11&N
EWS=N&AN=2014-54775-016 
Heyvaert, M., Hannes, K., Maes, B., & Onghena, P. (2013). Critical Appraisal of 
Mixed Methods Studies. Journal of Mixed Methods Research, 7(4), 302–
327. http://doi.org/10.1177/1558689813479449 
 Page 202 of 272 
Holt, A. (2010). Using the telephone for narrative interviewing: A research note. 
Qualitative Research, 10(1), 113–121. 
http://doi.org/10.1177/1468794109348686 
Houghton, P. (2016). Joining the debate around psychiatric medication. Clinical 
Psychology Forum, 286, 10–14. 
Houston, S. (2001). Beyond social constructionism: Critical realism and social 
work. British Journal of Social Work, 31(6), 845–861. 
http://doi.org/10.1093/bjsw/31.6.845 
Ilyas, S., & Moncrieff, J. (2012). Trends in prescriptions and costs of drugs for 
mental disorders in England, 1998-2010. British Journal of Psychiatry, 
200(5), 393–398. http://doi.org/10.1192/bjp.bp.111.104257 
Jackson, S. E., & Schuler, R. S. (1985). A Meta-Analysis and Conceptual 
Critique of Research on Role Ambiguity and Role Clarity in Work Settings. 
Organizational Behavior and Human Decision Processes, 36, 16–78. 
http://doi.org/10.1016/0749-5978(85)90020-2 
Johnson, R. B. B., Onwuegbuzie, A. J. A. J., & Turner, L. A. L. A. (2007). 
Toward a Definition of Mixed Methods Research. Journal of Mixed Methods 
Research, 1(2), 112–133. http://doi.org/10.1177/1558689806298224 
Johnstone, L. (2003). To prescribe or not to prescribe- that is the question? The 
Psychologist, 16(4), 184–191. 
Johnstone, L. (2018). Psychological Formulation as an Alternative to Psychiatric 
Diagnosis. Journal of Humanistic Psychology, 58(1), 30–46. 
http://doi.org/10.1177/0022167817722230 
Johnstone, L., Boyle, M., Cromby, J., Dillon, J., Harper, D., Kinderman, P., … 
Read, J. (2018). The Power Threat Meaning Framework: Towards the 
 Page 203 of 272 
identification of patterns in emotional distress, unusual experiences and 
troubled or troubling behaviour, as an alternative to functional psychiatric 
diagnosis. Leicester: British Psychological Society. 
Jorm, A. F. (2015). Using the Delphi expert consensus method in mental health 
research. Australian and New Zealand Journal of Psychiatry, 49(10), 887–
897. http://doi.org/10.1177/0004867415600891 
Kemper, E. A., Stringfield, S., & Teddlie, C. (2003). Mixed methods sampling 
strategies in social science research. In A. Tashakkori & C. Teddlie (Eds.), 
Handbook of mixed methods in the social and behavioral sciences. (pp. 
273–296). Thousand Oaks, CA: Sage. 
King, M. (2001). Prescription privileges and the counselling psychologist. 
Counselling Psychology Review, 16(1), 10–13. 
King, N. (2004). Using templates in the thematic analysis of text. In C. Cassel & 
G. Symon (Eds.), Essential guide to qualitative methods in organizational 
research (pp. 257–270). London: SAGE. 
Kingsbury, S. J. (1987). Cognitive Differences Between Clinical Psychologists 
and Psychiatrists. American Psychologist, 42(2), 152–156. 
http://doi.org/10.1037/0003-066X.42.2.152 
Krippendorff, K. (2004). Content analysis (2nd ed.). Thousand Oaks, CA: SAGE 
Publications. 
Lawson, T. (2003). Reorienting Economics. New York: Routledge. 
Lilienfeld, S. O., Ritschel, L. A., Lynn, S. J., Cautin, R. L., & Latzman, R. D. 
(2013). Why many clinical psychologists are resistant to evidence-based 
practice: Root causes and constructive remedies. Clinical Psychology 
Review, 33(7), 883–900. http://doi.org/10.1016/j.cpr.2012.09.008 
 Page 204 of 272 
Lincoln, Y., & Guba, E. G. (1985). Naturalistic inquiry. Newbury Park: CA: Sage. 
Lofgren, A., Hewitt, V., & das Nair, R. (2015). Doing Fence Sitting A Discursive 
Analysis of Clinical Psychologists’ Constructions of Mental Health. 
Qualitative Health Research, 25(4), 470–485. 
http://doi.org/10.1177/1049732314549479 
Marsh, S. (2017). Tens of thousands of under-18s on antidepressants in 
England. The Guardian. Retrieved from 
https://www.theguardian.com/society/2017/jun/18/number-of-under-18s-on-
antidepressants-in-england-rises-by-12 
McCoyd, J. L. M., & Kerson, T. S. (2006). Conducting Intensive Interviews 
Using Email. Qualitative Social Work: Research and Practice, 5(3), 389–
406. http://doi.org/10.1177/1473325006067367 
Mcevoy, P., & Richards, D. (2006). A critical realist rationale for using a 
combination of quantitative and qualitative methods. Journal of Research in 
Nursing, 11(1), 66–78. http://doi.org/10.1177/1744987106060192 
McEvoy, P., & Richards, D. (2003). Critical realism: A way forward for 
evaluation research in nursing? Journal of Advanced Nursing, 43(4), 411–
420. http://doi.org/10.1046/j.1365-2648.2003.02730.x 
Mead, G. H. (1934). Mind, Self and Society. Chicago: University of Chicago 
Press. 
Mertens, D. M., & Hesse-Biber, S. (2012). Triangulation and Mixed Methods 
Research. Journal of Mixed Methods Research, 6(2), 75–79. 
http://doi.org/10.1177/1558689812437100 
Mingers, J. (2003). The Place of Statistical Modelling in Management Science: 
Critical Realism and Multimethodology (Working Paper Series No. 45). 
 Page 205 of 272 
Canterbury Business School, Canterbury. 
Moncrieff, J. (2008). The creation of the concept of an antidepressant: An 
historical analysis. Social Science and Medicine, 66(11), 2346–2355. 
http://doi.org/10.1016/j.socscimed.2008.01.047 
Moncrieff, J. (2009). A straight talking introduction to psychiatric drugs. 
Herefordshire: PCCS BOOKS Ltd. 
Morse, J. (2003). Principles of mixed methods and multimethod research 
design. In A. Tashakkori & C. Teddlie (Eds.), Handbook of Mixed Methods 
in Social and Behavioral Research. Thousand Oaks, CA: SAGE 
Publications. 
Morse, J. M. (1995). The significance of saturation. Qualitative Health 
Research, 5(2), 147–149. http://doi.org/10.1177/104973239500500201 
Murdoch, M., Simon, A., Polusny, M., Bangerter, A., Grill, J., Noorbaloochi, S., 
& Partin, M. (2014). Impact of different privacy conditions and incentives on 
survey response rate, participant representativeness, and disclosure of 
sensitive information: a randomized controlled trial. BMC Medical Research 
Methodology, 14(1), 90. http://doi.org/10.1186/1471-2288-14-90 
Murphy, M. K., Black, N. A., Lamping, D. L., McKee, C. M., Sanderson, C. F., 
Askham, J., & Marteau, T. (1998). Consensus development methods, and 
their use in clinical guideline development. Health Technology Assessment 
(Winchester, England), 2(3), i–iv, 1-88. http://doi.org/10.3310/hta2030 
National Institute for Health and Care Excellence. (2005). Obsessive-
compulsive disorder and body dysmorphic disorder: treatment (Clinical 
guideline [CG31]). 
National Institute for Health and Care Excellence. (2016). Depression in adults: 
 Page 206 of 272 
recognition and management (Clinical guideline [CG90]). 
Newman, A. (2013). Could prescribing be part of the clinical psychologist's role? 
The Journal of Mental Health Training, Education and Practice, 8(1), 26-44. 
doi.org/10.1108/17556221311308005 
NHS Improving Quality. (2015). Winterbourne Medicines Programme: NHS 
Improving Quality Report. 
Novick, G. (2008). Is there a bias against telephone interviews in qualitative 
research? Research in Nursing and Health, 31(4), 391–398. 
http://doi.org/10.1002/nur.20259 
Nowell, L. S., Norris, J. M., White, D. E., & Moules, N. J. (2017). Thematic 
Analysis : Striving to Meet the Trustworthiness Criteria. International 
Journal of Qualitative Methods, 1(6), 1–13. 
http://doi.org/10.1177/1609406917733847 
Palinkas, L. A., Horwitz, S. M., Green, C. A., Wisdom, J. P., Duan, N., & 
Hoagwood, K. (2015). Purposeful Sampling for Qualitative Data Collection 
and Analysis in Mixed Method Implementation Research. Administration 
and Policy in Mental Health and Mental Health Services Research, 42(5), 
533–544. http://doi.org/10.1007/s10488-013-0528-y 
Patton, M. Q. (2002). Qualitative research and evaluation methods (3rd ed.). 
Thousand Oaks, CA: SAGE Publications. 
Payne, M. (1982). Working in Teams. Basingstoke: Macmillan. 
Peng, C.-Y. J., Lee, K. L., & Ingersoll, G. M. (2002). An Introduction to Logistic 
Regression Analysis and Reporting. The Journal of Educational Research, 
96(1), 3–14. http://doi.org/10.1080/00220670209598786 
Pring, R. (2000). Philosophy of educational research. London: Continuum. 
 Page 207 of 272 
Randall-James, J., & Coles, S. (2018). Questioning diagnoses in clinical 
practice: a thematic analysis of clinical psychologists’ accounts of working 
beyond diagnosis in the United Kingdom. Journal of Mental Health, 1–7. 
http://doi.org/10.1080/09638237.2018.1437599 
Reicher, S. (2000). Against methodolatry: some comments on Elliott, Fischer, 
and Rennie. British Journal of Clinical Psychology, 39(1), 1–6. 
http://doi.org/10.1348/014466500163031 
Resnick, R. (2003). To prescribe or not to prescribe—that is the question? The 
Psychologist, 16(4), 184–191. http://doi.org/10.1016/S1466-
853X(03)00038-5 
Robiner, W. N., Tumlin, T. R., & Tompkins, T. L. (2013). Psychologists and 
Medications in the Era of Interprofessional Care: Collaboration Is Less 
Problematic and Costly Than Prescribing. Clinical Psychology: Science and 
Practice, 20(4), 489–507. http://doi.org/10.1111/cpsp.12054 
Royal, K. (2016). “Face validity” is not a legitimate type of validity evidence! 
American Journal of Surgery, 212(5), 1026–1027. 
http://doi.org/10.1016/j.amjsurg.2016.02.018 
Sale, J. E. M., Lohfeld, L. H., & Brazil, K. (2002). Revisiting the quantitative-
qualitative debate: Implications for mixed-methods research. Quality and 
Quantity, 36(1), 43–53. http://doi.org/10.1023/A:1014301607592 
Sayer, A. (2000). Realism and Social Science. London: SAGE Publications. 
Sayer, A. (2004). Foreword: why critical realism? In S. Fleetwood & S. Ackroyd 
(Eds.), Critical Realist Applications in Organisation and Management 
Studies. London: Routledge. 
Schlenker, B. R., Britt, T. W., Pennington, J., Murphy, R., & Doherty, K. (1994). 
 Page 208 of 272 
The triangle model of responsibility. Psychological Review, 101(4), 632–
652. http://doi.org/10.1037/0033-295X.101.4.632 
Scotland, J. (2012). Exploring the philosophical underpinnings of research: 
Relating ontology and epistemology to the methodology and methods of 
the scientific, interpretive, and critical research paradigms. English 
Language Teaching, 5(9), 9–16. http://doi.org/10.5539/elt.v5n9p9 
Siebert, D. C. (2005). The caregiver role identity scale: A validation study. 
Research on Social Work Practice, 15(3), 204–212. 
http://doi.org/10.1177/1049731504272779 
Slay, H. S., & Smith, D. A. (2011). Professional identity construction: Using 
narrative to understand the negotiation of professional and stigmatized 
cultural identities. Human Relations, 64(1), 85–107. 
http://doi.org/10.1177/0018726710384290 
Smith, J. A., Flowers, P., & Larkin, M. (2009). Interpretative Phenomenological 
Analysis: Theory, Methods and Research. London: SAGE Publications Ltd. 
Starks, H., & Trinidad, S. B. (2007). Choose your method: A comparison of 
phenomenology, discourse analysis, and grounded theory. Qualitative 
Health Research, 17(10), 1372–1380. 
http://doi.org/10.1177/1049732307307031 
Statistics Solutions. (2018). Assumptions of Logistic Regression. Retrieved 
June 14, 2018, from http://www.statisticssolutions.com/assumptions-of-
logistic-regression/ 
Szasz, T. (1970). Ideology and Insanity: Essays on the psychiatric 
dehumanization of man. New York: Anchor Books. 
The Psychological Professions Network Alliance. (2018). Delivering the 
 Page 209 of 272 
Expansion in the Psychological Professions. Retrieved from 
https://www.nwppn.nhs.uk/index.php/resources/delivering-the-expansion-
in-the-psychological-professions-a-new-report-by-the-psychological-
professions-network-alliance 
Thompson Coon, J., Abbott, R., Rogers, M., Whear, R., Pearson, S., Lang, I., 
… Stein, K. (2014). Interventions to Reduce Inappropriate Prescribing of 
Antipsychotic Medications in People With Dementia Resident in Care 
Homes: A Systematic Review. Journal of the American Medical Directors 
Association, 15(10), 706–718. http://doi.org/10.1016/j.jamda.2014.06.012 
Tickle, A., Brown, D., & Hayward, M. (2014). Can we risk recovery? A grounded 
theory of clinical psychologists’ perceptions of risk and recovery-oriented 
mental health services. Psychology and Psychotherapy: Theory, Research 
and Practice, 87(1), 96–110. http://doi.org/10.1111/j.2044-
8341.2012.02079.x 
Tweed, A., & Charmaz, K. (2012). Grounded theory methods for mental health 
practitioners. In A. R. Harper & D. Thompson (Eds.), Grounded Theory 
Methods for Mental Health Practitioners (pp. 131–146). West Sussex: John 
Wiley & Sons, Ltd. 
VandenBos, G. R., & Williams, S. (2000). Is psychologists’ involvement in the 
prescribing of psychotropic medication really a new activity? Professional 
Psychology: Research and Practice, 31(6), 615–618. 
http://doi.org/10.1037/0735-7028.31.6.615 
Voluntary Organisations Disabilty Group. (2017). STOMP pledge for social care: 
Stopping the over-medication of people with a learning disability, autism or 
both. London: VODG. 
 Page 210 of 272 
Wall, A. (1998). Organisations. Knowing who’s boss. Health Service Journal, 
108(5630), 22–24. 
Willig, C. (2013). Introducing Qualitative Research in Psychology. Introducing 
Qualitative Research in Psychology. Berkshire: Open University Press. 
Yin, R. K. (2006). Mixed methods research: Are the methods genuinely 
integrated or merely parallel? Research in the Schools, 13(1), 41–48. 
Zito, J. M., Safer, D. J., de Jong-van den Berg, L. T. W., Janhsen, K., Fegert, J. 
M., Gardner, J. F., … Valluri, S. C. (2008). A three-country comparison of 
psychotropic medication prevalence in youth. Child and Adolescent 
Psychiatry and Mental Health, 2(1), 26. http://doi.org/10.1186/1753-2000-2-
26 
 Page 211 of 272 
Appendices 
 Page 212 of 272 
 
Appendix A: Charles et al. (1997) Shared Decision Making Criteria. 
1) Including the patient in the decision making process (for example, 
listening, finding out what the patient already knows, involving patients in 
the definition of the problem, ensuring that patients understand the 
clinical problem and the nature of the decision required). 
2) Exploring patients' worries, fears and expectations (for example, 
discussing uncertainties, providing opportunities for questions, and 
setting goals). 
3) Discussing potential treatment options (for example, agreeing levels of 
involvement in the decision making process - which may result in 
patients deciding they do not wish to be involved, discussing intervention 
options considering risks and benefits). 
4) Providing information (for example, communicating risk, providing 
information about interventions, discussing pros and cons). 
5) Ensuring information is understood (for example, discovering the level of 
a patients' understanding about a condition and the intervention options, 
obtaining patients' views about intervention). 
6) Ensuring patients are happy with the decision making process and the 
decisions made (for example, encouraging patients to be involved in 
actioning intervention plans, asking patients' preferences). 
7) Providing opportunities to review decisions made. 
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Appendix B: Online Survey 
Firstly, create a unique code so that your responses can be identified should 
you wish to withdraw from the survey at a later date. Please use the first three 
letters of your maiden name and the two numbers of your birth date. For 
example, if your maiden name was 'Smith' and you were born on the 5th of the 
month your code would be: SMI05. Please make a note of this code. 
Q1. What is your gender? 
 Male  
 Female  
Q2. How many years have you been qualified? 
 Less than 5  
 5-10  
 11-15  
 16-20  
 20+  
Q3. Do you work in an inpatient or community service? (Please select 
both if applicable) 
 Inpatient  
 Community  
Q4. Which type of service do you work in? (Please select more than one if 
applicable) 
 Adult Mental Health 
 Child and Adolescent 
 Intellectual Disability 
 Older Adult 
 Physical Health 
 Other   
Q5. What is the dominant psychological approach you use within your 
practice? 
 Cognitive 
 Behavioural 
 Cognitive-Behavioural 
 Psychodynamic 
 Systemic 
 Other   
Q6. Psychotropic medication refers to drugs capable of affecting the 
mind, emotions, and behaviour. 
Have you completed any significant training relating to psychotropic 
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medication? If you answer 'Yes' please select approximately how many 
days training. 
 Yes: Less than one day of training 
 Yes: Between one day and one week of training 
 Yes: More than one week of training 
 No 
 Unsure (please provide details)  
 
Q7  
Have you completed any significant training relating to psychotropic 
medication? If you answer 'Yes' please select approximately how many 
days training. 
 Yes: Less than one day of training 
 Yes: Between one day and one week of training 
 Yes: More than one week of training 
 No 
 
If ‘no’ is selected – skips to What kinds of involvement have you had with 
psychotropic medication in the last six months? (Please tick all that apply) 
 
Q8 Approximately how long has it been since you completed any 
significant training relating to psychotropic medication? 
 Less than 5 years ago 
 5-10 years ago 
 11-15 years ago 
 16-20 years ago 
 20+ years ago 
 
Q9 Which professional group did the trainer(s) belong to? 
 Psychiatrists 
 Pharmacists 
 Psychologists 
 Other ____________________ 
 
Q10. What kinds of involvement have you had with psychotropic 
medication in the last six months? (Please tick all that apply) 
 None 
 Referral to a psychiatrist/other prescriber for psychotropic medication 
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 Consulted with a psychiatrist/other prescriber about changing a service 
user's psychotropic medication 
 Involved in the decision making process to prescribe a service user 
psychotropic medication 
 Discussed psychotropic medication issues within individual service user 
sessions 
 Discussed psychotropic medication issues in group therapy sessions 
 Supplied information about psychotropic medication to a service user 
 Requested or recommended that specific psychotropic medication be 
prescribed for a service user 
 Requested or recommended that a service user be taken off a specific 
psychotropic medication 
 Engaged in a collaborative discussion with a service user to support them in 
making a decision about their psychotropic medication 
 A psychological or neuropsychological assessment prompted 
recommendations for psychotropic medication 
 Using psychological and/or neuropsychological tests to monitor and 
measure psychotropic medication effects 
 Reflecting with a service user on how their psychotropic medication may 
affect their engagement with psychology 
 Reflecting with a service user on their general experience of taking 
psychotropic medication 
 Taking the time to research information about a service users' psychotropic 
medication (e.g. internet search, asking colleagues) 
 Supporting service users to discuss their psychotropic medication with their 
prescriber 
 Other  
 Q11. Regardless of your current involvement, which of these options 
would you do given the opportunity? (Please tick all that apply) 
 None 
 Refer to a psychiatrist/other prescriber for psychotropic medication 
 Consult with a psychiatrist/other prescriber about changing a service user's 
psychotropic medication 
 Involvement in the decision making process to prescribe a service user 
psychotropic medication  
 Discuss psychotropic medication issues within individual service user 
sessions 
 Discuss psychotropic medication issues in group therapy sessions 
 Supply information about psychotropic medication to a service user 
 Request or recommend that specific psychotropic medication be prescribed 
for a service user 
 Request or recommend that a service user be taken off a specific 
psychotropic medication 
 Engage in a collaborative discussion with a service user to support them in 
making a decision about their psychotropic medication 
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 Recommend or request psychotropic medication prompted by a 
psychological or neuropsychological assessment 
 Use psychological and/or neuropsychological tests to monitor and measure 
psychotropic medication effects 
 Reflect with a service user on how their psychotropic medication may affect 
their engagement with psychology 
 Reflect with a service user on their general experience of taking 
psychotropic medication 
 Take the time to research information about a service users' psychotropic 
medication (e.g. internet search, asking colleagues) 
 Support service users to discuss their psychotropic medication with their 
prescriber 
 Other  
 Q12. Are there any options that you feel are inappropriate for Clinical 
Psychologists to be engaging in? (Please tick all that apply) 
 None - they are all appropriate 
 Referral to a psychiatrist/other prescriber for psychotropic medication 
 Consult with a psychiatrist/other prescriber about changing a service user's 
psychotropic medication 
 Involvement in the decision making process to prescribe a service user 
psychotropic medication 
 Discuss psychotropic medication issues within individual service user 
sessions 
 Discuss psychotropic medication issues in group therapy sessions 
 Supply information about psychotropic medication to a service user 
 Request or recommend that specific psychotropic medication be prescribed 
for a service user 
 Request or recommend that a service user be taken off a specific 
psychotropic medication 
 Engage in a collaborative discussion with a service user to support them in 
making a decision about their psychotropic medication 
 Recommend or request psychotropic medication prompted by a 
psychological or neuropsychological assessment 
 Use psychological and/or neuropsychological tests to monitor and measure 
psychotropic medication effects 
 Reflect with a service user on how their psychotropic medication may affect 
their engagement with psychology  
 Reflect with a service user on their general experience of taking 
psychotropic medication 
 Take the time to research information about a service users' psychotropic 
medication (e.g. internet search, asking colleagues) 
 Support service users to discuss their psychotropic medication with their 
prescriber  
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Q13. Which three forms of involvement do you consider the most 
important for Clinical Psychologists to be engaging in? (Please select 
three items, unless choosing option one)  
 None - I don't think there should be any involvement 
 Referral to a psychiatrist/other prescriber for psychotropic medication 
 Consult with a psychiatrist/other prescriber about changing a service user's 
psychotropic medication 
 Involvement in the decision making process to prescribe a service user 
psychotropic medication 
 Discuss psychotropic medication issues within individual service user 
sessions 
 Discuss psychotropic medication issues in group therapy sessions 
 Supply information about psychotropic medication to a service user 
 Request or recommend that specific psychotropic medication be prescribed 
for a service user 
 Request or recommend that a service user be taken off a specific 
psychotropic medication 
 Engage in a collaborative discussion with a service user to support them in 
making a decision about their psychotropic medication 
 Recommend or request psychotropic medication prompted by a 
psychological or neuropsychological assessment 
 Use psychological and/or neuropsychological tests to monitor and measure 
psychotropic medication effects 
 Reflect with a service user on how their psychotropic medication may affect 
their engagement with psychology 
 Reflect with a service user on their general experience of taking 
psychotropic medication 
 Take the time to research information about a service users' psychotropic 
medication (e.g. internet search, asking colleagues) 
 Support service users to discuss their psychotropic medication with their 
prescriber  
Q14. Would you say that you have strong views regarding the use of 
psychotropic medication? 
 Yes 
 No 
 Undecided  
 
Q15. Please elaborate on your views regarding the use of psychotropic 
medication  
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Q16. Do you consent to being contacted for a follow up interview? If you 
select 'Yes' please enter your email address. (Dependent on location this 
may be conducted via video conferencing) 
 Yes   
 No 
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Appendix C: Survey Advertisement 
 
Do Clinical Psychologists have a role in clients’ use of psychotropic 
medication? - DClinPsy Research Project. 
 
Clinical Psychologist participants wanted. 
I'm a second year trainee on the Trent doctorate and I am currently looking to 
recruit qualified Clinical Psychologists to complete an online survey as part of 
my DClinPsy research project. The survey may take approximately 20 minutes 
to complete. 
 
We are interested in your views of and experience with involvement of client's 
psychotropic medication. I am hoping to recruit as many Clinical Psychologists 
as possible regardless of views and experience. 
 
My project is a mixed method design and there is an option at the end of the 
survey to consent to being contacted for follow-up interviews. Not everybody 
who consents to this will necessarily be contacted. 
 
If you have any comments or questions, please feel free to contact me on 
15591138@students.lincoln.ac.uk  
Please click the following link to open the survey: 
https://lincolnpsych.eu.qualtrics.com/SE/… 
Thank you for your time. 
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Appendix D: Survey Advertisement (Division of Clinical Psychology 
Forum) 
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Appendix E: VandenBos and Williams (2000) Forms of Involvement with 
Psychotropic Medication 
 
Options of Involvement with Medication 
Psychiatric referral for medication 
Intake evaluation prompted recommendation for medical evaluation 
Consulted with physician about changing patient's medication 
Involved in decision making to prescribe medication to patients 
Extensively discussed medication issues in individual psychotherapy 
Psychological or neuropsychological assessment prompted 
recommendation for medical evaluation 
Consultant  with a team that included a professional with prescriptive 
authority 
Requested or recommended that physician prescribe specific medication 
for patient 
Used psychological and neuropsychological tests to monitor and measure  
medication effects 
Extensively discussed medication issues in group psychotherapy 
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Appendix F: Interview Schedule 
 
1. What are your views or feelings about the use of 
psychotropic medication?  
Prompts/follow-up: Where views came from. Views 
changing over time. Has type of service affected views. 
*jot down examples if given* 
Most popular last 6 months: 
reflecting with a service user on their general experience of taking psychotropic 
medication 
discussing psychotropic medication issues within individual service user sessions 
supporting service users to discuss their psychotropic medication with their 
prescriber 
Most popular ‘would do’: 
reflecting with a service user on their general experience of taking psychotropic 
medication  
supporting service users to discuss their psychotropic medication with their 
prescriber 
engaging in a collaborative discussion with a service user to support them in making 
a decision about their psychotropic 
3 most important options selected from survey: 
Engage in a collaborative discussion with a service user to support them in making a 
decision about their psychotropic medication 
support service users to discuss their psychotropic medication with their prescriber 
be involved in the decision making process to prescribe a service user psychotropic 
2. Do you encounter many opportunities to involve 
yourself with clients’ psychotropic medication? 
Prompts/follow-up: what opportunities? *look at 
involvement options from survey to prompt*. Does 
service type affect range of opportunity? 
Tell me about a time you had an opportunity to 
involve yourself with a client’s psychotropic 
medication. What happened? 
Prompts/follow-up: What did you do? Different kinds of 
involvement/further examples. What prompted 
decision? What factors helped you decide whether or 
not to get involved? 
3. Have you had similar opportunities but made 
different decisions about involvement? 
Prompts/follow-up: what affected decision making. 
4. How do you feel about the decisions you made 
now? 
Prompts/follow-up: Involvement successful? Has 
anything gone wrong? Do you wish you had made a 
different decision? Would you do it again? 
 Page 223 of 272 
5. Do you feel you’ve expressed a personal view to 
your clients in regards to their psychotropic 
medication? 
Prompts/follow-up: feelings about whether this was 
right/wrong, would or wouldn’t do this again 
medication 
reflect with a service user on their general experience of taking psychotropic 
medication  
Inappropriate 
most frequently selected response was requesting or recommending that specific 
psychotropic medication be prescribed for a service user 
no options were inappropriate 
requesting or recommending that a service user be taken off a specific psychotropic 
medication 
 
 
 
6. Do you think Clinical Psychologists should have 
training about psychotropic medication? 
Prompts/follow-up: what would you hope this training 
would enable you to do? What would you like to know 
more about? 
7. Is there anything you might have done that you 
didn’t due to lack of training? 
Prompts/follow-up: knowledge, confidence 
8. Do you think you should have a role with 
psychotropic medication? 
Prompts/follow-up: what would the role look like? Would 
this role look different to the one you may have now? 
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Appendix G: Transcription Confidentiality Agreement 
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Appendix H: University Ethical Approval 
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Appendix I: Participant Information Sheets 
Online Survey. 
 
Do Clinical Psychologists have a role in clients’ use of psychotropic 
medication? A mixed methods investigation exploring current forms of 
involvement 
 
 Before you decide to participate it is important that you know what the 
study will involve. Please take the time to read the following information 
before deciding if you wish to participate. 
 
My name is Amy Aston and I am a Trainee Clinical Psychologist studying at the 
University of Lincoln. I would like to invite you to take part in a research study 
looking at when and how Clinical Psychologists involve themselves with clients’ 
use of psychotropic medication.  
 
What is the purpose of the study? 
Traditionally pharmacology is not viewed as an aspect of the Clinical 
Psychologist role. Research in the United States of America, however, suggests 
that psychologists may be more involved with use of psychotropic medication 
than previously thought. Little is known about this relationship in the United 
Kingdom (UK), therefore, this study aims to explore the relationship between 
Clinical Psychology and psychotropic medication in terms of questioning what 
involvement Clinical Psychologists are currently having, and potentially what 
role Clinical Psychologists could have.  
It is anticipated that this study will provide new information into how Clinical 
Psychologists position themselves with regards to psychotropic medication use, 
and how decisions are made when there is potential to intervene within clinical 
practice. Given that there is currently no professional guidance for how Clinical 
Psychologists may involve themselves, it is anticipated that current involvement 
is based on personal opinion and judgement. By examining individual accounts 
of these experiences it is hoped that this can allow Clinical Psychologists to 
consider (and potentially reconsider) their position on where they sit in terms of 
involvement with psychotropic medication.  
 
This research has two phases. Phase one is the survey, which you are 
currently being invited to take part in. There will be an option for you to 
express an interest in being contacted about involvement in the second phase. 
This research is being funded by the Trent Doctorate in Clinical Psychology 
(DClinPsy). The project is being completed as part of the DClinPsy qualification 
and is being supervised by: 
 
Dr Sharron Smith 
School of Psychology, College of Social Science 
Senior Clinical Tutor 
University of Lincoln, Brayford Pool, Lincoln, Lincolnshire, LN6 7TS 
Email address: shsmith@lincoln.ac.uk 
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Dr Danielle De Boos 
Academic and Research Tutor, Faculty of Medicine & Health Sciences 
University of Nottingham, YANG Fujia, Jubilee Campus, Wollaton Road, 
Nottingham, NG8 1BB 
Email address: danielle.deboos@nottingham.ac.uk 
  
Dr Anna Tickle 
Academic Tutor, Faculty of Medicine & Health Sciences 
University of Nottingham, YANG Fujia, Jubilee Campus, Wollaton Road, 
Nottingham, NG8 1BB 
Email address: anna.tickle@nottingham.ac.uk 
  
What will I have to do? 
  
You have been invited to take part in phase one 
 
Phase one – online survey 
You have been invited to take part in phase one which is an online survey. The 
survey has 15 questions and should take approximately 20 minutes to 
complete. There are yes/no, multiple choice and free text response questions. 
You will also be asked to provide descriptive information about yourself such as 
gender, the type of service in which you work, and years qualified as a Clinical 
Psychologist.  
 
 Phase two - interviews 
It is planned that follow up interviews will be conducted with a small number of 
participants who take part in the online survey. The aim is to expand on the data 
collected within the online survey and gather further detail and personal 
experience. If you are happy to be contacted about participating in further 
interviews you can consent to this by ticking the option at the end of the survey 
and providing your email address. If you are contacted for a follow up interview 
a separate information sheet will be provided in order for you to decide whether 
you would like to take part. 
 
Who is organising the research? 
The research is being organised by the University of Lincoln. 
 
Why have I been asked to take part? 
You have been invited to take part in this study due to your qualification as a 
Clinical Psychologist, and because you are currently living and working in the 
UK. I am hoping to recruit as many Clinical Psychologists as possible within the 
National Health Service and private sector.  
 
Is my taking part confidential? 
This study will follow ethical and legal practice and all information about you will 
be handled in confidence. You will not be asked for personally identifiable 
information such as name or date of birth. If you consent to take part the data 
collected for the study will be looked at by the researchers listed below. All will 
have a duty of confidentiality to you as a research participant and we will do our 
best to meet this duty. Each response has its own unique code so that you 
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cannot be identified. All data will be kept strictly confidential and stored on a 
password protected database. 
  
You will only be asked to provide an email address if you wish to express an 
interest in taking part in the second phase of this research project. If you chose 
to leave your email address,this will be kept for the duration of the project and 
deleted upon study completion. All other data will be kept securely for seven 
years.  After this time your data will be disposed of securely.  
Although your responses are confidential, should you disclose anything which is 
felt puts you or anyone else at any risk, it may be necessary to report this to the 
appropriate persons.  
 
Do I have to take part? 
Participation in this research is voluntary. If you do decide to take part you will 
be asked to give your consent by ticking a box on the following page. If you 
decide to take part you are still free to withdraw at any time and without giving a 
reason.  
 
Should you change your mind about participating in the study later, you have 
two weeks in which to withdraw your data. If you decide that you wish to have 
your data withdrawn please contact the School of Psychology ethics committee 
on soprec@lincoln.ac.uk with your participant ID code and the name of the 
study. SOPREC will then arrange with the researcher for your data to be 
removed. No identifiable details will be forwarded to the researchers and your 
anonymity to the researcher will remain intact. 
 
Are there any risks in taking part? 
There are no known risks anticipated with this research study. Participants are 
reminded of the need to uphold confidentiality and as such do not provide any 
identifiable information about clients within their answers. Risks of an online 
security breach will be minimised by storing responses on an encrypted 
computer. 
 
If you decide to take part you are still free to withdraw at any time and without 
giving a reason. 
 
Are there any benefits in taking part?  
We cannot promise the study will help you but the information we get from this 
study may help to establish a starting point for understanding the role Clinical 
Psychologists are currently having with psychotropic medication. This could 
have future implications for considering whether guidance and/or training could 
be amended. 
 
What will happen to the results of the study? 
This study will be written up as part of the Trent Doctorate in Clinical 
Psychology (Universities of Lincoln and Nottingham) requirements. It may also 
be published in relevant journals and/or presented at relevant 
conferences/events. You will not be identifiable in any way should the research 
be published. Information on time and location of publication will be distributed 
should you consent to receive this information. 
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What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak 
to the researchers who will do their best to answer your questions. The 
researchers contact details are given at the end of this information sheet. If you 
remain unhappy and wish to complain formally, you can do this by contacting: 
School of Psychology Research Ethics Committee, SOPREC, College of Social 
Science, University of Lincoln, Brayford Pool, Lincoln, Lincolnshire, LN6 7TS 
E-mail address: soprec@lincoln.ac.uk 
 
If you decide to participate in the research and experience any discomfort or 
wish to stop then you may withdraw at any time and without giving a reason. 
Should you change your mind about participating in the study later, you have 
two weeks in which to withdraw your data. 
 
If you have any concerns about this study or what you have been asked to, then 
please contact the School of Psychology Research Ethics Committee on 
SOPREC@lincoln.ac.uk. 
 
What if I have other questions or queries? 
If you have any other questions or queries about the study then please feel free 
to ask the researcher on: 
Amy Aston 
Trainee Clinical Psychologist 
University of Lincoln, Brayford Pool, Lincoln, Lincolnshire, LN6 7TS 
Email address: 15591138@students.lincoln.ac.uk 
The research supervisors' details can also be found below. 
 
Research supervisors:  
Dr Sharron Smith 
School of Psychology, College of Social Science 
Senior Clinical Tutor 
University of Lincoln, Brayford Pool, Lincoln, Lincolnshire, LN6 7TS 
Email address: shsmith@lincoln.ac.uk 
 
Dr Danielle De Boos 
Academic and Research Tutor, Faculty of Medicine & Health Sciences 
University of Nottingham, YANG Fujia, Jubilee Campus, Wollaton Road, 
Nottingham, NG8 1BB 
Email address: danielle.deboos@nottingham.ac.uk 
 
Dr Anna Tickle 
Academic Tutor, Faculty of Medicine & Health Sciences 
University of Nottingham, YANG Fujia, Jubilee Campus, Wollaton Road, 
Nottingham, NG8 1BB 
Email address: anna.tickle@nottingham.ac.uk 
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Appendix J: Participant Information Sheets 
Interviews. 
 
Interview Information Sheet 
Title of Study: Do Clinical Psychologists have a role in clients’ use of 
psychotropic medication? A mixed methods investigation exploring current 
forms of involvement 
 
Name of Researcher(s): Amy Aston  
I would like to invite you to take part in our research study. Before you decide I 
would like you to understand why the research is being done and what it would 
involve for you. Please ask if you have any questions. 
 
What is the purpose of the study? 
This study aims to explore when and how Clinical Psychologists involve 
themselves with psychotropic medication. The majority of research into the 
relationship between psychology and medication has been conducted in the 
United States of America, however currently little is known about when and how 
Clinical Psychologists involve themselves with psychotropic medication in the 
UK. It is anticipated that Clinical Psychologists may frequently encounter 
opportunities to intervene within clinical practice, however currently little is 
known about how these decisions are made and the rationale for these 
decisions. It is hoped that this can allow Clinical Psychologists to consider (and 
potentially reconsider) their position on where they sit in terms of involvement 
with psychotropic medication. 
This phase of the study hopes to gather more detailed information as to how 
decisions are made when there is potential to intervene in regards to 
psychotropic medication within clinical practice. It is hoped that this can allow 
Clinical Psychologists to consider (and potentially reconsider) their position on 
where they sit in terms of involvement with psychotropic medication. 
 
Why have I been invited? 
You have been invited to take part in this study due to having expressed an 
interest to participate in interviews after completing the online survey. I am 
hoping to recruit approximately 10-15 Clinical Psychologists to take part in the 
interviews. 
 
Do I have to take part? 
Participation in this research study is voluntary.  If you do decide to take part 
you will be given this information sheet to keep and be asked to sign a consent 
form.  If you decide to take part you are still free to withdraw at any time and 
without giving a reason.  
 
What will happen to me if I take part? 
Dependent on your location, the researcher may travel to you in order to 
conduct the interview. This may take place at your work base, dependent upon 
permission granted by the service manager. Alternatively, the interview may 
take place over video conferencing software if this is more convenient. You will 
take part in one semi-structured interview which will last approximately 60 
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minutes. You will be asked questions about your opinions and experiences 
relating to psychotropic medication within your clinical practice and the interview 
will be audio recorded. 
 
What are the possible disadvantages and risks of taking part?  
The interviews are anticipated to last for approximately 60 minutes therefore 
this amount of time is required to be set aside. Participants should be mindful of 
confidentiality when discussing professional experiences during interview and 
should not state client names or any identifiable information. Interviews will also 
be conducted within a secure environment to protect confidentiality. If being 
conducted via video conferencing the location of interviews will be agreed 
beforehand. The audio recording will be stored on an encrypted data stick to 
minimise risk of confidentiality breaches. 
 
What are the possible benefits of taking part? 
We cannot promise the study will help you but the information we get from this 
study may help to establish a starting point for understanding the role Clinical 
Psychologists currently have in issues relating to psychotropic medication. This 
could have future implication for considering whether guidance and/or training 
could be amended and whether Clinical Psychology’s’ relationship with 
psychotropic medication should be reconsidered. 
 
What happens when the research study stops? 
If you wish to receive a summary of findings from the study and are happy to be 
contacted, you are able to leave details with the researcher who will contact you 
upon completion of the study.  
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak 
to the researchers who will do their best to answer your questions.  The 
researchers contact details are given at the end of this information sheet. If you 
remain unhappy and wish to complain formally, you can do this by contacting: 
School of Psychology Research Ethics Committee 
SOPREC 
College of Social Science 
University of Lincoln, Brayford Pool, Lincoln, Lincolnshire, LN6 7TS 
E-mail address: soprec@lincoln.ac.uk 
 
Will my taking part in the study be kept confidential? 
This study will follow ethical and legal practice and all information about you will 
be handled in confidence. If you consent to take part, the data collected for the 
study will be looked at by authorised persons from the Universities of Lincoln 
and Nottingham who are organising the research. They may also be looked at 
by authorised people to check that the study is being carried out correctly. All 
will have a duty of confidentiality to you as a research participant and we will do 
our best to meet this duty.  
 
All information which is collected about you during the course of the research 
will be kept strictly confidential. It will have your name removed (anonymised) 
and a unique code will be used so that you cannot be recognised from it. It will 
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be password protected and stored on an encrypted data stick. Data will be kept 
securely for 7 years.  After this time your data will be disposed of securely.  
Although your responses are confidential, should you disclose anything which is 
felt puts you or anyone else at any risk, it may be necessary to report this to the 
appropriate persons.  
 
What will happen if I don’t want to carry on with the study?  
Your participation is voluntary and you are free to withdraw at any time, without 
giving any reason, and without your legal rights being affected. If you withdraw 
then the information collected so far cannot be erased and this information may 
still be used in the project analysis. 
 
What will happen to the results of the research study? 
This study will be written up as part of the Trent Doctorate in Clinical 
Psychology (Universities of Lincoln and Nottingham) requirements. It may also 
be published in relevant journals and/or presented at relevant 
conferences/events. You will not be identifiable in any way should the research 
be published. Information on time and location of publication will be distributed 
should you consent to receive this information. 
 
Who is organising and funding the research? 
This research is being organised by the University of Lincoln and is being 
funded by the Trent Doctorate in Clinical Psychology. 
 
Who has reviewed the study? 
This research has been reviewed and given favourable opinion by the 
University of Lincoln Ethics Committee.  
 
Further information and contact details 
Chief investigator:  
Amy Aston 
Trainee Clinical Psychologist 
University of Lincoln, Brayford Pool, Lincoln, Lincolnshire, LN6 7TS 
Email address: 15591138@students.lincoln.ac.uk 
 
Research supervisors:  
Dr Sharron Smith 
School of Psychology, College of Social Science 
Senior Clinical Tutor 
University of Lincoln, Brayford Pool, Lincoln, Lincolnshire, LN6 7TS 
Email address: shsmith@lincoln.ac.uk 
 
Dr Danielle De Boos 
Academic and Research Tutor, Faculty of Medicine & Health Sciences 
University of Nottingham, YANG Fujia, Jubilee Campus, Wollaton Road, 
Nottingham, NG8 1BB 
Email address: danielle.deboos@nottingham.ac.uk 
Dr Anna Tickle 
Academic Tutor, Faculty of Medicine & Health Sciences 
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University of Nottingham, YANG Fujia, Jubilee Campus, Wollaton Road, 
Nottingham, NG8 1BB 
Email address: anna.tickle@nottingham.ac.uk 
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Appendix J: Consent Forms 
 Online survey. 
Please tick each box to continue: 
 I confirm that I am aged 18 or over and that I have read and understand the 
information above pertaining to this study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 
 I understand that my participation is voluntary and I understand that I can 
withdraw my data at any point up until two weeks after completing the study. 
 I understand that data will be kept confidential and securely and will be 
anonymised throughout. 
 I understand if I have any questions or concerns, that I can contact the 
researcher supervisor using the contact details given. 
 By proceeding with participation I am confirming that I wish to take part in 
this study and confirm that I agree to all the above statements. 
 I confirm that I am a qualified Clinical Psychologist working in the United 
Kingdom and I am registered with the Health and Care Professions Council 
(HCPC).  By clicking the NEXT button to begin the online questionnaire, I 
indicate my willingness to voluntarily take part in the study. 
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Appendix J: Consent Forms 
 Interviews. 
Title of Study: Do Clinical Psychologists have a role in clients’ use of 
psychotropic medication? A mixed methods investigation exploring current 
forms of involvement 
 
Name of Researcher: Amy Aston  
       
Name of Participant: 
 
1. I confirm that I have read and understand the information sheet 
version number 2 dated 20/06/16 for the above study and have 
had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason. I understand that 
should I withdraw then the information collected so far cannot be 
erased and that this information may still be used in the project 
analysis. 
3. I understand that data collected in the study may be looked at by 
authorised individuals from the Universities of Lincoln and 
Nottingham, the research group and regulatory authorities where it 
is relevant to my taking part in this study. I give permission for 
these individuals to have access to these records and to collect, 
store, analyse and publish information obtained from my 
participation in this study. I understand that my personal details 
will be kept confidential. 
4.  I agree that the information I have given and the information 
gathered about me can be stored by Amy Aston at the University 
of Lincoln, for possible use in future studies. Any samples or data 
used will be anonymised, and I will not be identified in anyway. 
5. I agree to take part in the above study. 
 
______________________ ______________     ____________________ 
Name of Participant   Date          Signature 
 
________________________ ______________     ____________________ 
Name of Person taking consent Date          Signature 
 
 
 
 
 
 
 
Please initial box 
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Appendix K: Debrief 
Debrief 
 
Thank you for taking part in this study. 
 
This study was investigating when and how Clinical Psychologists involve 
themselves with psychotropic medication. It is anticipated that this study will 
provide new information into how Clinical Psychologists position themselves 
with regards to psychotropic medication use, and how decisions are made when 
there is potential to intervene within clinical practice. Given that there is 
currently no professional guidance for how Clinical Psychologists may involve 
themselves, it is anticipated that current involvement is based on personal 
opinion and judgement. By examining individual accounts of these experiences 
it is hoped that this can allow Clinical Psychologists to consider (and potentially 
reconsider) their position on where they sit in terms of involvement with 
psychotropic medication.      
 
If you have any further questions about the study, please feel free to contact the 
researcher or their supervisor on:   
Amy Aston (Researcher): 15591138@students.lincoln.ac.uk   
Dr Sharron Smith (Primary supervisor): shsmith@lincoln.ac.uk     
  
If you have any concerns about the ethics of this study or you wish to complain 
about the study or how you have been treated, then please contact the School 
of Psychology ethics committee on soprec@lincoln.ac.uk with details of your 
complaint and it will be investigated.      
 
Should you change your mind about participating in the study later, you have 
two weeks in which to withdraw your data. If you decide that you wish to have 
your data withdrawn please contact the School of Psychology ethics committee 
on soprec@lincoln.ac.uk with your participant ID code and the name of the 
study.  
 
SOPREC will then arrange with the researcher for your data to be removed. No 
identifiable details will be forwarded to the researchers and your anonymity to 
the researcher will remain intact.      
 
Thank you again for taking the time to participate in our study. 
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Appendix L: Deductive Framework 
 
Highest 
frequencies 
from 
survey 
Involvement during last 6 months 
 reflecting with a service user on their general experience of taking 
psychotropic medication 
discussing psychotropic medication issues within individual service user 
sessions 
supporting service users to discuss their psychotropic medication with 
their prescriber 
Would do if given the opportunity 
reflecting with a service user on their general experience of taking 
psychotropic medication  
supporting service users to discuss their psychotropic medication with 
their prescriber 
engaging in a collaborative discussion with a service user to support 
them in making a decision about their psychotropic medication 
3 most important options 
Engage in a collaborative discussion with a service user to support them 
in making a decision about their psychotropic medication 
support service users to discuss their psychotropic medication with their 
prescriber 
be involved in the decision making process to prescribe a service user 
psychotropic medication 
reflect with a service user on their general experience of taking 
psychotropic medication  
Involvement that is deemed inappropriate 
requesting or recommending that specific psychotropic medication be 
prescribed for a service user 
no options were inappropriate 
requesting or recommending that a service user be taken off a specific 
psychotropic medication 
Other 
factors 
from 
survey 
Participants working in CAMHS, ID, and Other were statistically more 
likely to have been involved in the decision making process to prescribe 
a service user psychotropic medication, compared with participants 
working in other services. 
 Participants working in ID services were also statistically more likely to 
have requested or recommended that a service user be taken off 
psychotropic medication. 
Participants working in ‘Other’ services were statistically more likely to 
have used psychological and/or neuropsychological tests to monitor and 
measure psychotropic medication effects. 
Themes 
from qual 
survey data 
Role of medication in care 
 Medication "has a place" 
Medication has an important role in treatment.  
Medication is given priority over psychological approaches 
Medication might both help or hinder engagement with therapy 
Concerns about the use of psychotropic medication 
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Used as a first line treatment 
Long term use 
Inappropriate use 
Concern about side effects  
Risks of medication are underplayed 
Service user choice and consent 
Lack of informed choice 
Medication and coercion  
Inaccurate depiction of medication 
Collaboration in decision making about medication important 
Client facing a power imbalance 
Client’s opinion isn’t heard 
Effectiveness of psychotropic medication as an intervention 
False sense of hope 
Not addressing underlying needs 
Client and their difficulties not being understood 
Difficulties unresolved 
Not person centred 
Role of the Clinical Psychologist 
Medication is part of the clinical psychologist role 
Knowledge about medication is required for role 
Limited knowledge acting as a barrier to involvement 
Inappropriate to the role  1. prescribing 
2. preventing use 
3. recommendations 
4. giving detailed information 
5. discussions about medication 
Part of the role 1. discussing with client and team 
2. giving general information 
3. help inform decision making 
4. supporting client 
5. supporting medication reduction 
6. offering psychological 
perspective 
7. critical questioning role 
8. offering a reflective space 
9. monitoring effects of medication 
Wishes for the role  1. prescribing  
2. increasing psychology and 
psychiatry collaboration 
Need to work within professional boundaries 
Signposting when area of out remit 
Stance towards medication 
Need to adopt open-minded and neutral stance towards medication 
Adopting balanced perspective – disagree with use except in certain 
circumstances 
Strong views - against medication 
Medication use – at odds with how psychologists understand distress 
Views changing  
Critical view of evidence base 
Wider service issues 
Psychology minimized 
Working alongside colleagues 
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Challenges with colleagues (in relation to medication) 
Dominant mental health paradigm  
Medication perpetuates dominant biological understanding of mental 
health difficulties 
Widely held belief that pills fix problems 
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Appendix M: Qualitative Survey Data: Example of Coding 
 
Decisions about should be: 1. Evidence based. 2. Person centred. 3. Last resort.  Decisions in my 
experience are often: 1. Non-evidenced based or service users mislead on effectiveness. 2. 
Service users are given medication under compulsion which happens in no other area of medicine 
and in my mind hard to justify given the effectiveness data.  3. Service users are offered medication 
as a first line without any attempt to understand their distress as being an ordinary part of being 
human. 
Criteria for decisions.  
 
Decisions not evidence-based. SUs 
mislead in effectiveness. SUs given 
medication under compulsion.  
 
Practice is hard to justify.  
Meds = first line attempt.  
No attempts to understand SU 
distress. 
Within the service I work, which is for males with very high risk offending behaviours and severe 
and enduring MI, medication is a first line intervention. However I do have lots of input into the 
decision making process via the MDT which involves a consultant psychiatrist and senior clinical 
Meds = first line intervention. 
 
Lots of input into MDT decision 
making.  
 
Medication expertise in team.  
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pharmacist, Because of the expertise around medication in my team, discussion psychotropic meds 
is not appropriate in my role, however we do discuss the psychological impact such as dealing with 
side effects and offer a psychological perspective to noncompliance with meds for example. 
 
 
Discussion of meds inappropriate to 
role.  
Discuss psychological impact of 
meds.  
Offer psychological perspective to 
noncompliance.  
I think they are to heavily and readily relied upon and not always appropriate. They certainly have 
their place however I think reliance on medication for difficulties such as emotionally unstable 
personality disorders is false economy. The investment needs to be in the evidence base such as 
DBT resources. There is no substantial evidence base for meds in EUPD and yet our dbt resource 
remains underfunded. Medications are too readily prescribed with no appreciation from the 
prescriber of the side effects- namely weight gain and the body image difficulties/ depression this 
can trigger. Readily prescribing medications perpetuates the notion of mental health as an 'illness' 
within the person and does not address the contextual factors. It also leads clients to believe their 
only hope of feeling 'better' comes from taking medication and that psychological approaches 'will 
Too heavily and readily relied on. Not 
always appropriate. Meds have their 
place. 
Reliance for EUPD is false economy. 
Investment should be in therapeutic 
resources (rather than meds?).  
Meds used despite lack of evidence 
base. Too readily prescribed.  
Prescriber doesn’t consider side 
effects.  
 
Perpetuates mental health as an 
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not work' because it doesn't remove the affect like medication does. It's a false recovery in my 
opinion- the source of the issue often remain unresolved and so begins a lifetime of medication to 
numb the affect. An expensive and not always appropriate system. 
‘illness’. Doesn’t address contextual 
factors. 
 
Message of medication as only hope. 
Message that psychological 
approaches won’t work like meds 
can.  
 
False recovery.  
Source of issue unresolved. Not 
always appropriate. expensive 
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Appendix N:  Spreadsheet Tracking Interview Progress 
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Appendix O: Table of Interview Participants 
 
Participant 
number 
Service Involvement 
1 Adult Low 
2 ID High 
3 Physical Low 
4 CAMHS High 
5 CAMHS High 
6 ID Low 
7 Adult High 
8 Other – Eating disorder Low 
9 Other – Forensic Low 
10 ID High 
11 Older adult Low 
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Appendix P: Summaries of Interview Participants 
1 – works in acute and is generally pro-medication. Views have changed since 
working in acute and being shocked by how distressed, chaotic, and psychotic 
people can be. They have seen medication used in the first instance to reduce 
chaos and distress, and this has opened their eyes to the usefulness of it. If 
someone wasn’t on any medication they are likely to prompt why this is, 
although the team are hot on this so it is unlikely this happens. Similarly, the 
team are good at not using medication when it isn’t needed, so they are often 
relieved of having to question medication choices. Being in a very medical 
environment, it can feel uncomfortable and difficult to speak about medication or 
challenge its use. In these instances, it is felt that justification is needed e.g. 
referring to the evidence base, or the client in question is seen as having more 
of a psychological issue (e.g. PD) and so the psychologist has more authority to 
be talking about it. There also seems to be ideas about who the psychologist is 
‘allowed’ to work with – this seems to be clients who are seen as having more 
psychological issues, rather than those viewed to be treated with medication. 
Also, a lot of thought and planning would go into things before actually saying 
something about medication or challenging, in order to look competent around 
professionals who are very medically minded. There is a sense of when working 
with people who are in such high states of distress you need to ‘throw at it what 
you can’ and see what works. There was also a tendency to view antipsychotics 
as more helpful than other medications such as antidepressants. 
 
2 – works in LD service. Thinks there are particular difficulties for LD services 
because of the influence from external people. Providers or carers might come 
in and request something specific for a client, assuming they may not be able to 
advocate their own needs and have capacity, when in fact they do and might 
not want to take medication. Aware of critical narratives towards meds from 
psychology colleagues during training and is careful not to adopt this. Stance 
towards meds has softened over time and think there is a value in them. Meds 
can also offer choice and form part of a wider treatment package. Works in a 
service where they feel very fortunate to have psychologically minded 
psychiatrists who actively seek out advice from psychology before prescribing. 
There seems to be a tendency for psychiatry to feel like they need to prescribe 
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because they don’t know what else to do, and psychology seem to have the 
power of saying ‘no hold on a minute’. Psychiatry seem grateful for 
psychology’s input. Awareness of medication seems to be important in order to 
map behaviour outcomes [what is effective? Therapy or medication?]. Feel a 
duty of care to be honest about meds and that they aren’t likely to be the only 
answer. Information about med changes seems particularly important in an LD 
service due to the need to map any behavioural changes and because the client 
may not be able to articulate this for themselves. Even more need to have care 
teams on board and let them know that you need to be informed of any 
changes. Feel that it is a particular experience working in LD that there is 
increased involvement with medication due to the crossover with behavioural 
work and the need to advocate on behalf of the client.  
 
3 – works in a specialist cancer service in a team solely of psychologists. 
Thinking about a continuum, would place themselves on the ‘pro-medication’ 
side of this. This is based on both personal and professional experience – they 
have previously taken psychotropic medication and they are about to marry a 
psychiatrist. Don’t tend to prompt discussions about meds with clients because 
there is an added complexity of alternative drugs people are taking for cancer 
and don’t feel they know enough about this. As the service is a medical service 
there is also some thoughts around the clients usually going to see a doctor 
with a medical problem and being fixed, and they perceive the therapist 
relationship to be different and don’t want to promote an expert stance in a 
similar way. Experienced clinical training to be very critical of psychiatry and 
medication and disagreed with this. It also felt like training tried to encourage 
psychologists to take an advocacy role in promoting formulation and moving 
away from diagnosis and medication use. However, in real practice this did not 
seem feasible. Having a psychiatrist for a fiancé and previously having taken 
antidepressants in the past have led to previous views being challenged. This is 
due to having increased insight into how psychiatry training is delivered and 
experiencing positive effects of taking psychotropic medication. Feel that overall 
taking a critical stance is unhelpful and psychologists should offer a balanced 
view to support clients in making an informed decision about their medication. 
Would see opportunities to promote this way of thinking as part of role. 
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4 -  works in LD services. Considers self quite anti-medication personally and 
this shapes professional views. Doesn’t really see views as changing over time, 
in fact, they have been strengthened by having colleagues and a supervisor 
who hold equally strong views and this has encouraged permission that it is OK 
to hold these views. Has experience of medication being used previously in 
adult mental health to support engagement with therapy, and even then was 
uncomfortable with the referral due to a worry about reliance on medication. 
Talks about ‘layers’ of involvement and will sometimes take a direct approach or 
a more gentle one depending on relationship with the prescriber and the 
context. A direct approach might be taken in a ward round to challenge a 
prescribing decision and outright say that they disagree with the decision. In 
order to feel confident in doing this they would have knowledge prepared 
beforehand in order to quote papers etc. in relation to the evidence base. This 
approach has worked well in the past, whereas at times taking a gentle 
approach means you can be overlooked. However, this approach can 
sometimes be appropriate outside of meetings in terms of being more 
suggestive ‘let’s try this first?’. Other layers of approaches include offering a 
wide complex formulation and thinking about challenging labels, and how 
services can develop to offer interventions beyond medication. There is a sense 
of not wanting to be responsible for medication decisions due to limited 
knowledge, but a role in contributing to help another make that decision. If a 
formulation has been presented, and the professional remit has been filled, then 
they feel OK that they have done all they can even if they disagree with the 
decision made. In order to try and influence the nursing staff they would hold a 
presence on the ward and drip-in formulations to promote that psychology has a 
role with challenging behaviour, as previously the staff did not see the function 
of psychology in this area. They say early on in the interview that they have 
found a direct approach is quite successful in getting people to listen, but later 
on say that they worry that this might come across wrong and get peoples back 
up so they are more recently trying to adopt more of a curious stance. 
 
5 – works in CAMHS. Thinks there are particular issues when working in 
CAMHS such as containing parental anxiety when parents want medication for 
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their child if they are in a state of crisis. Within the team there are differences in 
the psychiatrists as in some may be more open to listening to psychological 
input than others, this might be down to when they trained. If the person seems 
to be struggling to engage in therapy then they might suggest talking to the 
psychiatrist, but would suggest this as an option and not influence any decision. 
A disclaimer would be given about knowledge. And actually, any improvement 
at engaging in therapy isn’t seen that often. They may also possibly suggest 
medication as an option if the person has already had rounds of therapy and it 
doesn’t seem to have helped – might be a case of seeing what else can be 
used/desperation at trying something else. They seem to have figured out 
people and situations whereby they can raise a query without negative 
experiences and this would be raised in a tentative way. there seems to be a 
sense of anticipating that it would not go well if raised with certain people due to 
not having appropriate authority and knowledge to do so. They admit that they 
don’t take a confrontational approach, but rather use a tentative questioning 
approach. This is because they don’t want to create rifts in the team. I’m getting 
a sense of them being scared to confront medical decisions, and will tentatively 
do it sometimes, and then the medics will say we’re going to just trial it. Then 
they say oh yes it’s good to trial things sometimes, but there is no mention of 
what happens when this trial stops. I think they seem to be happy that they 
questioned it and feel that being told it’s a trial means it’s OK and they won’t 
have to question it again because they’ve been reassured it’s only a trial. They 
feel fairly confident in their knowledge about medication and probably could 
have more conversations about it than they do, but worry about being blamed or 
giving bad advice and as such don’t go out of their boundaries. Don’t feel like 
they want to prescribe and reflect that actually when they do prompt a 
medication referral it’s often out of desperation and they don’t really believe it 
will help. They liked medication use to diagnosis, and neither fit with how they 
come to understand clients’ difficulties. 
 
6 – identifies as being a social constructionist and medication propels the idea 
of a disease model of mental distress. Found that in the early stages of career it 
was about finding a place in the team and not being to vocal about things. Now 
that they’re leaving their role it feels a bit easier to talk up more and think about 
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the legacy they want to leave. Feels it’s too difficult to influence change in the 
clinic room and does own reading/gathers professional allies in order to 
influence change from the ground up. This includes adopting a position that is 
not anti-meds but is social constructionist, as when you think about problems in 
this way it automatically gets rid of the need for medication use. This is done by 
information sharing and sending around critical articles to other people. There 
are times when they try to challenge decisions in the clinic room, which is done 
using a bit of a playful questioning approach, but they describe having to pick 
their battles as this can’t be generalised. Also they know that if they weren’t in 
the room then nothing would change, and so it is a more effective approach to 
stop people getting through the clinic door in the first place. As part of the 
tentative drip-feed approach one method is by providing alternatives to 
diagnosis as a means to preventing medication use. There are certain factors 
that influence whether they may decide to challenge a decision or not. This 
includes the mood of the psychiatrist and what they can get away with, how 
confident they feel that the case can be managed without it, and whether there 
is risk. They admit that if there is risk then this becomes difficult to challenge, 
due to agreeing that medication may help manage behaviour in the short term. 
If the idea of ADHD is challenged, then there is no more need to take 
medication anymore. They read a lot and follow people who publically voice 
critical views, and then pass these on to work colleagues themselves. They said 
its helpful when credible professionals stick their head above the parapet. 
Generally sees role as being an influencer and changing narratives and 
discourses. This is in line with their values and part of the legacy they want to 
leave when they finish their role. It is not enough just to be critical – need to 
raise awareness and also create action of providing alternatives.  
 
7 – starts off by saying they have mixed views. They trained at a course that is 
known for having quite an anti-psychiatry stance. They have experienced 
services that welcome alternative opinions and this has increased their 
confidence in adopting a curious and questioning role. The most obvious reason 
they would chose to be involved with medication is when the formulation points 
to a problematic relationship with medication for a client, so a reliance on it or 
the use masking something. In this instance they might prompt a reduction or 
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question the necessity of med use themselves. They may also explore client 
beliefs about medication if it appears that the client is misinformed about 
medication and diagnosis. Usually they might question why a client has been on 
medication for so long, prompting people to think about the current clinical need 
as they might have been on it for years without anyone questioning this. This is 
usually where their role ends – they raise the idea but then may leave this with 
the client. On occasion though they report arranging a joint appointment with 
the client and the psychiatrist so that they can ask the psychiatrist questions in 
front of the client – this is to act as an advocate because the client may not be 
able to ask themselves (power dynamics) or may not think to. Also it’s to make 
sure that the client is getting the same answer that the psychiatrist would give 
the staff. Having said all this, they feel that ultimately they make little change, 
and usually take more of a tentative approach over all. Similar to another 
participant, they have experience of the psychologist being the gateway person 
to challenge. They have found that colleagues may hold similar opinions but 
might not know the research or have the words to back it up. Once they have 
seen that this kind of thing can be challenged then they are more likely to do so 
without psychology’s presence there. They see that they were trained to take on 
a role of challenging the status quo, however, feel that newer psychologists are 
seeing themselves more as only therapists and so don’t feel empowered to do 
this. This means that the ‘psychologist’ position could be lost if we don’t 
continue to fulfil these roles. 
 
8 – generic mixed views – over used but think it can be helpful in certain 
situations such as helping people to engage with therapy. Works in eating 
disorder service and feels there can be more need for medication in specialised 
services such as this one. They are present in meetings when medication is 
discussed but don’t comment on it due to a lack of knowledge. They say that 
they will offer ‘alternatives’ to medication, but it actually seems like they offer 
additional ideas on top of the medication rather than suggesting something else 
in its place. Working in eating disorder services, often when the client isn’t in a 
place to engage in therapy they want to look at nutrition etc. first to help them 
feel better in terms of energy. It seems like they generally take a step back from 
medication related issues, and would only comment specifically if they are 
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confident and definite in their opinion – e.g. client is doing really well and 
doesn’t need to be on medication. They feel that the team are quite good at 
reducing medication anyway, due to the added physical risks of people with low 
body weight being on medication. They suggest that they might raise it if they 
felt someone was on too much medication, but that usually they don’t have to 
because the team are so good at it. I get the sense that this feels like a bit of a 
relief and they are glad that they don’t have to raise issues very often. They use 
an example of talking to the GP about a client’s medication when they express 
suicidal ideation and suggest taking an overdose. They say at the end when 
asked if they have anything else to add that they would generally consider 
themselves to err on the side of caution with medication rather than 
encouraging people to go to the GP, however, throughout the interview they 
suggested that they preferred to take a backseat and not really have much of a 
role.  
 
9 – starts off by saying they think it’s overused, people get stuck on them, it’s 
medicalised and a paternalistic way of managing distress – mainly negative. 
Then go on to say on the other hand sometimes it’s appropriate, like they don’t 
want to be seem to be fully against. Works in a service for men who have just 
come out of prison, there are no psychiatrists directly involved. This has lead 
them to think about a more holistic approach as there is space to do so given 
the lack of medicalised environment. There is a psychiatrist who visits monthly 
to offer advice, but they take a passive role and don’t dominate their working 
model. When newly qualified they worked in secure settings and found it sad 
that many patients were on medication, but were overweight and still 
experiencing psychosis. They did not feel that they had the confidence at the 
time to challenge and question the use of medication like they would now. They 
are big in offering client choice so to help people realise that they have a choice 
about being on medication as often clients can be taking medication for years 
and be stuck in a way of being. They also consider themselves to have a role in 
containing staff anxieties about clients coming off medication, as there seems to 
be an idea of panic that a client will become really risky if this happens. In terms 
of expressing personal opinions they said they will offer these, but then actually 
said they will give a pretty much balanced view ‘has a place, can be helpful for 
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some but also harmful’ so not sure if they do actually really give their personal 
views. They gave an example of working with a client who idealised medication 
as a way to cope and would constantly request changes, which would ‘work’ for 
a bit but then they’d want it changed again. They formulated this and showed it 
to the CMHT, who agreed and put a plan in place not to keep changing 
medication, but eventually the client started using other substances so its 
effectiveness was limited. They seem to have adopted a bit of a role of filling in 
the gaps that other professionals miss – so if the GP hasn’t supplied information 
about medication then they will look into this because they feel they have a duty 
of care to the client and also they like to be helpful. This might be because there 
is no psychiatrist working in the service and as such the clients miss out on 
advice in the same way they might do if there was a psychiatrist.  
 
10 – generally seems to be quite anti-medication. Clinical training was quite 
anti-diagnosis, and they acknowledge difficulties with being anti-diagnosis but 
being pro-medication and how those stances fit together. Despite having quite a 
critical stance during training they found that this didn’t quite gear them up to 
working in medically dominated services. They were trained to be quite curious 
but found this doesn’t actually work and you need to be more assertive. They 
think that they were already starting to take quite a critical stance on things prior 
to training and therefore training didn’t really influence them to do this post-
training. Part of their personality is being quite assertive which they think helps 
others to take them seriously. They find that if you come across as quite 
assertive this helps people take you seriously – psychologists are often 
encouraged to be quite tentative and curious, but they feel this leads to you 
being dismissed. They think about what influences them picking their battles. 
They would be more likely to challenge something if there is a suggestion of 
medication and it doesn’t really fit with what they know about the person. They 
would be less like to challenge if they don’t have an alternative to give, or it 
feels like everything else has already been tried. They said previously that you 
need to use quite an assertive direct approach in order to influence any change, 
but later on said it can be difficult to influence the psychiatrist because of the 
fear of dismissing their training and career. This might also be bad for building 
colleague relationships. To manage this they use a ‘drip’ approach – however, 
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this contrasts what they said earlier about tentative approaches not really 
working. They also talk about how it can be difficult to strike a balance of 
ensuring that clients are informed about medication but not forcing views. They 
use an example of a client taking clozapine which helps reduce voices, and the 
client felt that this had solved their problems. The psychologist, however, felt 
that it was only masking problems and wondered how sustainable it was – 
especially given using the drug for long term and the sacrifices this takes. 
Having said that, if the client wanted to mask the issues and not address the 
trauma this is their choice and it isn’t the psychologists place to say. They 
suggest that they will still express their opinion and do it in a way that offers a 
formulation, this contrasts the medics approach of saying ‘you have a disease 
and need this medication’.  
 
11 – views were shaped by mum taking antidepressants and not having support 
to reduce these, and also seeing/hearing others saying they don’t want 
medication but not having much choice. They now work in older adults in a care 
home which has a stepped care model. It is psychologically led, and the 
psychiatrist visits once a week. This means that clients don’t see a psychiatrist 
as routine and it’s down to the team to decide when to refer for a medication 
assessment. They work as part of an MDT and other clinicians might bring up 
the idea of medication but its ultimately down to the psychologist as care co-
ordinator to have the final say on whether to put in the referral or not for 
medication. They need to have a fair bit of knowledge because they don’t to be 
referring everything inappropriately. They say that they act as a bit of a 
middleman between clients families and the psychiatrist so it’s helpful to have 
some knowledge because they can tell a client that what they’re experiencing 
sounds like a side effect, or save the family having a conversation with the 
psychiatrist themselves. If they think a client is on too many medications or on 
appropriate medications they might refer for a med assessment. They said that 
their role is different to when they worked in adult inpatient settings – there they 
would take more of a questioning stance as to why clients were on medications, 
but do so less in older adult. They suggest that there might not be a role to 
reduce as much medication as possible because then it’s creating extra work 
when there might not be any problems. For example, if a client is on a low dose 
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you could say what’s the point in them taking it? But then working to reduce it 
when there’s no problems is creating extra work when staff are already 
stretched.  
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Appendix Q: Coding: Initial Thoughts and Ideas 
 
“One of the inappropriate options were requesting or recommending that a 
service user be taken off a medication, but it comes up quite often in interviews 
to challenge and argue for no medication. Maybe it feels more acceptable to 
challenge medication use before it’s prescribed rather than challenge it once 
someone is already taking it.” 
 
“My main reflections from the deductive framework is that there are some forms 
of involvement that were considered inappropriate but actually people in the 
interviews told me that they do this. A lot of the other themes came up and were 
supported. Also, in interviews not that many people actually did some of the 
forms of involvement that were most selected in the survey. There are extra 
options that came up in the interviews that weren’t options in the survey, e.g. 
liaising with psychiatry without the client? “ 
 
“There seems to be a bit of a process going on. Participants are considering 
whether they want to become involved and then something seems to tip this 
into action and pushes them to do it. There also seems to be a bit of hesitancy 
for some people. I think this is part of people navigating their boundaries which 
seem quite hard to define.” 
 
“A common concept seems to be struggling to put ideas into practice that are 
encouraged during training. People seem to think they have to go out and start 
challenging medicalisation, but then find this difficult in practice. Some people 
seem to have strong opinions and find this easier to do than others.” 
 
“There seem to be many layers to involvement. I tried to do a bit of a circular 
diagram to capture these layers but it feels so complex to incorporate 
everything in. There is a level of being very directly involved, then more 
indirectly and working with staff, then moving to the outside whereby there is 
involvement but it is more in the form of querying or doing things on the 
peripheral. These layers feel integral to the analysis but at this stage I’m a little 
unsure on how to bring them all together.”
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Appendix R: Interview Data: Example of Coding 
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Appendix S: Research Supervision Log Example 
 
 
Trent Doctorate in Clinical 
Psychology 
 
RECORD OF FORMAL SUPERVISORY MEETING 
Name: Amy 
Aston 
 Intake: 
1516 
 
Title of project: Do Clinical Psychologists Have a Role in 
Clients’ Use of Psychotropic Medication? A Mixed Methods 
Investigation Exploring Current Forms of Involvement 
 
Primary supervisor: Sharron Smith  
Second supervisor: Danielle De Boos  
Field supervisor:  
Supervision 
No.   
Date Approx. Time 
spent 
Supervisor(s) present 
10 26/04/1
8 
1 hour Danielle De Boos and Anna Tickle 
Trainee’s comments 
SUMMARY OF PROGRESS since last recorded meeting (edit/expand sub-
sections as necessary): 
Review of agreed actions from last meeting: 
Themes were drafted and had been returned by Danielle via email for feedback. A 
process diagram had been created outlining themes and subthemes. 
 
Achievements: 
Building a conceptual understanding of the data. 
 
Difficulties/challenges:  
Ensuring representation of participants 
 
Adherence to time-line: 
Hopefully on schedule for submission end of May. 
 
General progress: 
A meeting was held for external input into the analysis with Anna due to Sharron 
currently being off work. The thematic map was discussed and amended based 
on discussion. Some of the themes and subthemes were refined. Discussion was 
also held about how to report the data – all of the themes and subthemes will go 
into the main paper, with extra quotes in the extended to support the journal paper 
and ensure all participants are represented. It was also felt beneficial to include 
two different examples of an individual participant going through the process in 
the extended paper. 
 
Supervisor’s Report (Brief details of any problems and how they have been 
resolved. Detailed information is required only if student progress is 
unsatisfactory): 
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PLAN OF ACTION until next recorded supervisory meeting (to be briefly 
itemised by trainee, discussed with and approved by, supervisor) 
 
PLAN:  
 To refine thematic map  
 Re-write results based on the discussion of the meeting 
 
Student’s concerns/problems/comments: 
Signed: (Superviso
r) 
Date: 
Signed: (Student) Date: 
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Appendix T: Prominent Concepts across Transcripts 
 
 
 
 
 
 
 
 
 Page 263 of 272 
Appendix U: Mind-map Examples 
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Appendix V: Deductive Coding Example 
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Appendix W Mind-map of Salient Themes 
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Appendix X: Initial Thematic Process Diagram 
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Appendix Y: Test for collinearity  
Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity Statistics 
B Std. Error Beta Tolerance VIF 
1 (Constant) .016 .033  .477 .634   
Which type of service do you work in? (Please select more than one if 
applicable) - Selected Choice Adult Mental Health 
-.005 .031 -.017 -.152 .879 .585 1.709 
Which type of service do you work in? (Please select more than one if 
applicable) - Selected Choice Child and Adolescent 
.017 .037 .048 .460 .646 .652 1.535 
Which type of service do you work in? (Please select more than one if 
applicable) - Selected Choice Intellectual Disability 
-.019 .043 -.044 -.448 .655 .743 1.346 
Which type of service do you work in? (Please select more than one if 
applicable) - Selected Choice Older Adult 
-.020 .045 -.043 -.446 .656 .751 1.332 
Which type of service do you work in? (Please select more than one if 
applicable) - Selected Choice Physical Health 
.026 .036 .067 .731 .466 .838 1.193 
Which type of service do you work in? (Please select more than one if 
applicable) - Selected Choice Other 
.016 .035 .048 .472 .637 .684 1.461 
a. Dependent Variable: What kinds of involvement have you had with psychotropic medication in the last six months? (Please tick all that apply) - Selected Choice None 
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Appendix Z: Tests for Power   
Option of involvement Frequency 
option 
selected 
Frequency 
option not 
selected 
None 144 3 
Referral to a psychiatrist/other prescriber 
for psychotropic medication 
74 73 
Consulted with a psychiatrist/other 
prescriber about changing a service user's 
psychotropic medication 
56 91 
Involved in the decision making process to 
prescribe a service user psychotropic 
medication 
82 65 
Discussed psychotropic medication issues 
within individual service user sessions 
30 117 
Discussed psychotropic medication issues 
in group therapy sessions 
132 15 
Supplied information about psychotropic 
medication to a service user 
98 49 
Requested or recommended that specific 
psychotropic medication be prescribed for 
a service user 
117 30 
Requested or recommended that a service 
user be taken off a specific psychotropic 
medication 
118 29 
Engaged in a collaborative discussion with 
a service user to support them in making a 
decision about their psychotropic 
medication 
46 101 
A psychological or neuropsychological 
assessment prompted recommendations 
for psychotropic medication 
119 28 
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Option of involvement Frequency 
option 
selected 
Frequency 
option not 
selected 
Using psychological and/or 
neuropsychological tests to monitor and 
measure psychotropic medication effects 
134 13 
Reflecting with a service user on how their 
psychotropic medication may affect their 
engagement with psychology 
74 73 
Reflecting with a service user on their 
general experience of taking psychotropic 
medication 
27 120 
Taking the time to research information 
about a service users' psychotropic 
medication (e.g. internet search, asking 
colleagues) 
65 82 
Supporting service users to discuss their 
psychotropic medication with their 
prescriber 
41 106 
Sufficient power = minimum 60 
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Appendix AA: Significant Results 
 
Involved in the decision making process to prescribe a service user 
psychotropic medication (last 6 months) 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
Step 1a AdultMentalHealth .209 .475 .194 1 .659 1.233 
CAMHS 1.351 .572 5.587 1 .018 3.863 
ID 2.066 .729 8.022 1 .005 7.891 
OlderAdult -.410 .751 .298 1 .585 .664 
PhysicalHealth .467 .535 .761 1 .383 1.595 
Other 1.196 .529 5.110 1 .024 3.308 
Constant -1.130 .518 4.766 1 .029 .323 
a. Variable(s) entered on step 1: AdultMentalHealth, CAMHS, ID, OlderAdult, PhysicalHealth, Other. 
 
Requested or recommended that a service user be taken off psychotropic 
medication (last 6 months) 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
Step 1a AdultMentalHealth .675 .605 1.244 1 .265 1.964 
CAMHS -.967 .886 1.190 1 .275 .380 
ID 2.890 .754 14.702 1 .000 17.997 
OlderAdult .170 .890 .036 1 .849 1.185 
PhysicalHealth .277 .740 .140 1 .708 1.319 
Other .508 .628 .655 1 .418 1.662 
Constant -2.278 .651 12.236 1 .000 .102 
a. Variable(s) entered on step 1: AdultMentalHealth, CAMHS, ID, OlderAdult, PhysicalHealth, Other. 
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Using psychological and/or neuropsychological tests to monitor and 
measure psychotropic medication effects (last 6 months) 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
Step 1a AdultMentalHealth .890 .664 1.799 1 .180 2.435 
CAMHS 1.391 1.080 1.660 1 .198 4.021 
ID .373 1.223 .093 1 .760 1.452 
OlderAdult 1.109 1.319 .708 1 .400 3.032 
PhysicalHealth 1.379 .836 2.723 1 .099 3.970 
Other 3.005 .884 11.565 1 .001 20.179 
Constant -4.550 .931 23.873 1 .000 .011 
a. Variable(s) entered on step 1: AdultMentalHealth, CAMHS, ID, OlderAdult, PhysicalHealth, Other 
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BACKGROUND
Psychotropic medication  refers to drugs capable of affecting the mind, 
emotions, and behaviour which are commonly prescribed for the treatment of 
‘mental illness’1. Involvement with psychotropic medication is not traditionally 
viewed as an aspect of the clinical psychologists job, and there are currently 
no professional guidelines advising on a role. 
International research suggests that psychologists are likely to encounter a 
variety of opportunities to become involved, and are frequently (indirectly) 
involved in the process of prescribing and managing of clients’ psychotropic 
medications2. There is a lack of research into psychologists’ involvement with 
psychotropic medication in the United Kingdom (UK), but given the 
widespread use of psychotropic medication similar opportunities and practice 
may occur3. 
The collective clinical psychology profession is also taking an increased 
stance against biological approaches towards mental health such as issuing 
guidance on use of diagnosis and promoting movement away from its use4. 
The question remains as to whether the professional movement with 
diagnosis extends into any role with psychotropic medication, be this a critical 
stance or any other.
METHOD
A mixed method sequential explanatory design was used to meet the study 
objectives.
Online survey
An online survey was used asking participants to select options of 
involvement they had engaged with in the last six months, and their general 
views on psychotropic medication. 
Interviews
Intensity sampling was used to select participants who engaged in high and 
low levels of involvement and worked in a variety of services. Eleven 
participants took part in semi-structured interviews.
Analysis
Survey data were analysed using descriptive statistics and logistic regression 
analyses. Qualitative data from the survey was coded and organised into 
themes. Both data sets were combined to form a deductive framework. 
Interview data were analysed using a dual inductive-deductive thematic 
analysis.
RESULTS
Online Survey Findings
• 98% of participants reported they had recent involvement with clients’ of 
psychotropic medication.
• The most frequents forms of involvement were:
1. Reflecting with a client on their general experience of taking 
psychotropic medication
2. Discussing psychotropic medication issues within individual 
client sessions
3. Supporting clients to discuss their psychotropic medication with 
their prescriber
• Participants working in child and adolescent mental health services 
(CAMHS) and intellectual disability (ID) services were more likely to 
have been involved in the decision-making process to prescribe a 
service user psychotropic medication.
• Participants working in ID services were also statistically more likely to 
have requested or recommended that a service user be taken off 
psychotropic medication 
Interview Findings
The thematic map (below) demonstrates a prominent narrative within the 
data of the process by which a clinical psychologists weigh up factors prior 
to deciding to have involvement, and then flexibly navigates their approach 
and actions. 
Synthesis
• The survey data was largely supported within the interview data.
• Many forms of involvement within the survey were discussed during 
interview, but qualitative exploration enabled increased forms of 
involvement to arise e.g. directly challenging prescribing, using 
formulation to challenge diagnosis and prescribing.
• Participants working in CAMHS and ID services reflected a need to 
advocate on behalf of clients, possibly explaining increased involvement 
with decision-making and making recommendations about medication.
•
DISCUSSION
• Clinical psychologists are regularly engaging in roles with their client’s 
psychotropic medication. This is despite lack of guidance from 
professional bodies, no professional position statement, and minimal (or 
no) teaching during training.
• Involvement was both driven and justified by the belief that it was 
integral for remaining loyal to personal and professional values, 
frequently noting it was in clients’ ‘best interests’.
Implications
• Teaching on psychotropic medication during training would be helpful 
given the extent to which clinical psychologists are involved.
• Guidelines for clinical psychologists would help provide backing and 
consistency.
Limitations
• Potential for self-selection bias although attempts were made to control 
for this.
Future research
• Future research may work towards creating guidelines for clinical 
psychologists on working with psychotropic medication in practice. This 
might be done using consensus methods, such as a Delphi approach.
OBJECTIVES
1. What accounts do clinical psychologists provide in terms of their 
involvement in clients’ experience or use of psychotropic medication?
2. What rationales or reasons do clinical psychologists provide for the 
choices they make in this involvement?’
STUDY PROCEDURE
Online survey 
(147 responses)
Survey data analysed & deductive 
framework created
Intensity sampling: 11 participants 
interviewed
Inductive-deductive thematic analysis 
on transcripts
Results synthesised
